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“Learn	from	yesterday,	live	for	today,	hope	for	tomorrow.	The	important	
thing	is	not	to	stop	questioning.	Curiosity	has	its	own	reason	for	
existing.”	
	
Albert	Einstein
	 2	
  
	
Acknowledgements	
	
I	have	really	enjoyed	my	time	during	my	PhD	and	I	owe	it	to	all	of	the	individuals	that	
have	contributed	to	making	it	such	a	positive	experience.	Firstly,	 I	am	very	grateful	
to	my	supervisor	Professor	Paul	Evans	for	being	a	great	mentor,	for	all	the	guidance,	
constant	support	provided	over	the	past	years	and	for	encouraging	me	to	always	aim	
higher.	I	would	like	to	thank	all	members	of	the	Evans’	group	(Dr.	Shuang	Feng,	Dr.	
Matthew	Bryan,	Dr.	Hayley	Duckles,	Dr.	 Ismael	Gauci,	Dr.	Rosemary	Kim,	Ms.	Britta	
Moers,	Mr.	Neil	Bowden	and	Mr.	Giannis	Xanthis	)	for	their	support	with	my	project.	
A	special	thanks	to	Dr.	Sarah	Hsiao	and	Dr.	Jovana	Serbanovic-Canic;	not	only	that	I	
am	very	grateful	for	your	support,	I	am	thankful	for	your	friendship,	for	making	the	
tough	times	much	easier	to	deal	with	and,	of	course,	 for	being	great	company	and	
making	my	time	very	enjoyable!	I	couldn’t	have	wished	for	better	colleagues!	I	would	
also	like	to	thank	everyone	on	O-Floor	and	members	of	the	IICD	department	for	their	
help	and	support	over	the	years.	 In	particular,	Professor	Sheila	Francis	for	her	help	
and	 contribution	 to	 my	 project.	 I	 also	 wish	 to	 acknowledge	 Dr.	 Mark	 Ariaans	
(University	of	Sheffield)	and	Ms.	Ruoyu	Xing	and	Dr.	Kim	Van	der	Heiden	 (Erasmus	
MC)	for	their	help	and	valuable	contribution	with	the	cuff-insertion	experiments.		
	
I	am	thankful	to	my	friends	for	the	laughs	and	the	good	times!	Finally,	I	dedicate	all	
of	the	hard	work	that	I	have	put	into	my	PhD	to	my	amazing	parents,	without	your	
never-ending	love	and	support	I	would	not	be	where	I	am	today.	I	am	grateful	to	my	
sisters	and	brother	 for	being	 the	best	siblings	 I	 could	have	ever	asked	 for!	And	 for	
always	motivating	and	supporting	me,	thank	you!	
	
	
	
	
	
	
	
	
	
	 3	
Abstract		
	
Introduction	
Atherosclerosis	is	influenced	by	local	blood	flow	patterns	that	exert	wall	shear	stress	
(WSS)	 on	 endothelial	 cells	 (EC).	 Low,	 oscillatory	WSS	 promotes	 atherosclerosis	 by	
influencing	EC	dysfunction	(inflammation,	permeability	and	proliferation),	while	high	
WSS	 is	 athero-protective.	 A	 recent	 microarray	 study	 by	 our	 laboratory	 of	 EC	 at	
athero-prone	 or	 athero-protective	 WSS	 regions	 of	 the	 porcine	 aorta	 revealed	
differential	 expression	 of	 GATA4	 and	 TWIST1.	 These	 transcriptional	 activators	 can	
promote	 endothelial-mesenchymal	 transition	 (EndMT).	 We	 hypothesised	 that	
GATA4	 and	 TWIST1	may	 control	 EC	 dysfunction	 and	 atherogenesis	 at	 sites	 of	 low	
WSS	by	inducing	EndMT.	
	
Methods	&	Results:	Quantitative	RT-PCR	and	en	face	staining	confirmed	enhanced	
GATA4,	 Twist1	 and	EndMT	marker	 gene	 (Snail,	 Slug	 and	N	 cadherin)	 expression	at	
the	 inner	 curvature	 (lower-WSS)	 compared	 to	 the	outer	 curvature	 (higher-WSS)	of	
porcine	and	murine	aortae.	To	establish	a	causal	 link,	WSS	was	modified	 in	murine	
carotid	 arteries	 using	 a	 constrictive	 cuff,	 this	 elevated	 TWIST1,	 GATA4	 and	 SNAIL	
expression	at	the	low	WSS	site.	EC-specific	deletion	of	Twist1	reduced	SNAIL	and	N-
cadherin	 expression	 and	 proliferation	 at	 the	 inner	 curvature	 of	 the	murine	 aorta.	
Consistent	with	this,	TWIST1	expression	and	EC	proliferation	at	the	inner	curvature	
of	the	murine	aorta	was	reduced	by	EC	deletion	of	GATA4.	Similarly,	Gata4,	Twist1	
and	 EndMT	 effector	 genes	 were	 induced	 in	 PAEC	 or	 HUVEC	 exposed	 to	 low,	
oscillatory	WSS	using	in	vitro	flow	systems.	Gene	silencing	demonstrated	that	GATA4	
and	TWIST1	are	required	for	SNAIL	induction	in	EC	exposed	to	low,	oscillatory	WSS,	
and	 chromatin	 immunoprecipitation	 revealed	 GATA4	 interaction	 with	 Twist1	 and	
Snail.	 Low,	 oscillatory	 WSS	 promoted	 EndMT-characteristic	 changes	 including	 N-
cadherin	 induction,	 VE-cadherin	 disorganization	 and	 enhanced	 proliferation	 and	
migration.	Silencing	of	GATA4,	Twist1	and	Snail	significantly	reduced	these	processes	
alongside	EC	permeability.	These	results	reveal	that	low	WSS	changes	EC	function	via	
GATA4-TWIST1	activation.	
	
Conclusion:	 Low	 WSS	 induces	 EndMT	 and	 subsequent	 EC	 proliferation	 and	
permeability	 through	GATA4	and	 TWIST1.	Our	observations	 illuminate	 for	 the	 first	
time,	 the	 role	 of	 EndMT	 in	 arterial	 biomechanics	 and	 dysfunction.	 Future	 studies	
should	define	the	role	of	EndMT	in	focal	atherosclerosis.		
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1.1	The	vascular	endothelium	
	The	journey	to	the	discovery	of	the	endothelium	began	in	the	4th	century,	where	the	
greek	 polymath,	 Aristotle	 provided	 early	 observations	 for	 the	 existence	 of	 the	
vascular	 architecture	 and	 its	 role	 in	 providing	 a	 “frame”	 for	 the	 support	 of	 the	
organism	 (Aristotle,	 Platt	 1910).	 Until	 the	 1600s,	 it	 was	 believed	 that	 blood	 is	
delivered	to	essential	organs	by	food	consumption	and	that	the	sole	function	of	the	
heart	 was	 to	 provide	 heat	 (Reviewed	 in	 Ribatti	 2009).	 This	 understanding	 was	
changed	 in	 1628,	 when	 William	 Harvey	 provided	 an	 explanation	 for	 the	
cardiovascular	system	function.	He	observed	that	“blood	in	the	animal	body	moves	
around	 in	 a	 circle	 continuously”	 and	 that	 this	 continuous	motion	 is	mediated	by	a	
pumping	action	by	the	heart	(Ribatti	2009;	Harvey	1928).	 It	was	later	discovered	in	
1685	by	Marcello	Malpighi	that	blood	travels	in	capillary,	vessel	structures	(Malpighi	
1685).	In	the	1800s,	it	was	observed	that	the	vessels	are	lined	with	cells	and	the	term	
“endothelium”	 was	 first	 introduced	 by	 Wilhelm	 His	 (His	 1865).	 Further	
morphological	 and	 functional	 analyses	 in	 the	 20th	 century	 established	 the	
understanding	that	the	endothelium	lining	vascular	beds	consists	of	a	monolayer	of	
endothelial	 cells	 (EC),	 attached	 to	 one	 another	 by	 cell-cell	 junctional	 proteins	 and	
that	EC	serve	essential	functions	in	the	embryo	and	in	the	adult.	
	
During	 embryonic	 development,	 EC	 are	 formed	 during	 vasculogenesis	 (De	 Val	 &	
Black	2009).	In	this	process	mesodermal	progenitors	in	the	yolk	sac	and	the	embryo	
differentiate	 to	 form	 the	 primitive	 embryonic	 and	 extraembryonic	 vasculature	
(Flamme	 et	 al.	 1997;	 Patan	 2004).	 The	 early	 embryonic	 vasculature	 is	 then	
remodelled	 via	 angiogenesis	 involving	 the	 essential	 contribution	 of	 EC,	 which	
undergo	sprouting	to	form	new	vessels,	which	subsequently	mature	into	arteries	and	
veins	(Flamme	et	al.,	1997,	Patan,	2004).		
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The	 specification	of	 arteries	 and	 veins	 occurs	 genetically	 via	 the	 expression	of	 the	
ligand	 Ephrin-B2	 (Efnb2),	 Notch	 and	 the	 receptor	 EPH	 Receptor	 B4	 (Ephb4)	 and	
COUP-transcription	 factor	 2	 (COUP-TFII)	 respectively	 (De	 Val	 2011;	 Corada	 et	 al.	
2014).	 Vasculogenesis	 involves	 transcriptional	 regulation	 through	 T-Cell	 acute	
lymphocytic	leukemia	1/	stem	cell	leukemia	(Tal1/SCL),	GATA	binding	protein	(GATA)	
2		transcription	factors	and	Tie2	receptors	(Reviewed	in	De	val	and	Black,	2009).		
	
In	 the	adult,	EC	are	essential	 for	maintaining	vascular	homeostasis.	EC	monolayers	
form	a	selective	barrier	for	the	control	of	the	transport	of	substances	into	the	vessel	
wall	(Reviewed	in	Michiels,	2003).	The	control	of	the	permeability	to	such	substances	
is	 critical	 to	 the	maintenance	of	 a	quiescent,	 healthy	 vasculature.	 EC	 also	 regulate	
vascular	tone	via	establishing	a	balance	between	the	secretion	of	vasodilative	factors	
such	 as	 nitric	 oxide	 (NO)	 and	 vasoconstrictive	 factors	 such	 as	 endothelin	 1	 and	
angiotensin	 2	 (Reviewed	 in	 Michiels	 2003).	 EC	 control	 of	 vascular	 tone	 directly	
affects	 oxygen	 supply	 to	 tissue	 and	 is	 dynamically	 altered	 to	 meet	 metabolic	
demands.	Furthermore,	EC	regulate	blood	coagulation	and	platelet	functions	during	
quiescence	 and	 during	 vessel	 damage	 and	 inflammation	 (Reviewed	 in	 Michiels	
2003).	
	
	
In	 summary	 EC	 regulate	 the	 balance	 between	 vasodilative,	 and	 non-vasoldilative,	
inflammatory	 and	 non-inflammatory	 signalling	 pathways	 depending	 on	 the	
environment	 to	 mediate	 vascular	 homeostasis.	 A	 failure	 of	 EC	 to	 establish	 such	
balance	 triggers	 EC	 dysfunction,	 which	 is	 central	 to	 the	 development	 of	
atherosclerosis	(Reviewed	in	Libby	2002).	
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1.2	Atherosclerosis	and	EC	dysfunction	
1.2.1	Atherosclerosis	pathophysiology	
Atherosclerosis	 a	 disease	 that	 underlies	 cardiovascular	 diseases	 and	 stroke,	 is	
characterised	 by	 chronic	 inflammatory	 activation	 of	 EC.	 Alongside	 genetic	 pre-
disposition,	atherosclerosis	is	promoted	by	the	presence	of	systemic	risk	factors	such	
as	the	presence	of	low-density	lipoproteins	(LDL)	in	the	circulating	blood.	
	
The	 initial	 step	 in	 atherogenesis	 is	 the	 transport	of	 circulating	 LDL	 into	 the	 intimal	
layer	of	the	arterial	wall	(Libby,	2002;	Wentzel	et	al,	2012)	(Figure.	1)	.	After	moving	
into	the	sub-	endothelial	cell	space,	LDL	becomes	oxidised	by	reactive	oxygen	species	
(ROS)	(Mabile	et	al,	1997).	Oxidised	LDL	(ox-LDL)	initiate	inflammatory	activation	of	
endothelial	 cells	 (EC)	 (Libby,	 2002;	Witztum,	 1994).	 This	 promotes	 the	 production	
pro-inflammatory	cytokines	(such	as	interleukin	(IL-1),	tumour	necrosis	factor	(TNF)-
α	and	monocyte	chemoattractant	protein	(MCP)-1)	and	the	expression	of	adhesion	
molecules	 on	 the	 EC	 surface	 such	 as	 vascular	 cell	 adhesion	 protein	 	 (VCAM)-1,	
intercellular	 adhesion	molecule	 (ICAM)-1,	 P	 and	 E-selectins	which	 together	 initiate	
the	 leukocyte	 adhesion	 cascade	 (Witztum,	 1994;	 Libby,	 2002).	 Once	 monocytes	
transmigrate	and	 infiltrate	 into	the	vessel	wall	 they	differentiate	 into	macrophages	
and	begin	 to	 take	up	ox-LDL	particles.	 This	 results	 in	 the	differentiation	 into	 foam	
cells,	resulting	in	the	formation	of	fatty	streaks.	The	secretion	of	foam	cells	of	matrix	
metalloproteinases	(MMPs)	and	ROS	further	sustains	the	inflammatory	response	and	
promotes	 the	 development	 of	 an	 atherosclerotic	 plaque	 (Stoneman	 &	 Bennett	
2004).	
	
	Advanced	 atherosclerotic	 lesions	 consist	 of	 a	 necrotic	 core	 of	 cells,	macrophages,	
leukocytes,	 ox-LDLs	 and	 cellular	 debris,	 which	 all	 continue	 to	 augment	 the	
inflammatory	response	(Rader	and	Daugherty;	2008;	Wentzel	et	al,	2012;	Schaar	et	
al,	2004).		
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Figure	 1.	 Atherosclerosis	 lesion	 formation.	 LDL	 that	 have	 transported	 into	 the	 sub	 endothelial	
space	 in	 the	 vascular	 intima,	 become	 oxidised	 by	 ROS,	 giving	 rise	 to	 ox-LDL.	 This	 triggers	 EC	
inflammatory	 activation,	 followed	 by	 the	 release	 of	 cytokines	 and	 the	 expression	 of	 adhesion	
proteins	 (VCAM-1,	 ICAM-1	 and	 E-selectin)	 on	 the	 EC	 surface	 ,	 which	 mediate	 monocyte	
infiltration.	 Monocytes	 differentiate	 into	 macrophages	 and	 take	 up	 ox-LDL.	 This	 transforms	
macrophages	into	foam	cells,	which	exacerbate	the	inflammatory	response	by	releasing	ROS	and	
cytokines.	 This	 creates	 a	 positive	 feedback	 on	 EC	 inflammatory	 activation,	 promoting	 the	
recruitment	of	 lymphocytes.	Macrophage	necrosis	and	further	 inflammatory	signalling	gives	rise	
to	an	atherosclerotic	plaque,	which	consists	of	a	necrotic	core	that	is	surrounded	by	a	fibrotic	cap.	
Figure	1.	Atherosclerosis	lesion	formation	
	 15	
The	plaque	may	obstruct	blood	 flow	and	this	consequently	 limits	oxygen	supply	 to	
major	organs,	resulting	in	ischemic	damage	(Wentzel	et	al,	2012).	Alternatively,	the	
plaque	may	 undergo	 outward	 remodelling	which	 preserves	 the	 dimensions	 of	 the	
lumen	that	it	exists	within	(Glagov	et	al.	1992).	This	remodelling	along	with	the	force	
induced	 by	 the	 flowing	 blood	 can	 render	 the	 plaque	 susceptible	 to	 rupture	 and	
subsequent	thrombus	formation	(Libby,	2002).	
1.2.2	EC	dysfunction	in	atherogenesis	
EC	dysfunction	in	response	to	oxidative	agents	such	as	ox-LDL	and	disruption	of	the	
EC	barrier	function	is	a	critical	step	in	the	formation	of	atherosclerosis	(Reviewed	in	
Libby	et	al.,	2002,	Michiels,	2003).	Numerous	studies	have	linked	EC	dysfunction	with	
atherosclerosis	and	have	identified	EC	dysfunction	as	a	predictor	for	atheroseverity	
(Choi	et	al.	 2014;	 Schächinger	et	al.	 1994;	Halcox	et	al.	 2002)	Therefore,	 therapies	
that	 are	 known	 to	 treat	 atherosclerosis	 are	 targeted	 towards	 correcting	 EC	
dysfunction	by	promoting	anti-oxidative	and	anti-inflammatory	signalling	(Davignon	
&	 Ganz	 2004).	 Such	 successful	 therapies	 include	 statins	 which	 lower	 cholesterol	
content	 from	 the	 blood,	 thus	 inhibiting	 inflammation	 (Gould	 et	 al.	 1994;	 Kinlay	&	
Ganz	 2000;	 Laufs	 et	 al.	 1998)	 and	 antioxidant	 mediators	 such	 as	 sulforaphane	
(Zakkar	et	al.	2008;	Evans	2011)	and	reservatol	(Berbée	et	al.	2013).		
	
EC	dysfunction	 involves	 changes	 in	 cell	 function,	 including	 increased	 inflammation,	
proliferation	 and	 permeability,	 which	 influence	 one	 another	 (Figure	 2).	 EC	
inflammation	 is	 mediated	 by	 NF-κB,	 p38	 and	 JNK	 MAPK	 signalling	 (Reviewed	 in	
(Kempe	et	al.	2005;	Kyriakis	&	Avruch	2001).	The	direct	effect	of	NF-κB	signalling	in	
atherosclerosis	 has	 been	 demonstrated	 by	 studies	 showing	 a	marked	 reduction	 in	
atherosclerosis	 development	 as	 a	 result	 of	 genetic	 inhibition	of	NF-κB	 signalling	 in	
murine	atherosclerotic	murine	models	(Gareus	et	al.	2008;	Wolfrum	et	al.	2007).	NF-
κB,	p38	and	 JNK	MAPK	signalling	 inflammatory	pathways	sustain	EC	activation	and	
initiate	 the	 leukocyte	 adhesion	 cascade	 in	 EC,	 which	 results	 in	 an	 increase	 in	 EC	
permeability	 via	 vascular	 endothelial	 (VE)-cadherin	 proteolysis,	 to	 facilitate	
leukocyte	infiltration	(Miyazaki	et	al.	2011;	Zoja	et	al.	2002).	This	results	in	a	further	
increase	in	the	uptake	of	LDL	molecules	and	subsequently	increased	inflammation.		
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Figure	 2.	 EC	 dysfunction.	 Quiescent	 EC	 control	 a	 balance	 between	 pro	 and	 anti	
inflammatory	 pathways	 which	 cause	 a	 low	 rate	 of	 inflammation,	 proliferation	 and	
permeability	 that	maintains	tissue	homeostasis.	 EC	 loss	of	 this	balance	between	pro	and	
anti	 inflammatory,	 proliferative	 pathways	 results	 in	 an	 increase	 in	 inflammation,	
proliferation	and	permeability,	which	mediates	atherosclerosis.	
Figure	2.	EC	dysfunction	
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Proatherogenic	 agents	 (such	 as,	 TNF-α	 and	 ox-LDL)	 also	 trigger	 EC	 apoptosis	 and	
proliferation,	leading	to	elevated	cell	turnover	(Chaudhury	et	al.	2010;	Foteinos	et	al.	
2008;	 Hansson	 et	 al.	 1985;	 	 Davies	 et	 al.	 1986).	 This	 is	 partly	 mediated	 by	 JNK	
inflammatory	signalling,	which	has	a	direct	effect	on	EC	turnover	 (Chaudhury	et	al.	
2010;	Chen	et	al.	2011;	Han,	Y	,	Moon,	J	You,	R,	Kim,	S.	Z.,	Kim,	S.	H.,	Park	2009).	Cell	
turnover,	in	turn,	results	in	a	transient	loss	of	EC-EC	contacts	(Cancel	&	Tarbell	2011;	
Cancel	 &	 Tarbell	 2010;	 Birukova	 et	 al.	 2004;	 Forteinos	 et	 al.	 2008)	 this	 further	
exacerbates	 permeability	 and	 inflammation.	 Moreover,	 increased	 EC	 proliferation	
promotes	oxidative	 stress,	which	 contributes	 to	 furthering	 inflammatory	activation	
(Schaefer	et	 al.	 2006;	Dong	et	al.	 2005).	Guevera	et	al.	 demonstrated	 that	 genetic	
deletion	of	the	cell	cycle	regulator	p53	resulted	in	an	increase	in	EC	proliferation	and	
increased	atheroseverity	(Guevara	et	al.	1999),	thus	suggesting	that	EC	proliferation	
plays	a	dominant	role	in	atherogenesis.	Consistent	with	this,	genetic	deletion	of	JNK	
lowered	 EC	 proliferation	 and	 inhibited	 atherosclerosis	 development	 (Amini	 et	 al.	
2014),	 which	 further	 demonstrates	 the	 importance	 of	 EC	 proliferation	 in	 EC	
dysfunction	and	atherosclerosis.	
	
Taken	together,	EC	inflammation,	proliferation	and	permeability	in	dysfunctional	EC,	
positively	 feedback	 onto	 one	 another	 and	 contribute	 to	 the	 progression	 of	
atherosclerotic	lesion	formation	and	influence	atherosclerosis	development.		
	
	
1.3	Wall	shear	stress	(WSS)	
EC	 lining	 the	vessel	wall	 are	exposed	 to	mechanical	 stresses	 that	are	mediated	via	
the	 presence	 of	 pulsatile	 blood	 flow;	 these	 include	 circumferential	 stress,	 axial	
stress,	and	wall	shear	stress	(WSS)	(Hoefer	et	al.	2013).	WSS,	measured	in	dyne/cm2	
or	 in	pascals	(Pa=N/m2;	1	dyne/cm2=	0.1	Pa)	 is	defined	as	the	tangential	drag	force	
that	is	produced	by	the	movement	of	blood	flow	on	the	surface	of	the	endothelium	
(Cheng	et	al.	2006).	WSS	magnitude	is	directly	proportional	to	blood	viscosity	and	is	
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highly	dependent	on	the	vessel	radius,	the	bigger	the	radius,	the	lower	the	WSS	and	
vice	versa	 (Davies	2009).	WSS	measurements	can	be	derived	using	Poiseuille’s	 law.	
The	Hagen-	Poiseuille	equation	is	used	to	model	blood	flow	characteristics	of	steady,	
laminar	blood	flow	through	a	straight,	circular	tube;	
	
τ=4μQ/πR3	
	
	
The	Hagen-	Poiseuille	equation	shows	that	shear	stress	(τ)	is	directly	proportional	to	
the	 velocity	 of	 the	 fluid,	 the	 flow	 rate	 (Q)	 and	 fluid	 viscosity	 (μ).	 Flow	 velocity	 is	
directly	 determined	 by	 the	 flow	 rate	 (defined	 as	 volume	 of	 blood/	 time)	which	 in	
turn	is	dependent	on	the	arterial	radius.	Shear	stress	is	inversely	proportional	to	the	
arterial	 radius	 (R)	 (Davies,	 2009).	 	WSS	 values	 in	 large	 arteries	 such	 as	 the	 aorta,	
descending	 thoracic	 aorta	 and	 carotid	 arteries	 range	 between	 5-20	 dyne/cm2	 in	
human	and	porcine	systems	(Cheng	et	al.,	2006).	Whereas	in	the	murine	system,	due	
to	smaller	vasculature	diameters	these	values	range	between	20-250	dyne/cm2	(Suo	
et	al.	2007).	
	
	
The	Posieulle	equation	measures	blood	flow	characteristics	through	a	straight	vessel	
(non-disturbed	 flow),	 however	 at	 areas	 of	 complex	 geometry	 such	 as	 at	 branches	
and	 bends,	 blood	 flow	 directionality	 becomes	 altered	 (disturbed	 flow).	 Reynolds	
number	 (Re)	 is	used	to	define	changes	 in	 flow	directionality.	Reynolds	number	 is	a	
dimensionless	ratio	of	blood	flow	inertial	and	viscous	forces;	
	
	
Re=	inertial	forces/	viscous	forces=	ρVD/μ	
	
In	the	Reynolds	equation,	ρ	is	the	density	of	blood,	V	is	the	velocity,	D	is	the	vessel	
diameter	and	μ	is	blood	viscosity.	High	Reynolds	numbers	(≥4000)	are	reflective	of	a	
dominance	of	inertial	forces	over	viscous	forces,	and	are	used	to	describe	turbulent	
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flow.	Whereas	a	low	Re	number	is	reflective	of	a	dominance	of	viscous	forces	and	
thus	laminar	flow	(Davies	et	al.,	2009).	
	
	
1.3.1	EC	mechanosensing	of	WSS	
EC	translate	external	mechanical	signals	generated	by	WSS	into	biomolecular	events	
through	mechanosensing.	Several	mechanisms	have	been	postulated	to	mediate	EC	
mechanosensing.	 Tzima	 et	 al.	 identified	 a	 mechanosensory	 protein	 complex	
consisting	 of	 cluster	 of	 differentiation	 31	 (CD31),	 VE-cadherin	 and	 vascular	
endothelial	cell	growth	factor	receptor	(VEGFR)	2	on	the	cell	surface	that	mediates	
downstream	signalling	 in	response	to	WSS	(Tzima	et	al.	2005;	Conway	et	al.	2013).	
Furthermore,	cell	surface	proteins	such	as	glycocalyx	glycoproteins	and	the	primary	
cilium	were	 shown	 to	 control	 calcium	signalling	and	NO	production	 in	 response	 to	
WSS,	which	further	regulate	other	signalling	pathways	in	EC	(Yao	et	al.	2007;	Florian	
et	al.	2003;	Nauli	et	al.	2008).	 Integrins	are	heterodimeric	α/β	 chains	 that	mediate	
cell–extracellular	 matrix	 interaction.	 Integrins	 transduce	 signalling	 downstream	 of	
mechanosensors,	 depending	 on	 the	 cellular	 context,	 thus	 acting	 as	 mechanical	
switches	(Shyy	&	Chien	2002;	Ingber	1991;	Ingber	1998).	However	it	is	unlikely	that	
the	 EC	 mechanotransduction	 is	 controlled	 by	 the	 activation	 of	 a	 single	
mechanosensor.	The	EC	cytoskeleton	 is	physically	 linked	via	protein	 interactions	 to	
all	 of	 the	mechanosensors	mentioned	 above,	 thus	WSS-mediated	 deformations	 is	
likely	 to	 alter	 the	 activation	 of	 numerous	 mechanosensors	 at	 the	 same	 time,	
resulting	 in	a	wide	mechano-response	 in	EC.	 In	 summary,	EC	sense	WSS	 through	a	
number	 of	 mechanosensors	 and	 it	 is	 unknown	 whether	 there	 is	 a	 preferential	
activation	 of	 a	 combination	 of	 specific	 mechanosensors	 in	 response	 to	 certain	
magnitudes	 of	WSS,	 or	 whether	 the	 same	mechanosensors	 are	 activated	 by	WSS	
which	 then	 regulate	 downstream	 signalling	 events	 depending	 on	 the	 WSS	
magnitude.	
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1.3.2	WSS	and	EC	function	
EC	mechanotransduction	 in	 response	 to	WSS	 results	 in	 the	 activation	 of	 signalling	
events	that	promote	transcriptional	and	epigenetic	changes,	which	in	turn	change	EC	
function	(Brooks	et	al.	2012;	Passerini	et	al.	2004;	Dunn	et	al.	2014;	Jiang	et	al.	2015).	
In	vitro	experiments	have	enabled	testing	the	direct	effects	of	the	exposure	of	WSS	
on	EC	function	as	a	result	of	global	transcriptional	changes	(summarised	in	table	1).	
Cytoskeletal	reorganisations	in	response	to	WSS	almost	occur	instantaneously,	which	
subsequently	cause	changes	in	cell	morphology	(following	≥24h	of	exposure	to	WSS).	
EC	 exposed	 to	 low	WSS	 display	 a	 round,	 cobble-stone	morphology,	 whereas	 cells	
exposed	to	high	WSS	display	an	elongated,	aligned	morphology	(Brooks	et	al.	2012;		
Davies	et	al.	1986;	Coon	et	al.	2015;	Hahn	et	al.	2011).	
	
	Proinflammatory	signalling	pathways	such	as	p38	MAPK,	NF-κB	become	activated	in	
cells	 exposed	 to	 low	WSS,	 whilst	 being	 suppressed	 in	 cells	 exposed	 to	 high	 WSS	
(Brooks	et	al.	2012;	Passerini	et	al.	2004;	Orr	et	al.	2005;	SenBanerjee	et	al.	2004).	
This	promotes	the	expression	of	inflammatory	molecules	such	as	VCAM-1,	E-selectin	
and	MCP1	(Brooks	et	al.,	2004,	Davies	et	al.,	1986,	Orr	et	al.,	2005).	Consistent	with	
this,	antioxidant	molecules	involved	in	anti-inflammatory	signalling	such	as	kruppel-
like	factor	(KLF)	2,	KLF	4,	nuclear	factor	(erythroid-derived)	 	 (Nrf)	2	and	endothelial	
nitric	oxide	synthase	(eNOS)	show	increased	expression	in	cells	exposed	to	high	WSS,	
whilst	being	suppressed	in	cells	exposed	to	low	WSS	(Brooks	et	al.	2012;	Fang	et	al.	
2010;	Chien	2008;	Jiang	et	al.	2015;	Fledderus	et	al.	2007).	Thus,	cells	exposed	to	low	
WSS	in	vitro	display	increased	inflammatory	activation	compared	to	cells	exposed	to	
high	WSS	that	are	anti-inflammatory.	Moreover,	cells	exposed	to	low	WSS	display	an	
increase	 in	 pathways	 that	 promote	 cell	 cycle	 progression,	 including	 Transforming	
growth	 factor	 β	 (TGF-β)	 signaling	 via	 Smad1/5	 and	 p38	 signalling,	 leading	 to	
increased	turnover	compared	to	cells	exposed	to	high	WSS	(Davies	et	al.	1986;	Zhou	
et	 al.	 2012).	 In	 addition,	 following	 the	 exposure	 to	 low	WSS,	 EC	 display	 higher	 EC	
permeability	(Miao	et	al.	2005;	Sill	et	al.	1995;	Orsenigo	et	al.	2012).		
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Table	1.	Summary	of	EC	functions	that	are	differentially	regulated	by	exposure	to	WSS	in	vitro	
EC	function	 Exposure	to		
high	WSS	
Exposure	to	
	low	WSS	
Reference	
Inflammation	 	
Low	
	
High	
(Chaudhury	et	
al.,2010,	Passerini	et	
al.,	2004,	Davies	et	
al.,	2001,	Brooks	et	
al.,	2004)	
Proliferation	 	
Low	
	
High	
(Davies	et	al.,	1986,	
Brooks	et	al.,	2004)	
Permeability	 	
Low	
	
High	
(Warboys	et	al.,	
2010,	Ding	et	al.,	
2012,	Orsenigo	et	
al.,	2013)	
Migration	 	
Low	
	
High	
Tressel	et	al.,	2007,	
Syzimanski	et	al.,	
2008)	
Apoptosis	 	
Low	
	
High	
(Davies	et	al.,	1986,	
Passerini	et	al.,	
2004,	Brooks	et	al.,	
2004)	
Oxidative	stress	 	
Low	
	
High	
(Fang	et	al.,	2009,	
Jiang	et	al.,	2014,	
Zakkar	et	al.,	2008,	
Chien	et	al.,	2008)			 	
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Several	mechanisms	have	been	 implicated,	 one	of	 these	mechanisms	proposed	by	
the	Dejana	group	involves	VE-cadherin	phosphorylation	by	Src	kinases	that	promote	
VE-cadherin	degradation	and	a	subsequent	increase	in	EC	junctional	permeability	to	
macromolecules	 (Orsenigo	 et	 al.	 2012).	 A	 second	 mechanism	 is	 proposed	 by	 the	
Weinberg	 group	 this	 involves	 a	 pathway	 involving	 phosphatidylinositol-4,5-
bisphosphate	 3-kinase(PI3K)	 and	 NO	 signalling,	 which	 in	 turn	 could	 contribute	 in	
explaining	the	anti-inflammatory	effects	of	NO	on	EC,	by	linking	EC	permeability	and	
inflammatory	 protection	 in	 cells	 exposed	 to	 high	 WSS	 (Warboys	 et	 al.	 2010).	
Therefore	cells	exposed	to	low	WSS	have	higher	junctional	permeability	compared	to	
cells	exposed	to	high	WSS.	
	
In	 summary,	 in	 vitro	 studies	 on	 EC	 exposed	 to	 WSS,	 have	 demonstrated	 that	 EC	
inflammation,	proliferation	and	permeability,	processes	that	underlie	EC	dysfunction	
are	 enhanced	 in	 cells	 exposed	 to	 low	 WSS.	 Whereas,	 cells	 exposed	 to	 high	 WSS	
display	a	quiescent	phenotype.	This	suggests	that	blood-flow	generated	WSS	plays	a	
direct	 role	 in	 altering	 EC	 phenotype	 in	 vivo	 and	 subsequent	 vascular	 disease	
susceptibility.		
1.4	Focal	atherosclerosis	and	shear	stress	
Despite	 the	presence	of	 systemic	 and	 genetic	 risk	 factors,	 atherosclerosis	 shows	 a	
non-random	 distribution	 in	 the	 vasculature,	 with	 atherosclerotic	 plaques	
preferentially	developing	at	branches	and	bends	(Figure.	3).	At	these	sites	blood	flow	
exerts	 low	 WSS	 (time-averaged	 mean	 value	 approximately	 5	 dyne/cm2),	 whereas	
atheroprotected	 areas	 are	 subjected	 to	 relatively	 high	WSS	 (time-averaged	 mean	
value	approximately	15	dyne/cm2)	(Figure	4).	The	establishment	of	the	effect	of	WSS	
on	atherogenesis	was	derived	based	on	the	cumulative	contribution	of	early	studies;	
More	 than	 five	 centuries	ago,	 the	great	 scholar	 Leonardo	Da	Vinci	was	 the	 first	 to	
observe	that	atherosclerosis	formation	in	large	arteries	was	focal	and	postulated	the	
involvement	of	mechanical	forces	in	disease	pathology	(Keele	&	KD.	1952).	
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Figure	3.	Focal	atherosclerosis	development																 							
	
	
	
	
	
	
	
	
	 	
Figure	 3.	 Focal	 atherosclerosis	 development.	 Atherosclerosis	 (plaques	 depicted	 as	 purple)	
shows	a	non-random	distribution	 in	the	vasculature,	where	plaques	 tend	to	occur	at	regions	
that	 contain	 bends	 and	 branches;	 1)	 Aortic	 sinus,	 2)	 Inner	 aortic	 curvature,	 3)Right	 carotid	
artery,	 4)	 Left	 carotid	 artery,	 5)	 Subclavian	 artery,	 6)	 Thoracic	 descending	 aorta,	 7)	 Renal	
artery,	8)	Iliac	artery.	
1	
2	
3	 4	
5	
6	
7	 7	
8 8	
	 24	
	
	
Figure	4.	WSS	patterns	in	the	porcine	aorta	 	
High	WSS	Unidirec(onal,	high	WSS	
(Atheroprotected)	
Oscillatory,	low	WSS	
(Atherosuscep(ble)	
Figure	4.	WSS	patterns	in	the	porcine	aorta.	WSS	(Pa;	N/m2)	magnitudes	are	indicated	in	the	WSS	
scale	on	the	right.	At	 the	 inner	curvature	of	the	porcine	aortic	arch,	blood	 flow	exerts	oscillatory,	
low	 WSS.	 These	 regions	 are	 atherosusceptible.	 Whereas,	 at	 the	 outer	 curvature,	 flow	 exerts	
unidirectional,	 high	 WSS,	 which	 is	 atheroprotective.	 Image	 courtesy	 of	 Serbanovic-Canic,	 et	 al.	
Manuscript	submitted.	
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In	the	19th	century,	pathologists	Rokitansky	and	Virchow	concluded	that	differences	
in	blood	flow	in	the	arterial	tree	differentially	promoted	lipid	deposition	and	intimal	
thickening	 (Rokitansky	 1855;	 Virchow	 1971).	 In	 1966,	 Caro	 et	 al.	defined	 the	 flow	
characteristics	that	correlated	with	atherosclerosis	based	on	simplified	modelling	of	
blood	flow	in	the	circulation,	Caro	et	al.,	measured	the	dispersion	of	a	water	and	dye	
mixture	 through	 curved	 tubes.	 The	 observation	 correlated	 geometrical	 influences	
with	 varied	 flow	 pattern	 characteristics,	 and	 it	 was	 proposed	 that	 regions	 of	 the	
arterial	 tree	 containing	 bends	 and	 branches	 are	 exposed	 to	 flow	 disturbances	 as	
opposed	to	non-disturbed	flow	which	occurs	at	straight	and	unbranched	regions	of	
the	 arterial	 tree	 (Caro	 1966).	 Further	 experimental	work	 by	 Caro	et	 al	 on	 autopsy	
derived	 aortic	 casts	 showed	 that	 the	 regions	 of	 arterial	 vessels	 at	 bends	 and	
bifurcations	were	subjected	to	a	low,	oscillatory	WSS	(disturbed	flow),	while	straight	
and	un-branched	regions	were	subjected	to	unidirectional,	high	WSS	(non-disturbed	
flow)	 (Caro	 et	 al,	 1971).	 Moreover,	 Caro	 et	 al	 noted	 that	 the	 distribution	 of	
atherosclerotic	 lesion	in	the	arterial	tree	correlated	with	 low,	oscillatory	WSS	(Caro	
et	al,	1971).	
	
In	vivo	 investigations	in	animal	model	systems	further	established	the	link	between	
low,	 oscillatory	 WSS	 and	 the	 spatial	 distribution	 of	 atherosclerotic	 plaques	
(Gambillara	et	 al,	 2006a;	 Buchanan	et	 al,	 1999;	 Cornhill	 and	 Roach,	 1976).	 In	 vivo	
experimentation	 involving	 computational	 fluid	 dynamics,	 coronary	 angiography	
along	 with	 magnetic	 resonance	 imaging	 provided	 a	 quantitative	 measure	 of	 WSS	
characteristics	and	the	correlation	with	atherosclerotic	plaque	distribution	(Wentzel	
et	al,	2005;	Stone	et	al,	2003;	Steinman,	2002;	Suo	et	al,	2007).	Cheng	et	al	designed	
a	 system	 in	 which	 the	 causal	 relationship	 between	 haemodynamic	 forces	 and	
atherogenesis	was	established,	the	experimental	procedure	involved	the	insertion	of	
a	 constrictive	 cuff	 into	 the	 carotid	 arteries	 of	 atherosusceptible	 (high	 fat	 diet	 fed,	
apolipoprotein	E	(ApoE)	-/-)	mice.	The	cuff	altered	flow,	giving	rise	to	high	WSS	within	
the	 constriction,	 low	 unidirectional	 WSS	 upstream	 and	 low,	 oscillatory	 WSS	
downstream	of	the	constriction.	Following	6	weeks	of	cuff	insertion,	atherosclerotic	
plaques	 occurred	 at	 regions	 subjected	 to	 low	WSS	 (upstream	 and	 downstream	 of	
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cuff	 constriction),	 thus	 revealing	 that	 low	 WSS	 directly	 promoted	 atherosclerosis	
(Cheng	et	al,	2006).			
1.4.1	Low	WSS	promotes	EC	dysfunction	
1.4.1.1	Inflammatory	activation	
In	vivo	 studies	have	 reported	 that	atheroprone,	 low	WSS	promotes	EC	dysfunction	
(EC	 inflammation,	 proliferation	 and	 permeability)	 and	 that	 high	WSS	 promotes	 EC	
quiescence.	Studies	by	our	group	and	others	on	 the	murine	aorta	aortic	arch	have	
demonstrated	 that	 pro-inflammatory	 NF-κB,	 p38	 and	 JNK	 MAPK	 signalling	
preferentially	occurred	at	sites	of	low	WSS	(inner	curvature)	compared	to	regions	of	
high	 WSS	 (outer	 curvature)	 (Cuhlmann	 et	 al.	 2011;	 Chaudhury	 et	 al.	 2010).	 The	
activation	 of	 these	 pathways	 increased	 EC	 inflammation	 and	 proliferation,	 thus	
suggesting	 that	 low	 WSS	 promoted	 EC	 dysfunction	 via	 enhanced	 inflammatory	
signalling.	 Consistent	with	 this,	 anti-inflammatory,	 anti-oxidant	 signalling	mediated	
by	Nrf2,	KLF2	and	KLF4	was	inhibited	in	EC	at	sites	of	low	WSS	and	activated	in	EC	at	
sites	of	high	WSS	(Fledderus	et	al.	2007;	Fang	et	al.	2010;	Jiang	et	al.	2015;	Zakkar	et	
al.	2009;	Chien	2008).	Causal	evidence	for	the	activation	of	EC	inflammation	by	low	
WSS	provided	by	Cuhlmann	et	al,	following	the	insertion	of	a	flow	constrictive	cuff	it	
was	 evident	 that	 RelA	 (a	 member	 of	 the	 NF-κB	 family	 proteins)	 and	 VCAM-1	
expression	was	markedly	 increased	at	 sites	exposed	 to	 low	WSS	compared	 to	high	
WSS	 (Cuhlmann	 et	 al,	 2011).	 Thus,	 demonstrating	 that	 low	 WSS	 triggers	 EC	
inflammatory	 activation	 and	 athero-susceptibility,	 whereas	 high	WSS	 is	 protective	
(Cuhlmann	et	al,	2011,	Jiang	et	al,	2015,	Fang	et	al,	2010).	
1.4.1.2	Proliferation	
It	was	reported	by	Wright	in	1972,	that	EC	mitosis	was	enhanced	at	sites	of	low	WSS,	
suggesting	 that	 low	 WSS	 promoted	 EC	 proliferation	 (Wright,	 1972).	 It	 was	 later	
proposed	 that	 the	preferential	 increase	 in	EC	proliferation	at	 low	WSS	 is	mediated	
via	 Smad1/5	 signalling	 (Zhou	 et	 al,	 2012),	 JNK	MAPK	 signalling	 (Chaudhury	 et	 al.,	
2008)	and	by	p21-mediated	mechanisms	 (Obikane	et	al.	2007).	These	studies	have	
demonstrated	 that	 EC	 proliferation	 is	 preferentially	 enhanced	 at	 low	 WSS	 sites.	
Inhibition	 of	 JNK	 signalling,	 reduced	 EC	 proliferation	 and	 apoptosis	 at	 sites	 of	 low	
	 27	
WSS	and	gave	rise	to	a	marked	reduction	in	atherosclerosis	development	(Amini	et	
al.	2014).	Moreover,	EC	proliferation	at	low	WSS	sites	in	vivo	correlates	with	is	ROS	
generation,	 DNA-damage	 and	 senescence,	 all	 of	 which	 have	 been	 linked	 with	
inflammatory	 activation	 (	 Reviewed	 in	 Andreassi	 2008;	Warboys	 et	 al.	 2014).	 This	
reflects	 the	 relationship	 between	 low	 WSS-mediated	 EC	 inflammation	 and	
proliferation	during	EC	dysfunction.		
	
1.4.1.3	Permeability	
	Studies	by	the	Weinberg	group	have	shown	that	EC	uptake	of	macromolecules	was	
enhanced	at	bends	and	branches	(areas	of	 low,	oscillatory	WSS)	in	the	arterial	tree	
of	 rabbit	 and	murine	models	 (Staughton	 et	 al.	 2001;	 Clarke	 et	 al.	 2012;	Mohri	 &	
Weinberg	2012).	Moreover,	 the	Weinberg	group	has	shown	that	 the	enhancement	
of	 EC	 permeability	 is	 a	 direct	 response	 to	 low	 WSS.	 Mohri	 et	 al.,	 measured	 EC	
permeability	 in	 constrictive-cuff	 inserted	 mouse	 carotid	 arteries.	 It	 was	
demonstrated	 that	 EC	 permeability	 as	 measured	 by	 tracer	 fluorescence	 was	
markedly	 increased	 at	 regions	 upstream	 and	 downstream	 of	 cuff	 constriction	 and	
that	 these	 sites	 correlated	 with	 plaque	 formation	 in	 ApoE-/-	 mice	 sites,	 thus	
indicating	 that	 low	 WSS	 directly	 caused	 an	 increase	 in	 EC	 permeability	 and	
subsequently	atherogenesis	 (Mohri	&	Weinberg	2012).	Observations	 in	the	porcine	
aorta	by	Conklin	et	al.,	also	showed	that	EC	permeability	was	enhanced	at	low	WSS	
sites	in	the	arterial	tree	(Conklin	et	al.	2002).	These	studies	therefore	show	that	low	
WSS	 promotes	 EC	 permeability	 in	 vivo.	 As	 proposed	 by	 Miyazaki	 et	 al.,	 the	
mechanism	controlling	EC	permeability	involves	VE-cadherin	proteolysis	via	calpain.	
This	in	turn	gives	rise	to	VE-cadherin	junctional	disorganisation	and	a	loss	of	the	EC-
barrier	 function	 and	 subsequent	 inflammation	 (Miyazaki	 et	 al.	 2011).	 Another	
mechanism	 for	 enhanced	 cell	 permeability	 at	 sites	 of	 low	 WSS	 is	 due	 to	 a	
consequence	of	increased	cell	turnover,	which	consequently	gives	rise	to	a	transient	
loss	 of	 EC	 contacts	 (Cancel	&	 Tarbell	 2010;	 Cancel	&	 Tarbell	 2011;	 Birukova	 et	 al.	
2004).	
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Figure	5.	Summary	of	WSS-mediated	regulation	of	focal	EC	dysfunction	 		 	
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Figure	5.	Summary	of	WSS-mediated	regulation	of	focal	EC	dysfunction	
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In	 conclusion,	 low	WSS	plays	 a	 central	 role	 in	 governing	 the	 spatial	 distribution	of	
atherosclerosis	 in	 the	 vasculature	 by	 promoting	 EC	 dysfunction	 (Figure.	 5).	
Establishing	the	link	between	the	low-WSS	mediated	regulation	of	NF-κB,	MAPK	and	
antioxidant	 signalling	 has	 significantly	 contributed	 to	 the	 understanding	 of	 the	
molecular	basis	of	 focal	EC	dysfunction	 in	atherogenesis.	However	there	are	ample	
avenues	 to	 be	 explored	 to	 fully	 understand	 the	 complexity	 of	 the	 molecular	
networks	that	govern	focal	EC	dysfunction.		
1.5	TWIST1	
TWIST1	 is	 a	 transcription	 factor	 that	 belongs	 to	 the	 beta-Helix-Loop-Helix	 (bHlH)	
family	 (Thisse	 et	 al.	 1988).	 bHLH	 transcription	 factors	 are	 classified	 into	 three	
families;	Class	A,	B	and	C.	TWIST1	belongs	to	the	class	B	family,	alongside	HAND2	and	
TWIST2.	 These	 transcription	 factors	 are	 characterised	 by	 having	 tissue-specific	
expression	and	forming	heterodimers	with	class	A	bHLH	transcription	factors	such	as	
E47	and	Id1	(Castanon	&	Baylies	2002).	The	Human	Twist1	gene	located	at	7q21.2,	
contains	 one	 coding	 exon	 which	 encodes	 a	 21	 KDa	 protein	 (Wang	 et	 al.	 1997)	
(Figure.	 6).	 The	 N-terminus	 of	 the	 protein	 contains	 binding	 sites	 for	 histone	
acetylasetransferases	 (HATs)	 proteins;	 cAMP-reponse	 element	 binding	 protein	
(CREB)-binding	 protein	 and	 p300/CBP-associated	 factor	 (PCAF).	 This	 interaction	
enables	Twist1	to	inhibit	the	HAT	activities	of	these	proteins	and	the	suppression	of	
target	gene	expression	(Hamamori	et	al.	1999).	The	N-terminus	also	contains	nuclear	
localisation	signals	to	mediate	Twist1	localisation	to	the	nucleus	where	it	can	bind	to	
conserved	DNA	E-box	sequences	(5’	NCANNTGN-3’)	located	in	the	regulatory	regions	
of	many	genes	to	promote	gene	transcription	(Murre	et	al.	1989).		
	
TWIST1	 was	 originally	 discovered	 in	Drosophila,	 as	 one	 of	 the	 genes	 essential	 for	
mesoderm	specification	(Thisse	et	al,	1987).	Drosophila	embryos	 lacking	the	Twist1	
gene	 died	 at	 embryogenesis	with	 a	 “twisted”	 appearance,	 hence	 the	 name	of	 the	
gene	 (Thisse	 et	 al,	 1987).	 The	 Twist1	 gene	 is	 highly	 conserved,	where	 the	 Human	
TWIST1	 bHLH	 domain	 shares	 96%	 homology	 to	 the	Drosophila	 TWIST1	 and	 100%	
homology	to	the	mouse	TWIST1	bHLH	domains	(Howard	et	al.	1997).		
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Figure	6.	Twist1	protein	domain	structure	 		 	
TWIST1	
bHLH	NLS	
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P300/CBP,	CREB,	PCAF,		
Figure	6.	TWIST1	protein	domain	structure.	The	human	TWIST1	protein	(21	kDa)	
contains	 two	nuclear	 localisation	 signals	 (NLS)	at	 the	N-terminal.	At	 this	 region,	
chromatin	 remodelling	proteins	 (P300/CBP,	CREB	and	PCAF)	bind	and	modulate	
Twist1	 function.	 A	 beta-Helix-Loop-Helix	 (bHLH)	 domain	 is	 required	 for	 Twist1	
binding	to	target	DNA	sequences.	
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In	humans,	Twist1	genetic	mutations	give	rise	to	Saethre-Chotzen,	a	rare	autosomal	
dominant	disease	with	a	population	 incidence	of	1	 in	2,000,	which	 is	characterised	
by	craniocytosis	 (premature	closure	of	 the	clavarial	 (skull)	 structure),	 (Bourgeois	et	
al.	 1998).	 Heterozygous	 Twist1	 +/-	 mice	 demonstrate	 craniofacial	 defects,	 thus	
resembling	 those	 from	Saethre-Chotzen	patients	 and	developmental	 abnormalities	
in	 the	 limb.	Whereas	 Twist1	 null	mice	 are	 embryonically	 lethal	 (Chen	&	Behringer	
1995).	
	
1.5.1	The	role	of	TWIST1	in	development		
TWIST1	 plays	 an	 indispensable	 role	 during	 multiple	 stages	 of	 embryonic	
development,	 from	 controlling	 mesodermal	 differentiation	 during	 gastrulation	
estimated	 at	 embryonic	 day	 	 (E)	 6	 in	 murine	 embryonic	 development,	 up	 to	
controlling	valve	formation	at	E	16	(Reviewed	in	Qin	et	al.	2012).	
	
During	 early	 embryonic	 development,	 gastrulation	 gives	 rise	 to	 three	 germ	 cell	
layers;	the	ectoderm,	mesoderm	and	endoderm.	This	process	is	highly	intricate	and	
is	tightly	controlled	by	multiple	transcriptional	regulators	including	TWIST1,	which	is	
central	 to	 mesoderm	 formation	 and	 specification	 and	 the	 differentiation	 into	
different	tissue	types	(cardiac,	skeletal	and	epithelial	tissue)	(Nusslein-Volhard	et	al.	
1987;	Thisse	et	al.	1988).	TWIST1	 is	also	essential	at	controlling	body	patterning	 in	
the	 developing	 embryo,	 specifically	 at	 controlling	 the	 dorsal-ventral	 axis,	 which	 is	
established	via	the	formation	of	a	TWIST1	expression	gradient	(Simpson	1983).		
	
In	later	stages	in	embryogenesis,	TWIST1	acts	as	a	master	regulator	of	the	osteoblast	
differentiation	program	by	controlling	the	activity	of	downstream	pathways	that	are	
central	 to	 osteoblast	 differentiation	 and	 development,	 including	 fibroblast	 growth	
factor	 (FGF)	 and	bone	morphogenic	 protein	 (BMP)	 signalling	by	 controlling	 FGFR2,	
FGF8,	 FGF10,	 and	 BMP4	 transcription	 (Bialek	 et	 al.	 2004;	 Connerney	 et	 al.	 2008;	
Loebel	et	al.	2002;	Rice	et	al.	2010).	TWIST1	also	controls	the	expression	of	RUNX2,	a	
critical	osteoblast-differentiation	transcriptional	 regulator	 that	 is	essential	 for	bone	
formation	 (Bialek	 et	 al,	 2004).	 TWIST1	 controls	 limb	 formation	 and	 muscle	 cell	
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differentiation,	 via	 controlling	 FGF,	 BMP	 and	 sonic	 hedgehog	 (SHH)	 signalling	
pathways	 (O’Rourke	 et	 al.	 2002).	 The	 formation	 of	 the	 heart	 valve	 involves	 the	
differentiation	 of	 progenitor	 cells	 of	 the	 endocardial	 cushions	 to	 mature	 valve	
interstitial	 cells	 (VIC)	 that	 are	 underlined	 by	 extracellular	 matrix	 proteins	 (ECM),	
(Reviewed	 in	 Wirrig	 &	 Yutzey	 2014).	 TWIST1	 controls	 endocardial	 cushion	 cell	
proliferation	 and	 migration	 via	 controlling	 the	 transcriptional	 activation	 of	 T-box	
protein	(Tbx)	20,	Mmp13	and	cadherin-11	 (Chakraborty	et	al.	2010).	This	promotes	
the	migration	of	endocardial	cushion	cells	into	the	intervening	ECM	known	as	cardiac	
jelly	 where	 the	 endocardial	 remodels	 into	 mature	 valve	 leaflets.	 Finally,	 TWIST1	
drives	hematopoietic	 lineage	differentiation	by	driving	myeloid	 (macrophages)	 and	
lymphoid	(T	and	B-lymphocyte)	cell	development	(Reviewed	in	Merindol	et	al.	2014).	
	
TWIST1	 shares	 66%	 sequence	homology	with	 TWIST2,	 however	both	proteins	play	
non-redundant,	 distinctive	 roles	 during	 development	 (Reviewed	 in	 Franco	 et	 al.,	
2011).	Moreover	Twist2	null	mice	display	normal	embryogenesis,	but	die	3	days	after	
birth	 of	 cachexia	 (Šošić	 et	 al.	 2003),	 thus	 suggesting	 that	 TWIST1	 plays	 a	 more	
dominant	role	in	early	embryogenesis.	
		
1.5.2.The	role	of	TWIST1	in	adult	disease	
In	the	adult,	under	normal	conditions	TWIST1	is	expressed	in	adult	stem	cells	of	the	
bone	 marrow	 and	 its	 expression	 in	 other	 adult	 cells	 is	 rarely	 reported	 (Zhao	 &	
Hoffman	 2004;	 	 reviewed	 in	 Figeac	 et	 al.	 2007).	 However	 in	 the	 disease	 context,	
TWIST1	is	a	prominent	oncogene	that	drives	the	progression	of	many	types	of	cancer	
including	breast,	 gastric,	 pancreatic,	 bladder	and	oesophageal	 cancer	 (Reviewed	 in	
Qin	et	al.	2012).	The	discovery	of	the	role	of	Twist1	in	cancer	was	by	Yang	et	al.	To	
investigate	 the	 molecular	 mechanism	 underlying	 tumour	 survival	 and	 metastasis	
Yang	et	 al.,	 injected	 four	 types	of	mammary	 tumour	 cell	 lines	 into	mice	 to	 induce	
tumour	 formation	 in	 vivo	and	 carried	 out	microarray	 analysis	 on	 isolated	 tumours	
from	the	mice.	The	study	revealed	that	Twist1	was	one	of	the	most	highly	expressed	
genes	and	that	 its	expression	correlated	positively	with	 the	metastatic	potential	of	
the	isolated	tumours.	Consistent	with	this,	the	expression	of	TWIST1	was	detected	in	
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human	 tumour	 cells,	 more	 prominently	 in	 more	 invasive	 and	 metastatic	 tumour	
types.	 Moreover,	 Yang	 et	 al.,	 further	 demonstrated	 that	 Twist1	 controls	 tumour	
metastasis	 by	 treating	 tumour	 cell	 lines	 with	 Twist1-specific	 oligonucleotides	
following	 injection	 into	 mice.	 It	 was	 revealed	 that	 Twist1-siRNA	 treated	 tumours	
showed	a	marked	reduction	in	tumour	severity	and	metastasis	compared	to	control-
siRNA	treated	tumours	(Yang	et	al.	2004).	Therefore,	the	study	by	Yang	et	al.,	clearly	
established	 a	 prominent	 role	 of	 TWIST1	 in	 driving	 cancer	 cell	 metastasis.	 The	
mechanism	 by	 which	 TWIST1	 drives	 metastasis	 and	 invasion	 is	 via	 N-cadherin,	
Platelet	 derived	 growth	 factor	 receptor	 α	 (PDGFRα),	 AKT2	 and	 MMPs	 (Niu	 et	 al.	
2007;	Eckert	et	al.	2011;	Feng	et	al.	2009).  
 
Alongside	 its	 prominent	 role	 in	 metastasis	 TWIST1	 promotes	 cancer	 by	 driving	
proliferation.	 Microarray	 analyses	 on	 cancer	 cells	 either	 overexpressing	 Twist1	 or	
treated	with	Twist1	siRNA	revealed	that	TWIST1	positively	regulated	the	expression	
of	genes	known	to	be	involved	in	cell	proliferation,	these	 included	cyclin	D1,	sushi-
repeat	containing	protein,	X-linked	(SrpX),	epidermal	growth	factor	receptor	tyrosine	
kinase		(Erbb)3	and	myeloblastosis	transcription	factor	(Myb)	in	cancer	cells	(Feng	et	
al.	 2009).	 Consistent	 with	 the	 role	 of	 TWIST1	 in	 cancer	 cell	 survival,	 TWIST1	
suppressed	 apoptosis	 by	 inhibiting	 tumour	 suppressor	 genes	 p53	 and	
retinoblastoma	(Rb)	(Maestro	et	al.	1999).	By	doing	so	TWIST1	promotes	cancer	cell	
survival	 and	 resistance	 to	 chemotherapeutic	 drugs	 (Wang	 et	 al.	 2003).	 Therefore,	
since	 the	 inhibition	 of	 tumour	 metastasis	 is	 an	 aim	 of	 anti-cancer	 drug	 targets,	
TWIST1	 makes	 a	 prominent	 therapeutic	 target	 and	 currently	 TWIST1-specific	
therapeutics	are	being	developed.	
	
TWIST1	 is	 involved	 in	 the	 pathogenesis	 of	 several	 fibrotic	 disorders	 these	 include	
renal	fibrosis	where	TWIST1	promotes	fibrotic	development	via	driving	epithelial	cell	
proliferation	 and	 inflammation	 in	 hypoxia-induced	 and	 in	 injury-induced	 renal	
fibrosis	(Sun	et	al.	2009;	Lovisa	et	al.	2015).	Interestingly,	Lovisa	et	al.,	have	recently	
shown	 that	 Twist1	 gene	 suppression	 was	 sufficient	 to	 significantly	 reverse	 renal	
fibrosis	 (Lovisa	 et	 al.	 2015)	 thus	 reflecting	 the	 dominant	 role	 of	 TWIST1	 in	 this	
process.	In	addition,	recently	Ranchoux	et	al.	demonstrated	that	TWIST1	expression	
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was	 increased	 in	 pulmonary	 arterial	 hypertension	 (PAH)	 patients	 compared	 to	
healthy	controls,	suggesting	that	there	 is	a	correlation	between	TWIST1	expression	
and	disease	pathogenesis	(Ranchoux	et	al.	2015).		
	
Heart	 valve	 disease	 commonly	 known	 as	 aortic	 valve	 stenosis	 is	 characterised	 by	
enhanced	 proliferation	 of	 EC	 lining	 the	 aortic	 valves	 and	 the	 formation	 of	 fibrotic	
calcified	 caps.	 Within	 the	 fibrotic	 core	 angiogenesis	 and	 neovascularisation	 take	
place,	which	further	exacerbate	fibrotic	growth.	The	fibrotic	cap	creates	a	stenosis	in	
the	 valve	 leaflets,	which	 impedes	blood	 flow	 (Reviewed	 in	 Leopold	2012;	Wirrig	&	
Yutzey	 2014).	 TWIST1	 plays	 a	 central	 role	 in	 mediating	 aortic	 valve	 stenosis	 as	
evidenced	by	 its	enhanced	expression	along	with	 its	target	genes	Runx1	and	Bmp4	
and	 Bmp2	 in	 human	 aortic	 valve	 disease	 patients	 compared	 to	 healthy	 controls	
(Chakraborty	et	al.	2010;	Wirrig	&	Yutzey	2014).	Chakraborty	et	al.,	overexpressed	
Twist1	 in	 mouse	 models	 this	 resulted	 in	 valve	 fibrosis	 and	 calcification,	 thus	
providing	a	direct	evidence	for	the	involvement	of	TWIST1	in	mediating	aortic	valve	
disease	(Chakraborty	et	al.		2010).	
	
	
Interestingly,	 cancer	 metastasis	 is	 described	 as	 a	 “distrupted	 developmental	
phenotype”	(Ishii	&	Saito	2008)	and	the	“return	of	a	fetal	gene	program”	(Leopold,	
2012)	has	been	described	 for	 the	pathogenesis	of	aortic	valve	stenosis.	A	common	
factor	 in	the	 induction	of	these	adult	disease	processes	 is	the	activation	of	TWIST1	
expression.	This	suggests	that	TWIST1	plays	a	dual	role	in	organismal	biology	where	
it	 mediates	 beneficial	 processes	 required	 for	 organismal	 development	 during	
embyogenesis,	 whereas	 in	 the	 adult	 TWIST1	 controls	 processes	 that	 encompass	 a	
detrimental	impact.	
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1.5.3	The	regulation	of	TWIST1	in	development	and	disease	
The	 regulation	 of	 TWIST1	 occurs	 via	 transcriptional	 and	 post-transcriptional	
mechanisms	during	development	 and	 in	disease	 (Summarised	 in	 Figure.	 7).	During	
embryonic	 development	 the	 gene	 expression	 of	 Twist1	 in	 the	 mesoderm	 is	
controlled	by	 the	 combination	of	 SHH	and	FGF	 signalling,	 interestingly	 SHH	or	 FGF	
signalling	 in	 separation	 do	 not	 induce	 Twist1	 expression	 (Hornik	 et	 al.	 2004)	
suggesting	that	only	when	both	signalling	pathways	are	present	Twist1	expression	is	
mediated.	Moreover	TWIST1	controls	the	expression	of	FGF	and	SHH	later	on	during	
embryonic	 development,	 during	 mesoderm	 cell	 specification	 into	 osteoblast,		
suggesting	 that	 there	 is	 a	 positive	 feedback	 loop,	 where	 SHH	 and	 FGF	 promote	
TWIST1	expression	then	TWIST1	feeds	back	to	activate	these	pathways	 (Hornick	et	
al.	2004).	 In	 the	developing	valves	TWIST1	expression	 is	 controlled	by	BMP2-Smad	
signalling,	which	then	subsequently	mediates	TWIST1-mediated	endocardial	cushion	
cell	differentiation	(Ma	et	al.	2005).	Consistent	with	the	positive	feedback	between	
FGF	and	SHH	signalling	with	TWIST1,	this	positive	feedback	loop	exists	between	BMP	
signalling	as	TWIST1	promotes	Bmp2	and	4	expression	during	limb	formation	(Bialek	
et	al.	2004;	O’Rourke	et	al.	2002).	
	
In	 cancer	 cells	 Twist1	 gene	 expression	 is	 regulated	 by	 STAT3	 (a	 transcription	
activator	 belonging	 to	 the	 Janus	 kinase/	 signal	 transducer	 and	 activator	 of	
transcription	(JAK/STAT)	family	of	proteins)).	The	regulation	of	TWIST1	by	STAT3	was	
essential	for	the	induction	of	metastasis	(Cheng	et	al.	2008)	suggesting	that	STAT3	is	
one	 of	 the	 upstream	 molecular	 mechanisms	 that	 promotes	 TWIST1	 expression	
during	 metastasis.	 NF-κB	 signalling	 via	 p65/RelA	 has	 ben	 linked	 with	 the	
transcriptional	activation	of	TWIST1	and	metastasis	of	non-small	lung	cell	carcinoma	
(nSLCC)	and	in	breast	cancer	(Liu	et	al.	2015;	Yang	et	al.	2004;	Yang	et	al.	2008).	This	
suggests	that	NF-kB	signalling	could	be	acting	as	a	switch	alongside	STAT3	signalling	
in	 promoting	 TWIST1-mediated	 cancer	 cell	metastasis.	 TWIST1	 is	 reported	 to	 be	 a	
direct	 target	 of	 hypoxia	 inducible	 factor-α	 	 (HIF1α)	 in	 hypoxia-mediated	 renal	
fibrosis,	reflecting	that	Twist1	is	activated	by	hypoxic	conditions	(Sun	et	al.	2009).	
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Figure	7.	Summary	of	molecular	regulation	of	TWIST1	
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	Micro	 RNA	molecules	 (miRNAs)	 are	 also	 proposed	 to	 control	 TWIST1	 expression.	
Nairismägi	 et	 al	 showed	 that	 miR145a-5p	 and	 miR151-5p	 repressed	 Twist1	
expression	and	inhibited	cancer	cell	survival,	proliferation,	invasion	and	metastasis	in	
a	 number	 of	 human	 cancer	 cell	 lines,	 suggesting	 that	 the	 regulation	 of	 Twist1	 in	
cancer	metastasis	also	occurs	via	regulatory	RNA	(Nairismägi	et	al.	2013).	
	
Post	 translationally	 TWIST1	 protein	 stabilisation	 occurs	 via	 phosphorylation	
mechanisms.	 MAPK	 signalling	 through	 p38,	 JNK	 and	 extracellular-signal-regulated	
kinases	 (ERK)1/2	 promotes	 phosphorylation	 of	 TWIST1	 at	 serine-68	 (Hong	 et	 al.	
2011).	This	modification	protects	Twist1	from	degradation	through	ubiquitination.	In	
addition,	 MAPK-mediated	 phosphorylation	 of	 TWIST1	 is	 regulated	 by	 TGF-β	
signalling	in	cancer	cells.	Furthermore,	TWIST1	stability	is	controlled	by	its	formation	
of	 specific	 heterodimers	 from	 the	 class	 A	 of	 bHLH	 proteins.	 For	 example,	 TWIST1	
interaction	 with	 E47	 promotes	 TWIST1	 protein	 stability,	 whereas	 interaction	 with	
Inhibitor	 of	 DNA	 1	 (ID1)	 promotes	 TWIST1	 destabilisation	 and	 ubiquitous	
degradation	 (Ghouzzi	 et	 al.	 1997).	 Interestingly	 ID1	 expression	 is	 driven	 by	 BMP	
signalling	during	early	stages	of	embryonic	development,	which	is	important	for	the	
spatio-temporal	 regulation	 of	 TWIST1	 in	 the	 embryo	 that	 is	 required	 for	 body	
patterning	(Das	&	Crump	2012).	
	
TWIST1	expression	is	controlled	by	mechanical	forces	in	development	and	in	cancer.	
In	 the	Drosophila	 embryo	 TWIST1	 is	 responsive	 to	mechanical	 cues	 such	 as	 tissue	
deformations.	The	mechanical	activation	of	Twist1	in	the	study	by	Desprat	et	al	was	
reported	to	be	mediated	by	β-catenin	WNT	signalling	(Desprat	et	al.	2008).	Whereas	
in	cancer	cells	Twist1	expression	was	enhanced	by	an	increase	in	matrix	stiffness	in	
tumour	 cells	 (Wei	 et	 al.	 2015).	 Interestingly,	 TWIST1	 can	 directly	 alter	 the	
mechanical	 properties	 of	 cells,	 Gajula	 et	 al.	 show	 that	 Twist1	 overexpression	 in	
cancer	 cells	 increased	 matrix	 stiffness	 and	 cell	 traction	 forces	 (defined	 as	 the	
tangential	 tension	 exerted	 on	 the	 ECM)	 at	 the	migratory	 front	 of	metastatic	 cells,	
thus	enabling	enhanced	cell	metastasis	(Gajula	et	al.,	2013).	Therefore	in	addition	to	
mechanical	 forces	 regulating	 Twist1	 expression,	 it	 can	 also	 directly	 alter	 the	
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mechanical	 properties	 of	 cells,	 which	 could	 act	 as	 a	 positive	 feedback	 loop	 to	
maintain	Twist1	expression	and	could	activate	other	mechanoresponsive	genes.		
	
1.6	GATA4	
GATA4	 is	 a	 zinc	 finger	 transcription	 factor	 that	 belongs	 to	 the	 GATA	 family	 of	
transcription	 factors,	 containing	 GATA1-GATA6	 proteins.	 GATA	 proteins	 play	 non-
redundant	 roles	 and	 display	 tissue-specific	 expression;	 GATA1-3	 are	 more	 closely	
related	in	sequence	and	are	predominantly	expressed	in	the	hematopoietic	system,	
whereas	GATA4-6	are	more	closely	related	and	are	expressed	in	the	cardiovascular	
system	 and	 the	 gonads	 (Zhou	 et	 al.	 2012).	 The	 human	 Gata4	 gene	 (located	 at	
8p23.1)	 encodes	 a	 44.6	 kDa	 protein	 (Figure.	 8),	 which	 contains	 two	 Zinc	 finger	
domains,	located	at	the	N	and	C-	terminals	of	the	protein,	along	with	a	NLS	domain	
at	 the	C-terminal.	The	zinc	 finger	domains	are	highly	conserved	between	GATA1-6,	
with	a	75%	sequence	homology	and	across	species	(Zhou	et	al.	2012).		The	zinc	finger	
domain	 is	 conserved.	 This	 zinc	 finger	 domain	 enables	 GATA4	 to	 bind	 to	 its	 target	
GATA	box	sequence	(A/TGATAA(G))	that	is	located	in	the	regulatory	region	of	target	
genes	(Zhou	et	al.	2012).	The	first	GATA	protein	to	be	discovered	was	GATA1,	Tsai	et	
al.	 identified	 GATA1	 as	 part	 of	 the	 study	 that	 investigated	 transcription	 factor	
regulation	of	erythrocyte	immunoglobin	genes	(Tsai	et	al.	1989).	Based	on	sequence	
homology	GATA	2-6	were	then	later	identified.	
	
Gata4	 null	mutations	 in	mice	 are	 embryonically	 lethal	 due	 severe	 defects	 in	 heart	
development.	 Heterozygous	Gata4+/-	mice	 are	 viable	 but	 they	 suffer	 from	 cardiac	
hyperplasia,	heart	valve	defects	along	with	sexual	development	disorders	(Jay	et	al.	
2007;	Rajagopal	et	 al.	 2007;	 Lourenço	et	al.	 2011).	 In	humans,	mutations	 in	Gata4	
are	 linked	 in	sporadic	and	familial	cases	of	congenital	heart	disease	and	have	been	
reported	to	cause	gonad	development	abnormalities	(Wang	et	al.	2013;	Rajagopal	et	
al.	2007).	
	
	
	
	 39	
	
	
	
Figure	8.	GATA4	protein	domain	structure		 	
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Figure	 8.	 GATA4	 protein	 domain	 structure.	 The	 human	 GATA4	 protein	 (41.5kDa)	
contains	 two	 zinc	 finger	 (ZFN1)	 binding	 domains,	 which	 facilitate	 GATA4	 binding	 to	
DNA	 target	 sequences.	 A	 nuclear	 localisation	 signal	 is	 located	 at	 the	 C-terminal	 to	
allow	nuclear	expression	and	transcriptional	activity.	
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1.6.1	The	role	of	GATA4	in	development	
The	process	of	mammalian	heart	development	begins	with	looping	of	the	early	heart	
tube	 (consisting	 of	 cardiomyocytes	 and	 endothelial	 cells),	 which	 then	 becomes	
divided	 into	 four	 chambers	 that	 are	 separated	 by	 heart	 valves,	 this	 process	 is	
controlled	by	a	tightly	regulated	cardiac	transcriptional	network.	GATA4	is	regarded	
as	a	master	cardiac	transcription	factor	as	it	sits	upstream	of	the	transcriptional	gene	
network	controlling	heart	development,	including	myocyte	enhancer	factor	(Mef)2c,	
NK2	homeobox	5	(Nkx2.5),	serum	response	factor	(Srf)	and	Hand2	(Schlesinger	et	al.	
2011;	McFadden	 et	 al.	 2000;	 	 Zeisberg	 et	 al.	 2007).	 Grepin	 et	 al.	 established	 the	
dominant	 role	 of	 GATA4	 in	 cardiac	 development	 by	 revealing	 that	 Gata4	
overexpression	in	pluripotent	P19	embryonal	carcinoma	cells	commited	the	cells	to	
undergo	 differentiation	 to	 the	 cardiac	 lineage	 and	 gave	 rise	 to	 beating	
cardiomyocytes	 (Grépin	et	 al.	 1995).	Genetic	 inhibition	of	Gata4	 restricted	beating	
cardiomyocyte	 differentiation	 (Grépin	 et	 al.	 1995)	 thus	 indicating	 that	 Gata4	
expression	 is	 required	 to	 drive	 cardiomyocyte	 differentiation.	 A	 study	 by	 Takeuchi	
and	 Bruneau	 demonstrated	 that	 ectopic	 expression	 of	 Gata4	 alone	 triggered	
cardiomyocyte	 differentiation	 of	 uncommitted	 mesodermal	 cells	 (Takeuchi	 &	
Bruneau	 2009).	 Strikingly,	 the	 ectopic	 expression	 of	 Gata4	 in	 combination	 with	
cardiac	 transcription	 factors	 Mef2c	 and	 Tbx5	 reprogrammed	 fibroblasts	 into	
cardiomyocytes	 (Ieda	et	al.	2010).	These	studies	have	demonstrated	 that	GATA4	 is	
an	 essential	 driver	 of	 cardiomyocyte	 differentiation.	 Studies	 carried	 out	 on	 Gata4	
deficient	 embryos	 (which	 died	 during	 embryonic	 development)	 demonstrated	 the	
requirement	 of	 Gata4	 in	 the	 formation	 of	 the	 early	 heart	 tube	 and	 subsequent	
looping	and	compartmentalisation.	GATA4	 is	essential	 for	 the	 regulation	of	 several	
compartments	of	 the	developing	heart,	 including	 the	epicardium,	myocardium	and	
endocardium.	Consistent	with	this,	GATA4	deficiency	promotes	valve	defects	as	it	is	
required	 to	 promote	 in	 endocardial	 cushion	 cell	 differentiation	 and	 maturation	
(Rivera-Feliciano	et	al.	2006).	
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GATA4	also	plays	 important	 roles	 in	non-cardiac	development	where	 it	 is	 required	
for	the	regulation	of	sex	determination	and	differentiation	in	mammals	(Tevosian	et	
al.	2002;	Hu	et	al.	2013).	GATA4	expression	was	detected	 in	the	early	genital	 ridge	
(an	early	precursor	of	the	testis	or	ovary)	and	was	required	to	promote	genital	ridge	
differentiation	 by	 controlling	 the	 expression	 of	 downstream	 transcriptional	
regulators	Sry,	Lhx9	and	Sf1	(Hu	et	al.	2013).	
	
1.6.2	The	role	of	GATA4	in	adult	disease	
Under	non-disease	 conditions	 in	 the	 adult	GATA4	promotes	 tissue	homeostasis	 by	
regulating	 endothelial	 and	 cardiomyocyte	 proliferation	 and	 apoptosis.	 Oka	 et	 al.	
demonstrated	 that	 cardiomyocyte-specific	 deletion	 of	 Gata4	 in	 mice	 reduced	
hypertrophic	 responses	 following	 pressure	 overload	 of	 the	 ventricles	 (Oka	 et	 al.	
2006).	 Therefore	 in	 the	 adult	 GATA4	 controls	 cardiac	 homeostasis	 by	 controlling	
hypertrophy,	which	is	required	for	normal	heart	function.	This	function	of	GATA4	is	
proposed	 to	 be	 controlled	 by	 p38	MAPK	 signalling	 (Oka	 et	 al.	 2006).	 GATA4	 also	
promotes	 cardiac	 repair	 following	 injury,	Heineke	 et	 al.	 demonstrated	 that	GATA4	
promotes	 a	 pro-proliferative	 phenotype	 and	 promoted	 the	 expression	 of	 an	
angiogenic	gene	profile	(containing	VEGF	and	Angptl2)	in	adult	cardiomyocytes	and	
endothelial	cells	of	the	heart	following	ischemic	cardiac	injury	(Heineke	et	al.	2007).	
GATA4,	 along	 with	 MEF2C	 and	 TBX5	 regulate	 cardiac	 repair	 and	 cardiomyocyte	
generation	following	myocardial	infarction	in	murine	hearts	(Inagawa	et	al.	2012).	
	
Under	disease	conditions	GATA4	expression	is	linked	with	a	range	of	cancers	in	the	
gastrointestinal	tract,	the	lungs,	ovaries	and	the	brain	(Reviewed	in	Zheng	&	Blobel	
2010).	GATA4	is	proposed	to	be	a	potent	prognostic	predictor	in	the	development	of	
breast	 carcinoma-	 Takagi	 et	 al.	 reported	 that	 GATA4	 expression	 was	 detected	 in	
early	 human	 breast	 carcinoma	 tissue	 and	 its	 expression	 increased	 in	 late-stage	
metastatic	breast	carcinoma	tissue,	indicating	that	GATA4	promotes	tumour	survival	
and	 metastasis	 (Takagi	 et	 al.	 2014).	 The	 mechanism	 by	 which	 GATA4	 promotes	
cancer	 survival	 involves	 the	 activation	 of	 pro-proliferative	 target	 genes.	 Recently,	
Chia	 et	 al.	 revealed	 that	 GATA4	 forms	 a	 complex	 with	 GATA6	 and	 KLF5	 and	 this	
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complex	 promotes	 the	 expression	 of	 hepatocyte	 nuclear	 factor-	 alpha	 (HNF-α)	
expression,	which	in	turn	was	required	to	promote	gastric	cancer	proliferation	(Chia	
et	 al.	 2015).	 In	 Granulosa	 cell	 tumours	 GATA4	 was	 shown	 to	 protect	 ovarian	
granulosa	cells	from	apoptosis	via	promoting	the	expression	of	anti-apoptotic	Bcl-2	
gene	(Kyrönlahti	et	al.	2008).	Moreover,	GATA4-mediated	inhibition	of	granulosa	cell	
apoptosis	was	 responsible	 for	 resistance	 to	 TRAIL-induced	apoptosis	 (Kyrönlahti	 et	
al.	 2010).	 This	 suggests	 that	 alongside	 the	 role	 of	GATA4	 in	 promoting	 cancer	 cell	
proliferation	 it	 promotes	 cancer	 cell	 survival	 by	 inhibition	 of	 apoptosis.	 GATA4	
expression	by	MYC-induced	epigenetic	activation	was	shown	to	be	important	for	the	
induction	of	metastasis	in	lung	adenocarcinoma	cancer	cells	(Castro	et	al.,	2013).	The	
potential	 mechanism	 by	 which	 GATA4	 drives	 cancer	 cell	 metastasis	 includes	 the	
activation	of	N-cadherin	expression	(Reviewed	in	Zheng	&	Blobel	2010).	In	summary,	
these	studies	demonstrate	that	Gata4	acts	as	an	oncogene	via	promoting	cancer	cell	
survival,	 proliferation	 and	 metastasis.	 However,	 a	 study	 by	 Agnihotri	 et	 al.,	
suggested	 GATA4	 can	 act	 as	 a	 tumour-supressor	 in	 glioblastoma.	 Agnihotri	 et	 al.	
revealed	that	mutations	in	Gata4	that	resulted	in	reduced	expression	correlated	with	
a	 reduction	 in	 astrocyte	 proliferation,	 suggesting	 that	 GATA4	 inhibited	 astrocyte	
proliferation	and	cancer	survival	(Agnihotri	et	al.	2011).	Consistent	with	this,	GATA4	
was	 recently	 shown	 to	 positively	 regulate	 cellular	 senescence	 in	 fibroblasts	 in	
response	to	DNA	damage	(Kang	et	al.	2015).	Since	p53-mediated	cellular	senescence	
is	a	known	tumour	suppressor	mechanism	this	study	provided	further	evidence	for	
the	 role	 of	 GATA4	 as	 a	 tumour	 suppressor	 gene.	 Therefore,	 the	 role	 of	 GATA4	 in	
cancer	is	context	dependent,	which	reveals	the	complex	nature	of	GATA4-mediated	
changes	in	cell	function	in	disease	and	in	development.	
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1.6.3	Regulation	of	GATA4	in	development	and	disease.	
Regulatory	control	of	GATA4	occurs	at	transcriptional	and	post-transcriptional	levels	
(Summarised	 in	figure.	9).	GATA4	is	regulated	at	the	transcriptional	 level	 in	cardiac	
cells	by	both	canonical	WNT	signalling	through	β-catenin	and	by	non-canonical	WNT	
signalling	through	nuclear	factor	of	activated	T-cells	(NFAT)	(Lin	&	Xu	2008;	Sussman	
et	al.	1998;	Morad	&	Suzuki	2000).	During	cardiac	hypertrophy	and	fibrosis	following	
injury,	 GATA4	 expression	 is	mediated	 by	 C-Rel-mediated	 NF-κB	 signalling	 (Gaspar-
Pereira	 et	 al.	 2012).	 Another	 pathway	 that	 controls	 GATA4	 expression	 is	 the	 BMP	
pathway,	Rojas	et	al	demonstrated	that	BMP4	directly	promotes	GATA4	expression	
through	 Smad	 proteins	 in	 the	 lateral	 mesoderm	 during	 early	 embryonic	
development	 (Rojas	 et	 al.	 2005).	 Additionally,	 GATA4	 expression	 is	 regulated	 by	
cardiac-specific	miRs.	Studies	by	Callis	et	al.,	and	Ikeda	et	al.,	revealed	that	miR208	
and	 miR1	 deficient	 mice	 showed	 a	 marked	 reduction	 in	 Gata4	 expression,	 thus	
revealing	that	miRs	208	and	1	positively	regulate	Gata4	expression	(Ikeda	et	al.	2009;	
Callis	et	al.	2009).	
	
GATA4	DNA	binding	to	target	sequences	 is	stabilised	by	 interactions	with	cofactors	
and	transcription	factors.	One	of	these	co-factors	 is	friend	of	GATA	(FOG)-2.	Whilst	
FOG	2	alone	does	not	control	gene	expression,	it	physically	interacts	with	GATA4	and	
stabilises	 GATA4	 target	 gene	 activation.	 Ablation	 of	 FOG	 2-GATA4	 interaction	 in	
murine	 embryos,	 gave	 rise	 to	 embryonic	 lethality	 due	 to	 defects	 in	 heart	
morphogenesis	 and	 valve	 development	 (Rivera-Feliciano	 et	 al.	 2006;	 Zhou	 et	 al.	
2009).	In	addition,	Chip-seq	analyses	in	cardiomyocytes	showed	that	FOG	2	binding	
coincided	with	all	GATA4	binding	sites	(Zhou	et	al.	2009).	These	observations	provide	
strong	 evidence	 for	 the	 regulation	 of	 GATA4	 DNA	 binding	 by	 interaction	with	 the	
cofactor	 FOG	 2.	 Consistent	with	 this,	 GATA4	 interaction	with	 transcription	 factors	
GATA6,	 TBX5	 and	MEF2C	 further	 stabilises	GATA4	 transcriptional	 activation	during	
development	and	 in	 cancer	 cells	 (Chia	et	 al.	 2015;	Charron	et	 al.	 1999;	Garg	et	 al.	
2003;	 Lee	et	 al.	 1998).	 Thus,	demonstrating	 the	 importance	of	GATA4	 interactions	
with	transcription	factors	and	cofactors	in	promoting	downstream	gene	activation.	
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Figure	9.	Summary	of	molecular	regulation	of	GATA4										 	
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Figure	9.	Summary	of	molecular	regulation	of	GATA4.	
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At	 the	 protein	 level,	 GATA4	 is	 stabilised	 by	 post-translational	 modifications-	
phosphorylation,	 sumolylation	 and	 acetylation.	 Following	 pressure	 overload	 in	 the	
ventricles,	p38	MAPK	promotes	phosphorylation	at	serine-105.	This	phosphorylation	
was	required	for	mediating	GATA4	transcriptional	activation	of	target	genes	involved	
in	hypertrophy	(Tenhunen	et	al.	2004).	The	direct	effects	of	MAPK-mediated	GATA4	
phosphorylation	 was	 tested	 by	 genetic	 substitution	 of	 serine-105	 residue	 into	
alanine,	 which	 inhibited	 GATA4-mediated	 hypertrophy	 (van	 Berlo	 et	 al.	 2011)	
Therefore	 GATA4	 phosphorylation	 by	 p38	 is	 required	 during	 hypertrophy.	
Furthermore,	GATA4	sumoylation	at	lysine-366	by	SUMO-conjugating	enzyme	Ubc9	
increased	GATA4	transcriptional	activity.	Similarly,	GATA4	acetylation	by	P300	had	a	
stabilising	effect	on	GATA4	DNA	binding	activity.	These	studies	revealed	that	GATA4	
DNA	 binding	 activity	 and	 transcription	 of	 target	 genes	 is	 enhanced	 by	 post-
translational	modifications.	Recently,	GATA4	activity	was	shown	to	be	controlled	by	
p62	 mediated	 autophagy	 and	 subsequent	 degradation.	 GATA4	 autophagy	 was	
inhibited	 following	 the	 activation	 of	 DNA	 damage	 sensors	 ATM/	 ATR,	 which	
subsequently	 released	 GATA4	 from	 p62	 interaction,	 to	 allow	 GATA4	 to	 induce	
cellular	senescence	(Kang	et	al.	2015).	Thus	GATA4	autophagy	was	proposed	to	act	
as	 a	 “control	 switch”	 of	 cellular	 senescence	 in	 this	 study	 (Kang	 et	 al.	 2015).	
Interestingly,	Tenhunen	et	al	proposed	that	mechanical	forces	could	regulate	GATA4	
activity.	This	was	directly	revealed	by	GATA4	enhanced	expression	following	balloon-
inflation	in	isolated	rat	ventricles	(Tenhunen	et	al.	2004).		
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1.7	Endothelial-mesenchymal-transition	
Endothelial-mesenchymal	transition	(EndMT)	is	a	form	of	cellular	transformation	of	
mature	endothelial	cells	into	a	mesenchymal,	plastic	phenotype	(Figure.	10).	EndMT	
was	 discovered	 by	 Markwald	 et	 al.,	 where	 it	 was	 observed	 that	 cells	 of	 the	
endocardium	 transformed	 into	 a	 mesenchymal	 state	 during	 valve	 formation	
(Markwald	et	al.	1975).	EndMT	is	closely	related	to	a	parallel	process	that	occurs	in	
epithelial	cells;	known	as	epithelial	mesenchymal-transtion,	which	was	 identified	 in	
1894	 by	 Platt	 in	Drosophila	 gastrulation	 (Platt	 1894).	 Thus	 EndMT	 is	 a	 specialised	
form	of	 EMT.	During	 EndMT	 (Figure.	 10)	 cells	 express	mesenchymal	 gene	markers	
such	as	Twist1,	Snail,	Slug,	N-cadherin	and	α-SMA.	These	mesenchymal	genes	drive	
phenotypic	changes	that	 involve	the	 loss	of	EC	markers	VE-cadherin	and	CD31	and	
subsequent	loss	of	tight	cell-cell	contacts.	These	changes	are	followed	by	changes	in	
cell	function	including	enhanced	cell	proliferation	and	migration.	Ultimately	EndMT-
undergoing	cells	separate	from	the	monolayer	and	penetrate	the	underlying	ECM	(a	
process	referred	to	as	delamination)	and	become	highly	migratory	and	invasive	(Lim	
&	 Thiery	 2012a).	 Therefore	 enhancements	 in	 cell	 proliferation,	 migration	 and	
invasion	are	all	functional	outputs	of	cells	undergoing	EndMT.	
	
1.7.1	Overview	of	molecular	mechanisms	controlling	EndMT	
There	are	close	parallels	between	the	molecular	mechanisms	that	control	EMT	and	
EndMT,	which	further	supports	the	close	relation	between	the	two	processes.	Since	
this	 thesis	 is	 more	 focused	 on	 EndMT,	 the	 molecular	 mechanisms	 that	 control	
EndMT	will	be	discussed.	
	
Members	 of	 the	 TGF-β	 cytokine	 family,	 including	 BMPs	 and	 TGF-β	 subfamilies	 are	
examples	of	well-studied	molecular	switches	of	EndMT.	TGF-β	and	BMP	binding	 to	
TGF-β	 receptors	 types	 1	 (TGF-β	 receptor	 2,	 ALK1	 and	 5)	 and	 type	 2	 	 (BMP	 R2)	
promotes	the	phosphorylation	of	Smad		(Smad	1-5	and	8)	transcriptional	regulators,	
which	move	 into	 the	 nucleus	 and	 activate	 downstream	 target	 genes	 (Reviewed	 in	
(Lim	&	Thiery	2012).		
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Figure	10.	Molecular	and	functional	changes	during	EndMT		
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Figure	 10.	 Molecular	 and	 functional	 changes	 during	 EndMT.	 EC	 undergoing	
EndMT	 undergo	 molecular	 changes,	 including	 an	 increased	 expression	 of	
mesenchymal	genes	(N-cadherin,	Snail,	Slug,	Twist1	and	α-SMA)	and	a	reduction	
in	EC	marker	genes	(VE-cadherin	and	CD31).	These	molecular	changes	give	rise	to	
changes	 in	EC	function;	an	 increase	 in	proliferation,	migration,	permeability	and	
invasion	.	
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TGF-β	activation	promotes	the	activation	of	the	EndMT	gene	programme,	including	
the	 expression	 of	 EndMT-controlling	 transcription	 factors	 Snail,	 Slug,	 Twist1	
(Reviewed	 in	 Lamouille	 et	 al.	 2014).	 In	 vitro	 and	 in	 vivo	 functional	 studies	 have	
shown	that	 inhibition	of	TGF-β	signalling,	specifically	TGF-β	2,	BMP2	and	4	blocked	
the	induction	of	EndMT,	thus	revealing	that	these	specific	TGF-β	signalling	mediators	
play	a	dominant	role	in	the	induction	of	EndMT	(Medici	et	al.	2010;	van	Meeteren	&	
ten	Dijke	2012;	Azhar	et	al.	2009;	Deissler	et	al.	2006;	Medici	et	al.	2011;	McCulley	et	
al.	 2008;	 Kokudo	 et	 al.	 2008;	 Ma	 et	 al.	 2005).	 Whereas,	 BMP7	 binding	 to	 ALK2	
receptors	 acts	 to	 inhibit	 EndMT	 induction,	 which	 suggests	 that	 within	 the	 TGF-β	
family,	 there	 are	 balance-keeping	 mechanisms	 such	 as	 BMP7,	 which	 together	
regulate	 EndMT	 (Zeisberg	 et	 al.	 2007).	 TGF-β	 signalling	 also	 activates	 smad-
independent	molecules	such	as	p38	MAPK,	MAPK/ERK	kinase	 (MEK)/ERK	and	PI3K,	
which	 promote	 transcriptional	 activation	 of	 EndMT	 transcription	 factors	 including	
SNAIL,	TWIST1	and	GATA4	and	stabilises	TGF-β	2	signalling	(Medici	et	al.	2011;	Rysä	
et	al.	2010;	Tenhunen	et	al.	2004;	Hong	et	al.	2011a;	Echeverría	et	al.	2014).	Notch	
signalling	 through	 Notch	 ligand-receptor	 interactions	 and	 WNT	 signalling	
(canonical	via	β-catenin	and	non	canonical	via	NFAT)	are	also	positive	regulators	
of	EndMT	as	shown	by	 in	vitro	and	 in	vivo	 studies.	Specifically,	Notch	and	WNT	
signalling	have	a	direct	role	in	inducing	EndMT	by	transcriptional	induction	of	the	
EndMT	 programme	 or	 indirectly	 through	 the	 activation	 of	 EndMT-promoting	
pathways	 such	as	TGF-β	 (Liebner	et	al.	2004;	Chang	et	al.	2011;	Maddaluno	et	al.	
2013).	 Interestingly,	 it	 has	been	 reported	 that	Notch	and	WNT	 signalling	play	a	
synergistic	 role	with	TGF-β	signalling	 in	the	activation	of	EndMT	regulators	such	
as	Snail	and	Slug	(Kokudo	et	al.	2008;	Lim	&	Thiery	2012).	All	of	these	pathways	
lead	 to	 EndMT,	 which	 causes	 changes	 in	 EC	 function	 including	 proliferation,	
migration	and	invasion.	
	
Although	TWIST1	and	GATA4	regulate	various	separate	pathways	in	disease	and	
development,	 they	are	both	potent	 activators	of	 EndMT	 (Rivera-Feliciano	et	 al.	
2006;	 Hirasawa	 et	 al.	 2011;	 Chakraborty	 et	 al.	 2010).	 TWIST1	 and	 GATA4	 are	
downstream	 targets	 (through	 direct	 transcriptional	 activation	 or	 through	 post	
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translational	modifications)	 of	 EndMT	promoting	pathways;	 TGF-β,	BMP,	Notch	
and	WNT	 signalling	 (Lamouille	 et	 al.	 2014;	 Daoud	 et	 al.	 2014;	 Lin	 &	 Xu	 2008;	
Reinhold	et	al.	2006;	George	et	al.	2015).	 Interestingly,	TWIST1	and	GATA4	can	
also	act	as	positive	regulators	of	these	EndMT	promoting	pathways	(Chen	et	al.	
2014;	O’Rourke	et	al.	2002;	Moskowitz	et	al.	2011).	 In	vivo	 studies	have	shown	
that	 endothelial-specific	 deletion	 of	 Twist1	 or	 Gata4	 blocks	 the	 EndMT	
programme,	 suggesting	 that	 they	 play	 an	 important	 role	 in	 regulating	 EndMT.	
Specifically,	the	EndMT-promoting	mechanism	of	TWIST1	and	GATA4	involves	the	
transcriptional	 activation	 of	 mesenchymal	 genes	 Snail,	 Slug,	 α-sma	 (smooth	
muscle	 cell	 actin)	 and	N-cadherin	 (Rivera-Feliciano	 et	 al.	 2006;	 Lamouille	 et	 al.	
2014;Hong	 et	 al.	 2011;	 Chakraborty	 et	 al.	 2010).	 TWIST1	 directly	 inhibits	 VE-
cadherin	 transcription	 through	 binding	 to	 E-box	 sequences	 in	 the	 VE-cadherin	
promoter	and	blocking	transcription	through	chromatin	remodelling	(Reviewed	in	
Lamouille	et	al.	2014;	Lopez	et	al.	2009).	This	subsequently	promotes	loss	of	EC-EC	
contacts	and	cell	migration.	In	vitro	and	 in	vivo	studies	have	shown	that	TWIST1	
and	GATA4	promote	EC	proliferation,	migration	and	invasion	(Lee	&	Yutzey	2011;	
Zeisberg	et	al.	2005;	Rivera-Feliciano	et	al.	2006;	Vrljicak	et	al.	2012).	TWIST1	and	
GATA4	can	control	 the	expression	of	one	another	 through	 indirect	mechanisms	
during	 EndMT.	 One	 of	 these	 mechanisms	 includes	 the	 activation	 of	 TWIST1	
through	 GATA4-dependent	 Smad4	 activation.	 Moreover,	 GATA4	 and	 TWIST1	
both	 interact	 with	 BHLH	 transcription	 factor	 HAND2	 to	 promote	 target	 gene	
activation	 (Dai	et	 al.	 2002;	 Firulli	 et	 al.	 2005).	 Thus	TWIST1	and	GATA4	are	key	
regulators	 of	 EndMT	 and	 present	 in	 in-direct	 crosstalk	 during	 the	 induction	 of	
EndMT.	
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1.7.2	EndMT	in	development		
EMT	 is	 essential	 during	 gastrulation.	 Platt	 was	 the	 first	 to	 identify	 this	 role	 of	
EMT.	Specifically,	it	was	reported	that	cells	from	the	ectoderm	transformed	into	a	
mesenchymal	 form	and	contributed	 to	 forming	mesodermal	 tissue	 (Platt	1894).	
Genetic	 studies	 in	 Drosophila,	 Xenopus	 and	 chick	 embryos	 revealed	 that	 the	
process	 of	 EMT	 is	 essential	 in	 gastrulation	 and	 is	 evolutionary	 conserved	
(Reviewed	 in	Thiery	et	al.	2009).	 Four	 “waves”	of	EMT	occur	at	multiple	 stages	
during	 embryonic	 development,	 starting	 from	 gastrulation	 in	 early	 stages	 of	
development	leading	up	to	organogenesis	in	later	stages	of	development.	During	
gastrulation,	 EMT	 is	 required	 to	 mediate	 cellular	 movement	 and	 proliferation,	
which	 are	 central	 to	 promoting	morphogenesis.	 For	 example,	 neural	 crest	 cells	
(cells	 of	 the	 primitive	 neural	 tube)	 undergo	 EMT	 in	 order	 to	 delaminate	 and	
migrate	 into	 their	 target	sites,	where	 they	differentiate	 into	 their	 specified	 fate	
(Minoux	 &	 Rijli	 2010;	 Theveneau	 &	 Mayor	 2011).	 Similarly,	 during	 heart	
morphogenesis,	cardiac-specified	cells	undergo	EMT	to	first	form	the	heart	tube,	
this	is	followed	by	a	second	EMT	“wave”	and	the	reverse	process;	mesenchymal-
epithelial	 transition	 to	 form	 the	 epicardium	and	 the	myocardium	 linings	 of	 the	
heart,	followed	by	the	formation	of	the	endocardial	cushions	(Chua	et	al.,	2011).	
The	 molecular	 mechanisms	 controlling	 EMT	 during	 development	 include	
transcriptional	activation	by	TWIST1,	SNAIL	and	GATA4,	where	they	act	as	master	
regulators	 during	 this	 process	 (Jiang	 et	 al.	 1999;	 Kuo	 et	 al.	 1997).	 TWIST1,	
regulates	 the	balance	between	growth	 factor	 signalling	pathways	 such	as	BMP,	
TGF-β	and	FGF,	which	play	opposing	roles	 in	mediating	EMT	during	gastrulation	
(Connerney	et	al.	2006).	BMP-WNT	and	TGF-β	signalling	 forms	a	gradient	 in	the	
mesoderm	 that	 promotes	 EMT	 and	 delamination,	 whereas	 a	 gradient	 of	 FGF	
signalling	inhibits	this	process	(Reviewed	in	Lin	et	al.	2012;	Lim	&	Thiery	2012).	
	
During	heart	valve	formation,	endocardial	cushion	cells	lining	the	heart	undergo	
EndMT	in	order	to	migrate	and	invade	the	cardiac	jelly	and	form	a	mesenchymal	
cell	layer	in	the	out	flow	tract	and	atrioventricular	(AV)	canal	that	will	later	form	
the	heart	valve,	giving	rise	to	the	mature	heart	valves	(von	Gise	&	Pu	2012).	This	
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involvement	of	EndMT	in	heart	valve	formation	was	first	identified	by	Markwald	
in	1975.	 In	 the	1980s	Markwald	 further	established	 the	 role	of	EndMT	 in	heart	
valve	formation	by	studying	the	behaviour	of	chick	endocardial	cushion	explants	
in	 3D	 collagen	 culture.	 It	 was	 observed	 that	 the	 endocardial	 cushion	 cells	
migrated	and	invaded	into	the	collagen	gel	and	later	formed	mesenchymal	cells	
on	the	surface	of	the	gel,	thus	recapitulating	endocardial	cushion	formation	that	
occurs	in	vivo	(Bernanke	&	Markwald	1982;	Runyan	&	Markwald	1983).		
	
GATA4	controls	one	of	the	most	prominent	pathways	that	regulates	endocardial	
cushion	 EndMT	 (Zeisberg	 et	 al.,	 2005,	 Rivera-Feliciano	 et	 al.,	 2006).	 EC-specific	
Gata4	deletion	caused	endocardial	cells	to	fail	to	undergo	EndMT	and	gave	rise	to	
cardiac	 cushion	 defects	 (Rivera-Feliciano	 et	 al.	 2006).	 The	mechanism	 involves	
the	activation	of	Erb-B2	Receptor	Tyrosine	Kinase	3	(ERBB3),	a	cell	surface	receptor	
belonging	 to	 the	 epidermal	 growth	 factor	 receptor	 (EGFR)	 tyrosine	 kinase	 family	
(Rivera-Feliciano	et	al.	2006).	Erbb3,	another	essential	endocardial	EndMT	signalling	
component,	mediates	ERK	activation,	which	gives	rise	to	the	induction	EndMT	gene	
programme	 (Rivera-Feliciano	 et	 al.,	 2006).	 GATA4	 also	 regulates	 TGF-β	 signalling	
through	 feeding	 into	 Smad	 4	 activation,	 which	 then	 activates	 EndM	 via	 TWIST1	
(Moskowitz,	 et	 al.	 2011).	 Smad	4	 activation	promotes	 β-catenin-	mediated	 EndMT	
(Lim	&	Thiery	2012b;	Medici	et	al.	2011).	
	
Notch	 signalling	 is	 another	 essential	 molecular	 activator	 of	 endocardial	 EndMT.	
Studies	 have	 shown	 that	 Notch	 receptor	 mutants	 fail	 to	 undergo	 EndMT	 and	
displayed	 cardiac	 cushion	 defects	 (Timmerman	 et	 al.,	 2004).	 These	 mutants	 also	
displayed	a	reduction	in	TGF-β	2,	indicating	that	Notch	signalling	is	required	for	TGF-
β	 2	 signalling	 in	 endocardial	 EndMT	 (Timmerman	 et	 al.	 2004).	 Notch	 signalling	
promotes	the	activation	of	HEY2,	which	together	with	BMP2	triggers	EndMT	(Luna-
Zurita	 et	 al.	 2010).	 Of	 note,	 TWIST1	 and	 SNAIL	 interact	 with	 HEY2	 and	 BMP2	 in	
promoting	EndMT	and	inhibition	of	this	interaction	gave	rise	to	valve	malformations	
(Luna-Zurita	 et	 al.	 2010).	 Several	 studies	 have	 revealed	 that	 TWIST1	 promotes	
essential	 genes	 that	 control	 EC	 migration,	 proliferation	 and	 invasion	 during	 valve	
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formation,	 such	 as	 neuronal	 (N)-cadherin,	 osteoblast	 (OB)-cadherin,	 Tbx20	 and	
Mmp2	 (Lee	 &	 Yutzey	 2011;	 Chakraborty	 et	 al.	 2010;	 Shelton	 &	 Yutzey	 2008).	 In	
addition,	 TWIST1-mediated	 Tbx20	 activation	 is	 required	 for	 the	 induction	 of	
canonical	WNT	 signalling	 (Cai	 et	 al.	 2013)	which	 is	 required	 for	 valve	 formation	as	
revealed	 in	 functional	 studies	 (Liebner	 et	 al.	 2004).	 Moreover,	 EndMT	 plays	 an	
important	 role	 in	 mediating	 sprouting	 angiogenesis	 in	 the	 retina	 development	
(Coultas	et	al.	 2005).	Cells	 at	 the	 tips	of	 the	angiogenic	 sprouts	were	 shown	 to	be	
undergoing	EndMT.	The	proposed	mechanism	was	via	VEGF	and	TWIST1	signalling	(Li	
(Li	et	al.	2014;	Coultas	et	al.	2005).	
	
1.7.3	Role	of	EndMT	in	disease	
1.7.3.1	EndMT	in	cancer	
The	 tumour	 microenvironment	 supports	 cancer	 cell	 survival	 by	 promoting	
angiogenesis,	 vasculogenesis	 and	 tumour	 metastasis.	 Carcinoma-associated	
fibroblasts	(CAFs)	contribute	to	the	supportive	role	of	the	tumour	microenvironment	
by	 promoting	 metastasis	 (Reviewed	 in	 Medici	 &	 Kalluri	 2012).	 Zeisberg	 et	 al.,	
identified	the	role	of	EndMT	in	the	formation	of	CAFs	using	a	combination	of	in	vivo	
cancer	models,	 in	vitro	cell	cultures	and	cell	 lineage	tracing.	Zeisberg	et	al.	showed	
that	40%	of	tumour	CAFs	originated	from	EC	in	the	tumour	microenvironment	that	
underwent	 EndMT	 via	 TGF-β	 signalling.	 Subsequently	 EC	 transform	 into	 a	
myofibroblasts	to	form	CAFs,	which	positively	feedback	into	the	EndMT	pathway	by	
secreting	TGF-β	1,	triggering	tumour	metastasis	via	EMT	and	angiogenesis	via	EndMT	
(Zeisberg	 et	 al.	 2007).	 Of	 note	 EMT	 is	 the	 primary	mechanism	 by	 which	 tumours	
metastasise	 and	 is	 mainly	 driven	 by	 Twist1	 and	 Snail	 transcriptional	 activation	 of	
target	 genes	 and	 suppression	 of	 E-cadherin	 (Reviewed	 in	 Heerboth	 et	 al.	 2015).	
Other	 studies	 have	 highlighted	 the	 importance	 of	 EndMT	 in	 cancer	 survival	 by	
demonstrating	that	tumour	hypoxia	triggers	angiogenesis	through	HIF1-α	mediated	
activation	 of	 Twist1	 and	 subsequent	 EndMT.	 EndMT	 transcription	 factors	 TWIST1,	
SNAIL	 and	 GATA4	 promote	 cancer	 cell	 survival	 by	 activating	 cell	 proliferation	 and	
migratory	 genes,	 whilst	 inhibiting	 pro-apoptotic	 and	 for	 TWIST1	 inhibition	 of	
senescence	pathways	(Chakraborty	et	al.	2010;	Kyrönlahti	et	al.	2008).	
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1.6.3.2	EndMT	in	fibrotic	diseases	
Heart	failure	following	cardiac	stress	such	as	pressure	overload	and	acute	ischaemic	
injury	is	associated	with	cardiac	fibrosis.	This	process	of	cardiac	fibrosis	involves	the	
proliferation	 of	 cardiac	 fibroblasts.	 The	 Kalluri	 lab	 provided	 an	 insight	 into	 the	
involvement	 of	 EndMT	 in	 fibrotic	 diseases.	 In	 a	 study	 by	 Zeisberg	 et	 al	 it	 was	
revealed	 in	murine	models	 of	 pressure	overload	 and	 chronic	 allograft	 rejection	 EC	
underwent	TGF-β	1-dependent	EndMT	to	form	fibroblasts	which	in	turn	contributed	
to	cardiac	fibrosis	(	Zeisberg	et	al.	2007).	This	study	thus	provided	a	novel	insight	into	
the	 mechanisms	 that	 are	 involved	 in	 cardiac	 fibrosis.	 BMP7	 treatment	 prevented	
EndMT-mediated	 conversion	 of	 EC	 into	 fibroblasts,	 thus	 suggesting	 that	 BMP7	
administration	is	a	relevant	therapeutic	strategy	to	reverse	cardiac	fibrosis	(Zeisberg	
et	 al.	 2007	 ).	 Interestingly,	 cell	 tracking	 experiments	 by	 Ubil	 et	 al.	 showed	 that	
fibroblasts	 could	 undergo	 a	 reverse	 process	 of	 EndMT,	 known	 as	 mesenchymal-
endothelial	 transition	 (MEndT)	 (Ubil	 et	 al.	 2014).	 During	 this	 process	 fibroblasts	
convert	 into	 EC	 which	 directly	 contribute	 to	 cardiac	 repair	 by	 promoting	
neovascularisation	 following	 cardiac	 injury	 (Ubil	 et	 al.	 2014).	 The	 mechanism	
underlying	MEndT	 is	 dependent	 on	 p53	 activation	 by	DNA	damage	 sensor	 ϒH2AX.	
Ubil	et	al.,	 show	that	 inhibition	of	p53	blocks	MEndT	and	diminishes	cardiac	repair	
and	 function	 (Ubil	 et	 al.	 2014).	 Since	 TWIST1	 inhibits	 p53	 and	 drives	 EndMT	
(Maestro	 et	 al.	 1999;	 Wang	 et	 al.	 2003)	 it	 could	 be	 that	 TWIST1	 is	 potential	
molecular	switch	between	EndMT	and	MEndT.	Thus	inhibition	of	TWIST1	may	be	a	
potential	therapeutic	strategy	to	activate	MEndT	following	cardiac	injury.	
	
The	Dejana	lab	identified	the	involvement	of	EndMT	in	the	pathogenesis	of	cerebral	
cavernous	malformations	(CCM)	a	disease	that	 is	characterised	by	the	formation	of	
fibrotic	 lesions	 and	 vascular	malformations	 in	 the	 brain.	 The	mechanism	by	which	
EndMT	 supported	 CCM	 lesion	 formation	 was	 by	 TGF-β	 signalling	 through	 BMP6,	
which	 gave	 rise	 to	 an	 increase	 in	 EC	 proliferation	 and	 invasion	 (Maddaluno	 et	 al.	
2013).	 The	 Kalluri	 lab	 revealed	 the	 involvement	 of	 EndMT	 in	 renal	 fibrosis	 as	
evidenced	by	the	co-expression	of	EC	marker	(CD31)	with	mesenchymal	gene	α-Sma	
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following	renal	injury	in	three	different	murine	models	of	kidney	fibrosis	(Zeisberg	et	
al.	2008).	Additionally,	a	 recent	 study	by	Ranchoux	et	al.,	 showed	 that	EndMT	 is	a	
key	 driver	 of	 fibrosis	 in	 pulmonary	 arterial	 hypertension	 (PAH)	 (Ranchoux	 et	 al.	
2015).	 The	 mechanism	 proposed	 of	 EndMT	 in	 PAH	 was	 via	 TWIST1	 and	 TGF-β-
induction	of	EndMT	(Ranchoux	et	al.	2015).		
	
Since	EndMT	changes	 influences	cell	proliferation,	migration	and	permeability,	 it	 is	
plausible	 that	EndMT	could	be	 involved	 in	promoting	atherosclerosis.	 Evidence	 for	
involvement	of	EndMT	in	atherosclerosis	was	recently	provided	by	Sánchez-Duffhues	
et	 al.	 and	Moonen	 et	 al.,	 where	 both	 of	 these	 studies	 showed	 the	 expression	 of	
mesenchymal	 proteins	 SLUG	 and	 α-SMA	 in	 the	 luminal	 EC	 layer	 of	 atherosclerotic	
plaques	 (Sánchez-Duffhues	 et	 al.	 2015;	 Moonen	 et	 al.	 2015).	 In	 addition,	 these	
studies	showed	that	EndMT	is	activated	 in	vitro	and	 in	vivo	by	pro-atherogenic	 low	
WSS	 through	TGF-β	 signalling	 (Sánchez-Duffhues	et	 al.	 2015;	Moonen	et	 al.	 2015).	
However,	 very	 recently	 the	 Simons	 group	 showed	 direct	 evidence	 for	 the	 role	 of	
EndMT	in	atherosclerosis.	Chen	et	al.,	showed	that	low	WSS	inhibited	FGF	signalling	
and	 increased	TGFB	signalling,	which	then	triggered	EndMT.	EC-specific	blocking	of	
FGF	signalling	enhanced	atherosclerosis,	suggesting	that	FGF	signalling	blocks	EndMT	
and	 is	 atheroprotective	 (Chen	 et	 al.	 2015).	 Interestingly	 FGF	 signalling	 has	 been	
shown	to	promote	EndMT	 in	corneal	 fibrosis	 (Lee	&	Kay	2006),	 thus	revealing	 that	
FGF-mediated	 regulation	 of	 EndMT	 is	 context	 dependent	 and	 may	 rely	 on	 the	
control	 of	 an	 upstream	 molecular	 switch.	 The	 involvement	 of	 EndMT	 in	
atherosclerosis	 is	 novel	 and	 given	 the	 involvement	of	 various	 EndMT	 regulators	 in	
other	 fibrotic	 diseases,	 there	 are	 other	 possible	 EndMT	 regulators	 that	 could	 be	
playing	a	role	in	promoting	EndMT	in	atherosclerosis.	
	
In	 summary,	 EndMT	 is	 an	 essential	 process	 during	 development.	 However	 in	 the	
adult,	the	re-activation	of	EndMT	acts	a	potent	driver	of	cancer	and	fibrotic	diseases	
(Figure	11).	The	underlying	pathology	of	these	conditions	is	dependent	upon	EndMT-
mediated	 cellular	 proliferation,	 migration	 and	 invasion,	 which	 are	 controlled	 by	
several	pathways	and	transcriptional	regulators	including	TWIST1	and	GATA4.	
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Figure	11.	Role	of	EndMT	in	development	and	disease	 	
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Figure	 11.	 Role	 of	 EndMT	 in	 development	 and	 in	 disease.	A)	 Summary	 for	 the	
role	of	EndMT	in	development	and	disease.	The	left	panel	depicts	a	schematic	for	
the	 role	 of	 EndMT	 in	 valve	 formation	 and	 in	 retinal	 vascular	 development.	 The	
panel	 on	 the	 	 right	 depicts	 a	 schematic	 for	 the	 role	 of	 EndMT	 in	 cancer	 cell	
survival	and	in	fibrotic	diseases.	
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1.8	Hypothesis	
	
Low	WSS	promotes	EC	dysfunction	and	atherosclerosis	through	TWIST1	and	GATA4-
mediated	induction	of	EndMT.		
	
	
	
	
1.9	Aims:	
1. To	 study	 the	 effects	 of	 WSS	 on	 TWIST1	 and	 GATA4	 gene	 expression	 in	
cultured	cells	using	in	vitro	flow	systems.	
	
2. To	study	the	effects	of	WSS	on	TWIST1	and	GATA4	gene	expression	in	vivo,	in	
the	 porcine	 and	 murine	 aortic	 arch	 and	 in	 experimental	 cuffed	 carotid	
arteries.		
	
3. To	 study	 the	 functional	 output	 of	 TWIST1	 and	 GATA4	 on	 EC	 function,	 by	
assessment	 of	 EndMT,	 EC	 proliferation,	 permeability	 and	migration	 in	 vitro	
and	in	vivo.	
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Chapter	2:	Materials	and	Methods	
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2.1	Materials		
Materials	and	reagents	used	are	listed	in	the	following;		
1) Primary	cell	culture/	cell	transfection	(table2)	
2) Immunostaining/	Chromatin	Immunoprecipitation	(ChIP)	(table	3)	
3) RNA	isolation/qRT-PCR/standard	PCR	(table	4)	
4) In	vivo	techniques	(table	5)	
	
2.2	Methods	
2.2.1	Isolation	and	culture	of	Human	umbilical	vein	endothelial	cells	(HUVEC)	
HUVEC	were	 isolated	from	umbilical	cords,	collected	anonymously,	without	patient	
identifiers	with	ethical	consent	(Sheffield	REC	10/H1308/25).	The	cords	were	cleaned	
from	 excess	 blood	 using	 Azowipe™	 tissue.	 A	 14	 gauge,	 2x45	 mm	 cannula	 was	
inserted	 into	 the	umbilical	 vein	and	clipped	 in	place	using	crocodile	clips.	10	ml	of	
serum-free	M199	was	flushed	through	the	vein	to	remove	blood	clots.	The	distal	end	
of	 the	 cord	was	 sealed	with	 a	 crocodile	 clip	 and	10	ml	 of	 pre-warmed	 serum	 free	
media	containing	1	mg/ml	collagenase	(from	Clostridium	histolyticum;	sterile	filtered	
using	a	0.2	 	μm	Filtropur	filter)	was	 injected	 into	the	vein.	The	cord	was	 incubated	
with	the	collagenase	for	10-15	min	at	room	temperature.	Following	 incubation	the	
clip	 at	 the	 distal	 end	was	 removed	 and	 the	 flow-through	 containing	 the	 extracted	
HUVEC	in	collagenase	was	flushed	into	a	tube	and	was	centrifuged	at	1200	rpm	(210	
G)	for	5	min	to	collect	the	cells.	The	cell	pellet	was	resuspended	in	12	ml	of	complete	
M199	growth	medium	(all	media	constituents	are	 in	appendix	1)	and	were	seeded	
onto	1%	gelatin	coated	T75	cell	culture	flasks.	The	cells	were	maintained	 in	a	37⁰C	
incubator	with	5	%	CO2	and	the	following	day	the	cells	were	washed	using	phosphate	
buffer	saline	(PBS)	and	the	growth	media	was	changed.	The	media	was	then	changed	
every	 2-3	 days.	 Once	 the	 cells	 reached	 approximately	 90	%	 confluence	 they	were	
passaged	 using	 trypsin	 (Table	 2).	 The	 cells	 were	 used	 at	 a	 passage	 of	 3-5	 for	 all	
experiments.	
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Table	2.	Materials	used	for	primary	cell	culture/cell	transfection		
Material	name	 Product	number;	Company	
Primary	cell	culture/	cell	transfection	
14	gauge,	2x45mm	cannula,	Vetiflon™	
	
47776,	BD	Biosciences	
34	mm	diameter	6-well	plates,	Cellstar®,	 657160,	grenierbio-one	
Amphotericin	B	 BP264550,	Thermo-sceitnfic	
Azowipe™	tissue	 Synergy	health	
Collagenase	from	Clostridium	
histolyticum	
C8051;	Sigma-Aldrich	
Endothelial	growth	factor	(EGF)	
supplement	
02-101,	Millipore	
Filtropur™	filter	(0.2μm)	 40645103,SARDTEDT	
Gelatin	from	bovine	skin	
G9391,	Sigma-Aldrich	
Gentamicin	 15710-080,	Invitrogen	
Heparin	 H3149,	Sigma-Aldrich	
L-Glutamine	 25030-081;	Thermo-scientific	
M199	media,	Gibco®	 21180-021,	Sigma-Aldrich	
Three-way	tap	 39511;	BD	biosciences	
Trypsin-EDTA	X1	(in	PBS)	 B10613,	GmbH	
96-well	flat	bottom	plate,	Cellstar®	 655180,	Grenierbio-one	
T75cm2	tissue	culture	flask,	Nunc®	 598287;	Thermo-scientific	
T25	cm2	tissue	culture	flask,	Nunc®	 136196;	Thermo-scientific	
Transwell	inserts,	Corning®	(24mm,	
0.4μm	polyester	membrane)	
CC401;	Appleton	woods	
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Collagen	solution	(from	bovine	skin)	 C4243;	Sigma-Aldrich	
Recombinant	murine	VEGF	 450-32;	Peprtotech	
Pen/Strep	 15140122;	Thermo-scientific	
Phosphate	buffered	saline	(PBS)	 P4417;	Sigma-Aldrich	
Fetal	Bovine	serum	 Sigma-Aldrich	
Fibronectin	 F0895;	Sigma-Aldrich	
Lipofectamine	RNAiMAX™	 56532;	Invitrogen	
M199		Gibco®	cell	culture	medium	 11150-059;	Thermo-Scientific	
DMEM	cell	culture	medium	(With	1g/l	
glucose)	
12614-Q;	Lonza	
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Table	3.	Materials	used	for	immunostaining/ChIP		
Material	name	 Product	number;	Company	
Immunostaining/	chromatin	immunoprecipitation	(ChIP)	
SIGMAFAST™	DAB	with	Metal	Enhancer	
tablet.	
	
	
D0426;	Sigma-Aldrich	
Avidin-biotin	complex	(ABC)	kit,	
Vectastain®	
PK4000;	Vector	laboratories	
TOPRO	 T3605;	Thermo-scientific	
DPX	mountant	 06522;	Sigma-Aldrich	
Triton™X-100	 T8787,	Sigma-Aldrich	
Menzel-Glӓser,	Superfrost®	microscope	
slide	
AA00000112E;	Thermo-scientific	
Absolute	goat	serum	 G9023;	Sigma-Aldrich	
4%	Formaldehyde	
9713.5000,	VWR	Chemicals	
4',6-diamidino-2-phenylindole	(DAPI)	 D9452,	Sigma-Aldrich	
34mm	round	Menzel-Glӓser	glass	cover	
slips	
1283,	Thermo-scientific	
Carazzi’s	haematoxylin	 75290;	Raymona	A.	Lamb;	Company	
Trypsin	 215240;	DIFCO	
SimpleChip	chromatin	plus	enzymatic	IP	
kit	
9005;	Cell	signalling	
Prolong®	gold	antifade	mountant	 P1044;	Thermo-scientific	
PKH26	membrane	label	 PKH26GL;	Sigma-Aldrich	
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Table	4.Materials	used	for	RNA	isolation/	qRT-PCR/	standard	PCR		
Material	name	 Product	number;	Company	
RNA	isolation/qRT-PCR/	standard	PCR	
Hotstart	Taq	mastermix	kit	
	
203443;	Qiagen	
RNeasy	minikit	 74106;	Qiagen	
β-mercaptoethanol	 M6250;Sigma-Aldrich	
Scalpel	blade	 66XX;	Swann-Morton	
Plastipak™	syringes	(1ml)	 30013,	BD	biosciences	
RNase	zap®	 AM9780	;	Life	technologies	
iScipt™cDNA	synthesis	kit	 170-8891,	BIORAD	
Ethanol	
	
E7023,	Sigma-Aldrich	
Clear	adhesive	film	for	384-well	plate	 95016806,	Anachem	
384	well	plate	 HSP3805,	BIORAD	
21	gauge	needle,	MicroLance™	 ;BD	Biosciences	
Q5®High	fidelity	Taq	DNA	polymerase	kit	 M0491L;NEB	
Agarose	 A9539;	Sigma-Aldrich	
DNA	gel	loading	dye	 R0611;	Life	technologies	
100bp	DNA	ladder	 N3231;	NEB	
Tris-HCl	 T5941;	Sigma-Aldrich	
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EDTA	 ED;	Sigma-Aldrich	
Tween-20	 P1379;	Sigma-Aldrich	
Proteinase	K	 P10144;	Life	technologies	
				
	
Table	5.	Materials	used	for	in	vivo	techniques		
Material	name	 Product	number;	Company	
In	vivo	techniques	
	
25	gauge	needle,	MicroLance™	
	
BD	Biosciences	
Corn	oil	
15256;	Sigma-Aldrich	
	
Tamoxifen	
	
T5648;	Sigma-Aldrich	
	
Ethanol	
	
E7023,	Sigma-Aldrich		
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2.2.2	Isolation	and	culture	of	porcine	aortic	endothelial	cells	(PAEC)	
PAEC	were	 isolated	 from	 descending	 aortae	 of	 approximately	 60	 kg,	 6	month	 old	
female	pigs	collected	from	a	local	abattoir.	The	aortae	were	cleaned	from	connective	
tissue	 and	 the	 inter-costal	 arteries	 were	 sealed	 using	 a	 cotton	 thread	 and/or	
crocodile	clips.		A	three-way	tap	was	inserted	into	the	aorta	and	10	ml	of	serum	free	
DMEM	media	was	flushed	through	the	vessel.	The	distal	end	of	the	vessel	was	sealed	
using	cable	ties	and	10-15	ml	of	serum-free	DMEM	media	containing	0.2	mg/ml	of	
collagenase	 (sterile	 filtered)	 was	 injected	 into	 the	 vessel.	 This	 was	 covered	 with	
Azowipes™	and	was	placed	in	a	37⁰C	incubator	for	10	min,	in	order	to	enhance	the	
enzymatic	 activity	 of	 the	 collagenase.	 Following	 incubation,	 the	 flow-through	
containing	the	PAEC	was	collected	into	a	tube	and	was	then	centrifuged	at	1200	rpm	
(210	 G)	 for	 5	min	 to	 collect	 the	 cells.	 The	 cell	 pellet	 was	 resuspended	 in	 7	ml	 of	
complete	 DMEM	 growth	medium	 and	 cells	were	 seeded	 into	 a	 T25	 tissue	 culture	
flask.	The	cells	were	maintained	in	a	37	⁰C	incubator	with	5	%	CO2	.The	following	day,	
the	cells	were	washed	with	PBS	and	given	fresh	complete	DMEM	growth	medium	1.	
Once	the	cells	reach	confluence,	they	were	passaged	accordingly	and	the	media	was	
changed	 every	 2-3	 days.	 Once	 the	 cell	 passage	 was	 beyond	 P1	 complete	 DMEM	
growth	media	2	was	given.	The	cells	were	used	at	passage	3-5	for	experiments.	
	
2.2.3	Isolation	of	RNA	from	EC	in	the	porcine	aorta	
Porcine	hearts	with	the	intact	aortic	arch	and	descending	aorta	(from	approximately	
60	kg,	6	month	old	female	pigs)	were	collected	from	a	local	abattoir.	The	tissue	was	
stored	 in	 ice-	 cold	 transport	 media.	 The	 aortic	 arch	 was	 cleaned	 from	 excess	
connective	tissue	and	blood.	A	1x1	cm	square	region	was	dissected	from	the	 inner	
curvature	(low	WSS	region)	and	the	outer	curvature	(high	WSS	region)	(Figure	12;	as	
identified	by	reference	to	a	shear	stress	map,	de	Luca,	Serbanovic-canic	and	Evans	et	
al.	Manuscript	Submitted).		
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Figure	12.	Schematic	of	RNA	isolation	from	the	porcine	aortic	arch						
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Figure	12.	Schematic	of	RNA	isolation	from	the	porcine	aortic	arch.	To	study	the	
expression	of	genes	of	interest	from	the	distinct	flow	areas	in	the	porcine	aorta,	a	
1x1cm	region	was	dissected	from	the	inner	(low	WSS)	and	the	outer	 (high	WSS)	
region	 of	 the	 porcine	 aorta.	 Endothelial	 RNA	 was	 extracted	 using	 collagenase	
treatment	followed	by	RNA	purification.	The	shear	stress	map	was	generated	by	
measurement	 of	 vascular	 geometry	 (via	 MRI)	 followed	 by	 computational	 fluid	
dynamics	(CFD)	by	Dr.	Amalia	de	Luca	(unpublished).	
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	The	tissue	sections	were	placed	 lumen-side	down	onto	a	1	ml	drop	of	collagenase	
solution	 (1	mg/ml	 collagenase	added	 to	 serum	 free	DMEM;	placed	on	RNase	 zap®	
cleaned	 parafilm)	 and	 incubated	 at	 room	 temperature	 for	 10	 minutes.	 The	
collagenase	 solution	 was	 collected	 into	 a	 1.5	 ml	 microfuge	 tube	 and	 the	 tissue	
sections	were	gently	scraped	using	a	scalpel	blade	in	order	to	isolate	the	endothelial	
cell	layer	of	the	lumen	intima.	The	cells	were	centrifuged	at	3000	rpm	(564	G)	for	3	
min.	 	 The	 pellet	 of	 EC	 from	each	 tissue	 section	was	 resuspended	 into	 350	 μl	 lysis	
buffer	solution,	prepared	by	adding	0.01%	of	β-mercaptoethanol	to	a	final	volume	of	
350	μl	per	aortic	tissue	section	of	lysis	buffer	(RLT	buffer;	Qiagen	Rneasy	kit	TM).	The	
cell	lysate	was	homogenised	by	passing	it	through	a	21	gauge	needle	5-6	times.	350	
μl	of	70	%	Ethanol	was	added	and	total	RNA	was	extracted	using	the	RNeasy™	mini	
kit,	 following	 the	 manufacturer’s	 protocol.	 RNA	 concentration	 and	 purity	 were	
assessed	 spectrophotometrically	 with	 a	 Nano	 Drop	 ND-1000	 (Life	 technologies).	
Analysis	of	RNA	quality	involved	measurement	of	optical	density	to	determine	260-
280	nm	and	260-230	nm	ratios,	using	the	ND-1000	v	3.7.0	software.	
2.2.3	Exposure	of	EC	to	flow	using	in	vitro	flow	systems	
To	 study	 the	 direct	 effects	 of	 flow-induced	 WSS	 on	 EC	 physiology,	 two	
complimentary	 in	 vitro	 flow	 systems	were	 used	 for	 this	 purpose,	 and	 the	method	
used	to	set	up	both	systems	will	be	presented.	
2.2.3.1	The	6-well	orbiting	plate	system	
HUVEC	 and	 PAEC	were	 seeded	 onto	 1	 %	 gelatin	 coated	 6-well	 (34	mm	 diameter)	
culture	 plates	 at	 a	 density	 of	 approximately	 300,000	 cells	 /well,	 the	 cells	 were	
cultured	 overnight	 and	 became	 confluent	 the	 following	 day.	 The	media	 was	 then	
removed	and	3	ml	of	complete	M199	growth	media	was	added	to	each	well	and	the	
cells	 were	 placed	 on	 an	 orbital	 shaking	 platform	 (PSU-10i;	 Grant	 instruments)	
housed	inside	a	cell	culture	incubator	(37	⁰C,	5	%	CO2)	rotating	at	210	rpm	with	an	
orbiting	radius	of	10	mm,	for	the	duration	of	72	h	(Figure	13).								
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HUVEC	or	PAEC	plated	onto	6-
well	plates		
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Figure	13.	Schematic	for	orbital	shaking	system.	A)	The	effects	of	flow	on	EC	was	studied	using	the	
orbital	 plate	 system.	 HUVEC	 and	 PAEC	 cultured	 onto	 6-well	 plates	 were	 placed	 onto	 an	 orbital	
shaking	platform,	rotating	at	210	rpm	with	an	orbiting	radius	of	10	mm,	for	the	duration	of	72h.The	
orbital	shaking	creates	a	swirling	motion	of	media	in	the	well	and	computational	fluid	dynamics	and	
particle	 imaging	 velocimetry	 analyses	 show	 that	 at	 the	centre	 of	 the	well,	 cells	 are	 exposed	 to	 a	
constant	 low	mean	WSS	magnitude	 (4.8	 dyne/cm2)	 but	 rapid	 in	 variations	 in	 directions	 (biaxial/	
disturbed	flow),	whilst	 in	the	periphery	of	the	well	 the	WSS	magnitude	 is	relatively	high	WSS	 	 (13	
dyne/cm2)	 and	 with	 pulsatile	 relatively	 uniform	 flow	 direction	 (uniaxial/	 non	 disturbed	 flow).	
Following	 orbital	 shaking,	 cells	 from	 the	 low	 and	 high	 WSS	 were	 either	 isolated	 for	 total	 RNA	
extraction	or	were	directly	used	for	immunostaining.	CFD	measurements	of	WSS	were	generated	in	
Warboys	et	al.,	2014.	
	
Figure	13.	Schematic	for	orbital	shaking	system	
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The	orbital	shaking	creates	a	swirling	motion	of	media	in	the	well	and	measurements	
of	 computational	 fluid	 dynamics	 and	 particle	 imaging	 velocimetry	 analyses	 have	
revealed	 that	 at	 the	 centre	 of	 the	well,	 cells	 are	 exposed	 to	 a	 constant	 low	mean	
WSS	 magnitude	 (4.8	 dyne/cm2)	 but	 rapid	 in	 variations	 in	 directions	 (biaxial/	
disturbed	flow),	whilst	 in	the	periphery	of	the	well	the	WSS	magnitude	is	relatively	
high	 WSS	 	 (13	 dyne/cm2)	 and	 with	 pulsatile	 relatively	 uniform	 flow	 direction	
(uniaxial/	non	disturbed	flow)	(Warboys	et	al.	2010;	Warboys	et	al.	2014;	Dardik	et	
al.	 2005).	 Following	 orbital	 shaking,	 cells	 from	 the	 low	 and	 high	WSS	were	 either	
isolated	for	total	RNA	extraction	or	were	fixed	and	used	for	immunostaining.	
	
2.2.3.2	The	Ibidi™	pump	parallel	plate	system	
HUVEC	were	seeded	onto	1	%	coated	Ibidi™	µ	0.4	Luer	slides	at	a	seeding	density	of	
250,000	cells/slide	in	a	total	of	120	μl	complete	M199	growth	medium.	Following	1-2	
h	 from	 seeding,	 the	 cells	were	 checked	 for	 attachment	 and	 for	 the	 presence	 of	 a	
confluent	 monolayer.	 The	 slide	 was	 then	 connected	 to	 the	 Ibidi™	 fluidic	 units	
following	 the	 Ibidi™	pump	set	up	manual.	Flow	parameters	were	set	on	the	 Ibidi™	
pump	control	software,	(v	1.5.3)	and	the	cells	were	exposed	to	flowing	media	by	the	
pressure	driven	by	the	 Ibidi™	pumps	feeding	 into	the	reservoirs	of	 the	fluidic	units	
(Figure	 14).	 The	 flow	 parameters	 studied	 were	 high,	 unidirectional	 WSS	 at	 13	
dyne/cm2,	 low,	 unidirectional	 WSS	 at	 4	 dyne/cm2	 and	 low,	 oscillatory	 WSS	 at	
4dynes/cm2,	with	 0.2Hz	 oscillations.	 Cells	were	 exposed	 to	 flow	 for	 72	 h	 then	 the	
cells	were	isolated	for	total	RNA	extraction.	
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Figure	14.	Schematic	for	the	Ibidi	™	parallel	plate	system					
					
Figure	14.	 Schematic	 for	 the	 Ibidi	™	parallel	plate	 system.	Specific	 flow	parameters	 (flow	
magnitude;	 WSS	 in	 dyne/cm2	 and	 flow	 direction)	 were	 set	 on	 the	 Ibidi™	 pump	 control	
software	on	a	 computer.	The	parameters	set	onto	 the	 software	are	 relayed	 	 to	 the	 Ibidi™	
pump,	 which	 then	 controls	 the	 air	 pressure	 to	 create	 the	 specific	 flow	 characteristics	 by	
controlling	the	flow	of	media	 from	the	fluidic	units	onto	the	cells	plated	onto	the	 Ibidi™	μ	
slide,	housed	inside	of	an	incubator.	Schematic	image	courtesy	of	Ibidi™	(GmbH).	
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2.2.4	RNA	extraction	from	EC	exposed	to	flow	
Following	 the	 exposure	 of	 cells	 to	 flow	 using	 the	 orbital	 plate	 system,	 the	 6-well	
plate	was	 kept	 on	 ice,	media	was	 removed	 and	 2	ml/	well	 of	 ice-cold	 PBS	 x2	was	
used	to	wash	the	cells.	1	ml	of	 ice-cold	PBS	was	added	per	well	and	the	plate	was	
placed	 on	 a	 map	 (Figure	 13),	 which	 outlines	 the	 specific	 low	 (centre)	 and	 high	
(periphery)	WSS	areas	on	 the	plate.	Using	 the	plunger	of	a	1	ml	syringe	cells	were	
first	 scraped	 from	 the	periphery	of	 each	well	 on	 the	plate	 and	 collected	 in	 a	 tube	
kept	on	 ice.	 Excess,	 uncollected	 cells	were	 removed	by	washing	 twice	with	2ml	of	
PBS	and	the	process	was	repeated	for	cells	 in	the	centre	of	the	well.	To	isolate	the	
cells	 collected	 from	 the	 centre	 and	 the	 periphery,	 the	 tubes	 were	 centrifuged	 at	
1200	 rpm	 (210	 G)	 for	 5	 min.	 Lysis	 buffer	 was	 prepared	 by	 adding	 0.01%	 of	 β-
mercaptoethanol	into	the	RLT	lysis	buffer.	The	cell	pellets	were	resuspended	in	350	
μl	of	lysis	buffer,	and	the	cell	lysate	was	homogenised	by	passing	the	suspension		
through	a	21	gauge	needle	using	a	1ml	syringe	five-six	times.	A	volume	of	350	μl	of	
70	%	ethanol	was	added	to	the	cell	lysate	to	precipitate	the	nucleic	acid	content	and	
total	RNA	was	extracted	using	the	Rneasy	kit,	following	the	manufacturer’s	protocol.	
RNA	 concentration	 and	 purity	 was	 assessed	 as	 described	 previously.	 For	 cells	
exposed	to	the	Ibidi	flow	system,	the	cells	were	also	kept	on	ice	and	120	μl	x3	of	lysis	
buffer	was	flushed	through	the	inlet	of	the	Ibidi®	µ	I	0.4	Luer	slide	and	was	collected	
in	a	1.5	ml	microfuge	tube.	The	cells	were	pelleted	by	centrifugation	at	3000	rpm	for	
5	min	(564	G).	The	cell	lysate	was	homogenised	and	total	RNA	extracted	as	described	
previously.	
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2.2.5	Gene	expression	analysis	by	q-PCR	
2.2.5.1	cDNA	synthesis	
The	expression	of	the	genes	of	 interest	was	assessed	by	quantitative	real	time	PCR	
(qRT-PCR).	 Total	 RNA	 at	 a	 concentration	 of	 200	 ng/μl	 was	 used	 for	 reverse	
transcription/	 cDNA	 synthesis	 using	 the	 iScipt™cDNA	 synthesis	 kit	 (Table	 4).	 The	
reaction	 constituents	 added	 were;	 5	 μl	 of	 5x	 iScript	 reaction	 mix,	 1	 μl	 of	 iScript	
reverse	transcriptase,	RNA	template	(200	ng)	x	μl	and	nuclease-free	water	at	x	μl	to	
give	 a	 total	 reaction	 volume	 of	 25	 μl.	 A	 thermal	 cycler	 (Veriti	 96	 well;	 Applied	
biosystems)	was	used	for	the	synthesis.	The	thermal	profile	of	the	reaction	used	was;	
step	1	at	25⁰C	for	5	min,	step	2	at	42⁰C	for	30	min,	step	3	at	85⁰C	for	5	min	and	step	
4	at	4⁰C	for	10	min.	
	
2.2.5.2	qRT-PCR		
	A	384	well	plate	set-up	was	adopted.	A	total	of	10	μl	reaction	volume	was	used,	this	
consisted	 of;	 4.4	 μl	 of	 cDNA	 (1.46	 ng/μl)	 and	 5.6	 μl	 of	 qRT-PCR	 SsoAdvanced	
universal	SYBR®	Green	master	mix	(0.3	μl	forward	primer,	0.3	μl	reverse	primer	and	
5	 μl	 SsoAdvanced	 universal	 SYBR®	Green	 supermix	was	 added	 per	well).	 For	 each	
gene	of	interest,	the	reaction	was	carried	out	in	triplicate.	The	384	well	plate	(Table	
4)	was	then	sealed	with	clear	adhesive	film	and	was	centrifuged	at	1000	rpm	(123	G)	
for	 1	 minute.	 qRT-PCR	 was	 conducted	 using	 the	 CFX384™	 Real-time	 instrument	
(BIORAD).	The	thermal	profile	used	was;	Step1	at	95	⁰C	for	3	min,	step	2	at	95	⁰C	for	
5	seconds,	step	3	at	60	⁰C	for	30	seconds	x	40	repeat,	a	final	dissociation	step	at	60⁰C	
then	 at	 95	 ⁰C	 for	 5	with	 gradual	 temperature	 increase	 by	 0.5	 ⁰C	 increments.	 The	
primer	melting	curve	was	analysed	 to	assess	amplification	of	product	and	 rule	out	
primer-dimer	contributions.	The	human	and	porcine	primers	used	are	listed	in	table	
6.	
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2.2.6	Analysis	of	qRT-PCR	data.	
During	 the	 PCR	 reaction,	 the	 SYBR	 dye	 is	 incorporated	 into	 double	 stranded	 DNA	
sequences	belonging	to	the	gene	of	interest	that	is	being	amplified	;	 	this	results	in	
an	increase	in	the	fluorescent	signal	emitted	by	the	dye	which	is	proportional	to	the	
amount	of	amplified	DNA	present	in	the	sample.	A	threshold	cycle	(Ct)	value	is	given;	
this	 is	 the	 number	 of	 cycles	 required	 for	 the	 PCR	 product	 to	 exceed	 the	
threshold/baseline	level	of	fluorescence.	Therefore	this	value	is	inversely	correlated	
with	 the	amount	of	DNA	sequence	present	 in	 the	 sample,	 the	more	abundant	 the	
sequence	 is	 the	 lower	the	number	of	cycles	required	to	exceed	the	threshold	 level	
(Ct	 value).	 Analysis	 of	 the	 qRT-PCR	 data	 was	 carried	 out	 via	 the	 BIO-RAD	 CFX	
manager	3.0	software	that	determined	the	Ct	value	for	each	gene	of	interest	being	
investigated.	 The	 data	 was	 analysed	 using	 the	 comparative	 Ct	 (2−ΔΔCT)	 method	
(Schmittgen	&	Livak	2008).	The	Ct	of	each	sample	was	normalised	to	the	Ct	value	of	
a	non-flow	responsive	housekeeping	gene	(Hypoxanthine	phopho	ribosyl	transferase	
(HPRT)),	to	give	the	ΔCT	value.	The	ΔΔCT	was	calculated	by	subtracting	the	average	
ΔCT	 value	 of	 sample	 1	 (eg.	 Low	WSS	 sample)	 from	 sample	 2	 (High	 WSS	 sample;	
experimental	control),	and	then	subtracting	the	average	ΔCT	value	of	sample	2	(High	
WSS;	experimental	control)	from	itself.	Relative	mRNA	fold	change	between	sample	
1	 and	 sample	 2	was	 calculated	 using	 the	 2−ΔΔCT	calculation.	 An	mRNA	 relative	 fold	
change	of	greater	than	1	was	indicative	of	an	increase	in	gene	expression	compared	
to	 the	 experimental	 control,	 whereas	 a	 value	 lower	 than	 1	 was	 indicative	 of	 a	
decrease	in	expression.		
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Table	6.	Primer	sequences			
Gene	 Forward	primer	 Reverse	primer	
Gata4	 TCCCAGACGTTCTCAGTCAG	 GGAGCTGGTCTGTGGAGACT	
Twist1	 CGGACAAGCTGAGCAAGAT	 CTGGAGGACCTGGTAGAGGA	
Klf4	 GAACCCACACAGGTGAGAAA	 CCCGTGTGTTTACGGTAGTG	
Slug	 CTGGCCAAACACAAGCAG	 ACCCAGGCTCACATATTCCT	
N-cadherin	 GCACAGATGTGGACAGGATT	 CAGCACAAGGATAAGCAGGA	
α-sma	 TTTCAGCTTCCCTGAACACCA	 GGGCAACACGAAGCTCATTG	
Cd31	 GGTGTTGGTGGAAGGACTG	 GGGACAGAACAGTTGACCCT	
Hprt	 TTGGTCAGGCAGTATAATCC	 GGGCATATCCTACAACAAC	
Klf2	 ACCAGTCACAGTTTGGGAG	 GCACGCACACAGGYGAGAAG	
Mcp-1	 GCAGAAGTGGGTTCAGGATT	 TGGGTTGTGGAGTGAGTGTT	
VE-cadherin	 GCCAGTTCTTCCGAGTCACA	 TTTCCTGTGGGGGTTCCAGT	
Twist1	
promoter	
AGCAATCCCAAATCGGCCC	 TGGCAACAGCTTCTACACAGT	
Snail	
promoter	
GCGGAGGTGACAAAGGGG	 AACCACTCGCTAGGCCGT	
	
	
	
	
Gene	 Forward	primer	 Reverse	primer	
Gata4	
	
GGAAGGCAGAGAGTGTGTCA	 GCTGATGCCATTCATCTTGT	
Twist1	 GGGAGTCCGCAGTCCTAC	 TGGATCTTGCTCAGCTTGTC	
B2m	 GGTTCAGGTTACTCACGCCAC	 CTTAACTACTTGGGCTTATCG	
cJun	 GAAAAGGAAGCTGGAGAGGAT	 CTGCTGCGTTAGCATGAGTT	
Mcp-1	 TCACCTGCTGCTATACACTTAC	 ATCACTGCTTCTTTAGGACACTTG	
Cd31	 TCAATGCTCCGTGAAAGAAG	 CCTGGGTGTCATTCAAAGTG	
VE-
cadherin	
GAGTTCACCTTGTGCGAGGA	 GAGGGAGATCACTGCGATGG	
α-sma	 CCAGAGCAATCAGGGACC	
	
CAATGGACGGGAAAACAGCC	
	
Slug	
	
	
CCTGGTCAAGAAGCATTTCA	
	
	
CTCCGGTTGTGGTATGACAG 
	
N-cadherin	 CCACAGACACCTCAAACCTG	
	
GACCCAGAGAAGCAGGGATA	
	
Klf4	 CTAAGCAGCAGGGACTGTCA	
	
GGCATGAGCTCTTGGTAATGG	
	
					Snail	 GCGAGCTACACGACTCTTCT	
	
GCCAGGAGAGAGTCCCAGAT	
	
A) Human	primers	
	B)	Porcine	primers	
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2.2.7	RNA	interference;	HUVEC	transfection	with	siRNA	
To	assess	gene	 function,	 genes	of	 interest	were	 silenced	using	gene	 specific	 siRNA	
oligonucleotides	(Table	7).	HUVEC	were	plated	into	1	%	gelatin	coated	6-well	plates	
at	 250,000	 cells/	 well.	 Gene	 specific	 siRNA	 or	 scrambled	 non	 targeting	 control	
oligonucleotides	 (final	 concentration	 of	 25	 nM)	were	 introduced	 into	 the	 cells	 via	
transfection	 using	 the	 Lipofectamine	 RNAiMAX	 transfection	 system	 	 following	 the	
manufacturer’s	 protocol.	 Briefly,	 the	 transfection	 mix,	 consisting	 of	 the	
Lipofectamine	 reagent	 (7.5	 μl	 Lipofectamine	 in	 142.5	 OPTIMEM	media/	 well)	 and	
gene	 specific	 siRNA	 oligonucleotides	 (1.25	 μl	 in	 148.75	 μl	 OPTIMEM/well)	 were	
added	 to	 cells	 cultured	 in	 700	 μl	M199	 transfection	medium.	 The	 cells	were	 then	
incubated	with	 the	 transfection	mix	 for	 5	hours	 (37⁰C,	 5	%	CO2	).	 The	 transfection	
media	was	then	removed	and	this	was	replaced	with	3ml	of	complete	M199	growth	
media	for	2	h	following	the	5	h	incubation	period,	the	media	was	changed	to	allow	
the	 cells	 to	 recover	 and	 the	 cells	 were	 exposed	 to	 flow	 using	 the	 orbital	 plate	
system,	in	order	to	assess	gene	function	under	the	effect	of	WSS.	
	
2.2.8	Immunocytochemistry	staining	of	cultured	EC	
The	expression	of	proteins	of	interest	was	assessed	by	immunostaining	using	specific	
antibodies	 (Tables	 8	 and	 9)	 followed	 by	 widefield	 fluorescence	 microscopy	
(LeicaDMI4000B).	HUVEC	exposed	to	flow	were	either	stained	directly	on	the	6-well	
plate	 or	 on	 34	mm	 glass	 slides	 (cells	 seeded	 onto	 glass	 slide	 prior	 to	 exposure	 to	
flow).	Following	orbital	shaking,	media	from	cultured	HUVEC	was	removed	and	500	
μl/well	of	4	%	formaldehyde	(10	min;	room	temperature)	was	added	to	fix	the	cells.	
The	cells	were	 then	permeabilised	by	adding	700	μl	of	0.1	%	 triton	 (10	min;	 room	
temperature).	To	block	non-specific	interactions	with	the	secondary	antibody	(Table	
9),	500	μl/well	20	%	goat	serum	was	added	(30	mins;	room	temperature).	This	was	
followed	 by	 adding	 500	 μl/well	 of	 specific	 antibodies	 diluted	 at	 the	 final	
concentration	 in	 5%	 goat	 serum.	 Alternatively,	 non-specific	 isotype	 controls	
(matching	 the	 species	 of	 the	 primary	 antibody)	 were	 added	 as	 a	 control	 for	
background	 /	 non-specific	 fluorescence.	 The	 primary	 antibodies	 were	 incubated	
overnight	 at	 4	 ⁰C.	 The	 primary	 antibody	 was	 then	 removed	 and	 the	 cells	 were	
washed	x3	with	1	ml/well	PBS	(for	5	min	at	room	temperature,	with	shaking)	and		 	
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Table	7.	siRNA	oligonucleotide	information		
Gene	 SiRNA	product	number;	company	purchased	from	
Gata4	 Silencer®	select	s5603;	Thermo-scientific	
Twist1	 Silencer®	select	s14523;	Thermo-scientific	
Snail	 OnTargetPlus	smartpool	L-010847-01;	Dharmacon	
Scrambled	 OnTargetPlus	Non	targeting	siRNA	1	D-001810-01-50;	Dharmacon	
	
	
	
	
	
	
	
	
	
	 	
	 76	
	
	
	
Ap
pli
ca
tio
n	a
nd
	fin
al	
dil
ut
ion
	us
ed
	
An
tib
od
y	
na
m
e	
Ho
st	
sp
ec
ies
	
Co
m
pa
ny
/P
ro
du
ct	
nu
m
be
r	
Im
m
un
oc
yt
oc
he
m
ist
ry
	
Im
m
un
oh
ist
oc
he
m
ist
ry
	
Ch
ro
m
at
in	
IP	
(C
hIP
)	
En
	fa
ce
	
im
m
un
os
ta
ini
ng
	
	
N-
ca
dh
er
in	
Ra
bb
it	
ab
12
22
1;	
	A
bc
am
	
(1
:25
0;	
4	μ
g/
ml
)	
-	
-	
	 -	
N-
ca
dh
er
in	
Ra
bb
it	
ab
18
20
3;	
Ab
ca
m	
	
-	
-	
-	
(1
:38
4;1
.25
μg
/m
l)	
Ki6
7	
Ra
bb
it	
Ab
	15
58
0;	
Ab
ca
m	
(1
:22
5;	
4	μ
g/
ml
)	
-	
	
(1
:18
0;	
5μ
g/
ml
)	
Al
ex
a	F
luo
r®
	
48
8	a
nt
i-
m
ou
se
	CD
31
	
co
nju
ga
te
	
Ra
t	
10
25
14
;	B
iol
eg
en
d	
-	
-	
-	
(1
:10
0;	
5μ
g/
ml
)	
M
ou
se
	Ig
G	
M
ou
se
	
I53
81
;	S
igm
a	
	
M
at
ch
ed
	to
	pr
im
ar
y	
M
at
ch
ed
	to
	pr
im
ar
y	
-	
M
at
ch
ed
	to
	
pr
im
ar
y	
Ra
bb
it	
IgG
	
Ra
bb
it	
I50
06
;	S
igm
a	
M
at
ch
ed
	to
	pr
im
ar
y	
M
at
ch
ed
	to
	pr
im
ar
y	
-	
M
at
ch
ed
	to
	
pr
im
ar
y		
Go
at
	Ig
G	
Go
at
	
I52
56
	;	S
igm
a	
	
	
	
M
at
ch
ed
	to
	
pr
im
ar
y	
	
Ta
bl
e	
8.
	P
rim
ar
y	
an
tib
od
ie
s		
	 77	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Antibody	name	 Product	no./company	
purchased	from	
Host	 Target	
species	
Dilution/final	
concentration	
AlexaFlour®568			 A-11011;	Thermoscientific	 Goat	 Rabbit	 (1:500;	4μg/ml)	
AlexaFlour®568		 A11004;	Thermoscientific	 Goat	 Mouse	 (1:500;	4μg/ml)	
AlexaFlour®568		 A11077;Thermoscientific	 Goat	 Rat	 (1:500;	4μg/ml)	
Alexa	Fluor®	488		 A-11088;	Thermoscientific	 Goat	 Rabbit	 (1:500;	4μg/ml)	
Biotinylated		 BA1000;	Vector-	
aboratories	
Goat	 Rabbit	 1:200	
Table	9.	Secondary	antibodies		
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500	μl/well	 of	 secondary	antibodies	were	 incubated	 for	2	h	 at	 room	 temperature,	
with	shaking.	The	cells	were	washed	with	PBS	as	described	previously	and	the	nuclei	
were	stained	using	a	DNA-binding	dye;	DAPI	added	at	500	μl/well,	in	PBS	(Incubated	
for	10	mins,	at	room	temperature).	At	least	5	images	were	captured	from	every	WSS	
region	(i.e.	At	least	5	images	from	the	centre	and	5	from	the	periphery	of	the	well).	
The	images	were	captured	using	the	same	exposure	and	gain	for	all	conditions,	and	
were	normalized	to	the	background	signal	of	an	isotype	control	stained	sample.	The	
expression	 of	 the	 proteins	 of	 interest	 was	 quantified	 by	 either	 assessing	 the	
fluorescent	 intensity	 of	 blindly	 selected	 multiple	 cells	 (at	 least	 50	 per	 site)	 using	
Image	J	(version	1.49p)	or	by	determining	the	%	positive	cells.	Different	experimental	
numbers	 (N)	 correspond	 to	 independent	 experiments	 using	 HUVEC	 from	 different	
human	donors.	
2.2.9		In	vitro	tube	formation	assay	on	pre-sheared	cells	
Tube	formation	was	assessed	as	described	(Zhao	et	al.	2007).	50,000	cells/	well	were	
seeded	 onto	 1mg/ml	 collagen	 (bovine	 skin	 collagen,	 made	 up	 in	 DMEM	 media),	
which	was	 added	 at	 50	 μl/well	 in	 a	 96	well-	 flat	 bottom	 tissue	 culture	 plate.	 The	
collagen	was	added	overnight	and	maintained	at	37	⁰C,	5	%	CO2	prior	to	cell	seeding.	
The	 cells	 were	 cultured	with	 110	 μl	 of	 2	 %	 serum	 complete	M199,	 containing	 50	
ng/ml	VEGF.	Following	48	h,	the	cells	were	fixed	with	4	%	formaldehyde.	To	visualise	
the	 formed	 tube	 structures,	 the	 cells	 stained	with	membrane	 labelling	 dye	 PKH26	
and	nuclei	were	labelled	using	DAPI,	followed	by	widefield	fluorescence	microscopy	
(LeicaDMI4000B).	The	tube	structures	were	quantified	by	assessing	cumulative	tube	
length	and	by	counting	the	branch	points	per	 frame	of	view,	using	 Image	J	version	
(1.49p).	 A	 scientist	 blinded	 to	 the	 experimental	 conditions	 recorded	 the	
measurements.	
2.2.10	In	vitro	cell	migration;	scratch	assay	on	pre-sheared	cells	
Cell	 migration	 was	 assessed	 as	 described	 (Warboys	 2014;	 Liang	 et	 al.,	 2007).	
Following	orbital	 shaking,	 a	 scratch	using	 a	P200	pipette	 tip	was	 created	 vertically	
along	each	well	of	 the	6-well	plate,	 to	create	a	“wound”	 in	 the	monolayer	at	both	
the	periphery	 (high	WSS)	 and	 the	 centre	 (low	WSS)	 region	of	 the	well	 (Figure	15).	
The	media	was	replaced	with	2ml	of	complete	M199	growth	media.	
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Figure	15.	Schematic	of	scratch	asaay			
		
P200$pipe(e$)p$
Time$lapse$microscopy$
Figure	15.	Schematic	of	scratch	assay.	Following	72h	of	orbital	shaking,	a	scratch	across	
the	well	of	the	6-well	plate	was	made	using	a	P200	pipette	tip,	 this	created	a	wound	in	
the	monolayer	at	the	region	of	high	WSS	(periphery;	purple)	and	the	region	of	low	WSS	
(centre;	 red).	 Cell	 migration	 into	 the	 wounded	 area	 was	 monitored	 by	 time	 lapse	
microscopy.	
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Cell	migration	into	the	wounded	area	following	the	formation	of	the	scratch	(Time	0	
time	 point)	 was	 visualized	 using	 time-lapse	 microscopy	 (Leica	 AF6000	 Timelapse	
microscope).	Images	were	captured	from	every	well	at	3	min	intervals	for	up	to	20h	
after	 scratch	 formation.	 The	 distance	migrated	was	 determined	 by	measuring	 the	
position	of	the	monolayer	edge	in	relation	to	the	starting	point	(at	3	points	per	field	
of	view)	using	the	LAS_AF	Lite	software	(v	2.3.0).	The	average	velocity	was	calculated	
by	dividing	the	average	distance	migrated	over	time.		
2.2.11	EC	permeability	assay	
To	 assess	 the	 effect	 of	 gene	 function	 on	 EC	 permeability	 under	 flow,	 a	 method	
published	by	the	Weinberg	group	(Warboys	et	al.	2010)	was	followed.	Briefly,	HUVEC	
were	 seeded	 at	 200,000cells/	 well	 onto	 fibronectin	 (50	 μg/ml)	 coated	 transwell	
inserts	(24	mm	diameter,	0.4	μm	pore,	polyester	membrane;	Table	2)	placed	in	a	6-
well	plate	and	were	then	cultured	overnight.	2.6	ml	of	complete	M199	growth	media	
was	added	to	the	bottom	compartment	and	1.5	ml	to	the	top	compartment	(Figure	
16),	the	cells	were	then	placed	on	an	orbital	shaking	platform	at	150	rpm	for	72h.	At	
24h	 before	 taking	 the	 permeability	 measure	 (at	 48	 hours	 of	 orbital	 shaking)	 the	
media	was	changed	from	20	%	complete	M199	growth	media	into	10	%.	And,	1	hour	
before	 taking	 the	 permeability	 measure,	 media	 in	 the	 top	 compartment	 was	
changed	 into	10	%	serum	M199	media,	containing	1	%	BSA.	A	Rhodamine-albumin	
tracer	 (Warboys	et	al.,	2010)	at	a	concentration	of	1	mg/ml	was	used	to	assess	EC	
permeability.	 Following	 72h	 of	 orbital	 shaking	 (alternatively	 cells	 were	 cultured	
under	 static	 conditions	 for	 72h)	media	 in	 the	 top	 compartment	was	 changed	 into	
media	 containing	 the	 tracer	 (10	 %	 M199	 growth	 medium;	 rd-albumin	 tracer	 1	
mg/ml;	 1	%	BSA).	 Following	 1	 hour	 of	 incubation	 of	 cells	 in	 the	 top	 compartment	
(under	static	conditions)	of	the	transwell	with	the	tracer	the	transwell	 inserts	were	
removed	from	the	plate,	and	media	from	the	bottom	compartment	was	collected,	to	
assess	 EC	 permeability	 by	measuring	 the	 concentration	 of	 tracer	 that	 had	 passed	
from	 the	 top	 compartment	 through	 the	 EC	 monolayer.	 The	 concentration	 of	 Rd-
Albumin	 (mg/ml)	 was	 assessed	 using	 a	 fluorimeter	 (Varioskan,	 Thermoscientific)	
with	excitation	at	570	nm	and	emission	at	600	nm.	
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Figure	 16.	 Schematic	 for	 EC	 permeability	 assay.	 HUVEC	 were	 cultured	 onto	
transwell	 inserts.	 Following	 72h	 of	 orbital	 shaking,	 under	 static	 conditions	 a	
rhodamine-albumin	 tracer	was	 added	 to	 the	 top	 compartment	 of	 the	 transwell	
plate	for	1	hour.	The	concentration	of	tracer	in	media	collected	from	the	bottom	
compartment	was	used	as	a	measure	of	permeability.	
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Figure	16.	Schematic	for	EC	permeability	assay	
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2.2.12	Chromatin	immunoprecipitation	(ChIP)	
ChIP	 was	 used	 to	 assess	 whether	 GATA4	 interacts	 with	 the	 Twist1	 or	 Snail	
promoters.	 Genomic	 (Twist1	 or	 Snail)	 sequences	 were	 interrogated	 for	 putative	
GATA4	binding	 sites	 (A/TGATAA	 (G)	using	 the	Eukaryotic	 promoter	database	 (EPD;	
http://epd.vital-it.ch/).	 ChIP	 Primers	 (Table	 6)	 were	 then	 designed	 based	 on	 the	
identified	GATA4	binding	site	DNA	sequences	in	the	promoter	regions	of	Twist1	and	
Snail	using	Primer3	(primer3.ut.ee/)	Following	72	h	of	orbital	shaking,	HUVEC	were	
fixed	with	formaldehyde	(1	%	for	10	min,	room	temperature).	The	following	steps	of	
the	 ChIP	 experiment	 were	 carried	 out	 using	 the	 simpleChIP®Plus	 Enzymatic	
Chromatin	 IP	 Kit	 (9005;	 Cell	 signalling)	 following	 the	manufacturer’s	 protocol.	 For	
one	immunoprecipitation	a	cell	density	of	4.5x106	(three	6-well	plates,	with	250,000	
cells/well)	 was	 used.	 ChIP-grade	 GATA4	 antibodies	 (C-20	 sc-1237,	 Santa	 Cruz)	 or	
isotype-matched	 control	 (Goat	 IgG)	 were	 used	 in	 5%	 goat	 serum.	 Following	 the	
purification	 of	 precipitated	 genomic	 DNA	 sequences	 using	 the	 DNA	 purification	
columns	present	in	the	simpleChIP®Plus	Enzymatic	Chromatin	IP	Kit.	The	assessment	
of	 the	 specific	 Twist1	 or	 Snail	 promoter	 DNA	 sequences	 co-precipitated	 with	 the	
GATA4	antibody	or	non	specifically	bound	with	the	 isotype	control	was	carried	out	
by	qRT-PCR.	The	thermal	profile	used	was;	Step	1	at	95⁰C	for	3	min,	step	2	at	95⁰C	
for	15	seconds	and	step	3	at	60⁰C	for	1	min	x	45	repeats.	The	qRT-PCR	results	were	
assessed	 using	 the	 ΔCt	method	 (following	 normalisation	 to	 a	 housekeeping	 gene).	
Values	 of	 the	 DNA	 sequences	 co-precipitated	 by	 the	 GATA4	 antibody	 were	
normalised	to	those	of	the	isotype	control.	
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2.2.13	Immunohistochemistry	staining	on	human	coronary	sections	
Immunohistochemistry	 was	 used	 to	 assess	 the	 expression	 of	 specific	 proteins	 in	
coronary	 sections	 isolated	 from	 human	 patients	 of	 heart	 transplants,	 either	 with	
ischemic	 heart	 disease	 (severe	 atherogenesis)	 or	 from	 patients	 of	 idiopathic	
cardiomyopathy	 (mild	 atherogenesis),	 obtained	 with	 ethical	 consent	 from	 the	
donors	 (National	Research	Ethics	number,	12/NW/0036).	5μm	sections	were	made	
from	paraffin-wax	embedded	human	coronary	tissue	(fixed	with	4%	formaldehyde)	
using	 a	 microtome	 (LeicaRM2135;	 Leica).	 The	 sections	 were	 de-waxed	 and	 re-
hydrated	by	 incubating	 through	graded	alcohol	 solutions	 to	water	 (Xylene;	 10	min	
minimum,	100%	Ethanol	(EtOH),	90%	EtOH,	70%	EtOH,	50%	EtOH,	water	(all	 for	10	
seconds).	Endogenous	peroxidase	activity	was	blocked	by	incubation	in	3%	hydrogen	
peroxide	 for	 10	min,	 followed	 by	 rinsing	 in	water.	 For	 staining	 using	 anti-TWIST1,	
anti-SNAIL	 and	 anti-GATA4	 antibodies	 the	 antigen	 retrieval	 method	 adopted	
involved	incubation	of	sections	in	citrate	buffer	at	pH6	for	20	min	at	95⁰C,	followed	
by	cooling	for	20	min,	at	room	temperature	and	rinsing	in	PBS.	Alternatively,	for	anti-
vWF	staining	(to	label	EC)	the	sections	were	incubated	in	0.1%	trypsin/TBS	for	10	min	
at	37⁰C,	followed	by	rinsing	in	water.	
	
Incubating	 the	 sections	 with	 1%	 milk	 in	 PBS	 for	 30	 min,	 at	 room	 temperature,	
blocked	 non-specific	 antibody	 binding.	 The	 sections	 were	 then	 incubated	 with	
primary	antibodies	either	overnight	at	4⁰C	(for	TWIST1,	GATA4	and	SNAIL)	or	 for	1	
hour	 at	 room	 temperature	 (for	 vWF).	 A	 PBS	 washing	 step,	 x3	 washing	 at	 5	 min	
intervals	at	room	temperature	was	carried	out.	This	was	followed	by	incubation	with	
biotinylated	 secondary	 antibodies	 for	 30	 min,	 at	 room	 temperature.	 The	 sections	
were	then	washed	(PBS	x3,	5	min,	at	room	temperature)	then	incubated	with	Avidin-
Biotin	complex	(ABC)	complex	(for	30	min	at	room	temperature.	The	sections	were	
washed	 (PBS	x3,	5	min	 intervals	at	 room	temperature)	 then	3,3ʹ-Diaminobenzidine	
(DAB)	substrate	was	added	to	the	slides,	for	approximately	5	min	(until	the	reaction	
resulted	in	a	change	in	colour	of	the	tissue	sections).	The	sections	were	then	rinsed	
in	 water	 to	 end	 the	 DAB	 reaction	 and	 counterstained	 by	 incubation	 in	 Carazzi’s	
haematoxylin	for	30	seconds	(room	temperature).	This	was	then	followed	by	rinsing	
in	water	and	dehydration	through	graded	alcohol	solutions,	to	xylene	and	mounting	
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onto	microscope	slides	using	DPX	mountant.	The	sections	were	imaged	using	a	light	
microscope	coupled	to	the	NIS	elements	software	(v3.22.15).	Assessment	of	protein	
expression	was	 calculated	 as	 a	 percentage	 out	 of	 cells	 positive	 for	 vWF	 to	 give	 a	
measure	 of	 %	 positive	 endothelial	 cells.	 Different	 experimental	 numbers	 (N)	
correspond	 to	different	 tissue	 sections	 collected	 individually	 from	different	human	
patients.	
	
	
2.2.14	Mouse	breeding	strategies	and	transgenic	animals	
All	 animal	 work	 was	 carried	 out	 in	 accordance	 with	 the	 UK	 Animal	 (Scientific	
procedures)	Act,	1986	and	the	NIH	Guide	for	the	care	and	use	of	laboratory	animals.	
	
2.2.14.1	Genotyping		
To	assess	the	genotype	of	mice,	DNA	was	isolated	from	earclips	by	adding	150ul	of	
earclip	 lysis	buffer	 (1M	Tris-HCl	 (pH	8.5),	0.5M	EDTA	(pH	8.0),	10%	Tween-20;	with	
30	μl/	1000	μl	Proteinase	K;	Table	4)	to	each	ear	clip,	which	was	then	incubated	at	
55⁰C	 overnight.	 The	 earclip	 lysate	 was	 vortexed	 briefly	 and	 the	 proteinase-K	 was	
inactivated	by	incubation	at	100⁰C	for	12	min.	A	volume	of	600	μl	of	sterile	nuclease-
free	water	was	added	and	the	earclip	DNA	was	stored	on	ice	at	4⁰C.	A	standard	PCR	
reaction	was	set	up	to	a	final	volume	of	25	μl	consisting	of	10	μl	earclipd	DNA	+	15	μl	
PCR	master	mix	(PCR	primer	sequences	are	in	2).	The	PCR	master	mix	contained	1.25	
μl	 of	 specific	 forward	 and	 reverse	 primers	 (used	 at	 20μM)	 to	 detect	 specific	
transgenic	 alleles,	 0.5	 μl	 dNTPs,	 5μl	 Reaction	 buffer,	 0.25	 μl	 DNA	 polymerase	 (all	
from	Q5	high	fidelity	DNA	polymerase	kit)	and	6.75	μl	of	water	to	give	a	final	volume	
of	15	μl.	The	thermal	profile	of	the	PCR	reaction	consisted	of;	95⁰C	for	1min,	95⁰C	for	
30	 seconds	 (annealing	 temperature	 depending	 on	 specified	 different	 primer	 sets)	
x40	repeats,	72⁰C	for	1	minute	and	final	step	at	4⁰C	for	storage	of	the	sample.	The	
PCR	 products	were	 separated	 using	 gel	 electrophoresis.	 The	 samples	were	 loaded	
onto	a	1.5%	agarose	gel	with	DNA	gel	loading	dye	(used	at	1X).	The	gel	was	imaged	
using	 a	 bioimaging	 system	 (Chemi-genius;	 Geneflow)	 and	 using	 the	 GeneSnap	
software	(v	7.04.05).	
	 85	
	
2.2.15	The	SCL-Cre-ERT;	R26R-Td	tomato	transgenic	model	
For	EC	 lineage	 tracing,	 the	 cells	were	genetically	marked	using	a	 transgenic	model	
developed	 by	 Göthert	 et	 al.	 (Göthert	 et	 al.	 2004).	 A	 basic	 helix-loop-helix	 (bHLH)	
Stem	cell	enhancer	 locus/	T-cell	acute	 lymphocytic	 leukemia	1	(SCL/Tal)	 is	essential	
for	haematopoiesis	and	endothelial	cell	differentiation.	The	SCL	 locus	contains	 two	
distinct	 elements,	 an	 SCL	 5ʹ	 endothelial	 enhancer	 which	 directs	 expression	 to	 the	
adult	 endothelium	 and	 embryonic	 hematopoietic	 progenitors	 whereas	 an	 SCL	 3ʹ	
enhancer	 is	 responsible	 for	 SCL	 expression	 in	 early	 hematopoietic	 progenitors	 and	
embryonic	 endothelium	 (Göthert	 et	 al.	 2004).	 To	 achieve	 an	 endothelial	 specific	
expression	of	a	 tamoxifen-inducible	 recombinase	Cre-ERT,	mice	expressing	a	5’	 SCL	
/TAL	driven	Cre	ERT	(tal-tg	Cre	ERT	)	were	used	(mice		used	are	heterozygous;	carried	
one	copy	of	Cre-ERT	to	avoid	non-	specific	Cre-mediated	genomic	recombination).	To	
label	 the	 EC,	 the	 endothelial-SCL-Cre-ERT	 expressing	 mice	 were	 bred	 with	 mice	
expressing	a	Td-tomato	reporter	allele	to	create	SCL-Cre-ERT;	R26R-Td	tomato	mice.	
The	 Td-	 tomato	 allele	 was	 flanked	 by	 LoxP	 sites,	 with	 a	 stop	 cassette	 inserted	
downstream	of	the	ROSA26	promoter.	Cre-ERT	activation	by	tamoxifen	results	in	the	
recombination-mediated	excision	of	 the	 Lox	P	 sites,	mediating	 the	 transcription	of	
the	Tomato	td	allele	by	the	ROSA	26	promoter	(Figure	17	A).	To	activate	the	Cre-ERT,	
mice	 were	 given	 an	 intraperitoneal	 (I.P)	 injection	 of	 20	 mg/ml	 tamoxifen	 for	 5	
consecutive	 days.	 The	 fluorescent	 R26R	 Td-tomato	 protein	 expressed	 in	 the	
cytoplasm	and	the	nucleus	of	EC	indicates	positive	adult	endothelium.		
	
SCL-Cre-ERT	 male	 mice	 	 (heterozygous	 for	 Cre)	 were	 bred	 with	 R26R	 Td-tomato	
(homozygous)	 expressing	 female	 mice	 from	 approximately	 6	 weeks	 old	 animals.	
Following	DNA	isolation	from	ear	clips,	PCR	reactions	followed	by	gel	electrophoresis	
were	performed.	Genotyping	results	revealed	the	proportion	of	R26R	heterozygote	
mice	carrying	the	Cre-ERT	allele,	which	was	approximately	50%	Cre-ERT	positive	and	
50%	Cre-ERT	negative	 (Figure	 17	 B).	 Double	 transgenic	mice	 SCL-Cre-ERT;	 R26R	 Td-
tomato	 (heterozygous	 for	 both	 alleles)	were	 used	 as	 experimental	mice	 and	 R26R	
Td-tomato	heterozygote	mice	were	used	as	experimental	controls.		
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igure	17.	SCL-Cre-ERT;	R26R	Td-tomato	mice	breeding	and	genotyping					
nucleus	
ROSA26	 STOP	 Td	tomato	 Td	tomato	
Tamoxifen			
Cre-ERT	
ROSA26	
Td	tomato	
nucleus	
SCL	Cre-ERT/+	;	R26R	Td-tomato	+/+	
50%	SCLCre-ERT/+	;	R26R	Td-tomato	ﬂ/+		
Progeny	
		
50%	SCL	+/+;	R26R	Td-tomato	ﬂ/+	
SCL	+/+	;R26R	Td-tomato	ﬂ/ﬂ		
Tamoxifen		
(2mg/mouse/day)	
A	
B	
1	
R26R	Td-tomato-ﬂox	=	196	bp	
SCLCre-ERT	/+	(	Cre	posiHve)	
SCL	+/+		(Cre	negaHve)	
	All	R26R	Td-tomato	ﬂ/+		
R26R	Td-tomato-WT	=	297	bp	
SCL-Cre-ERT	=	approx.	300	bp	C	
Experimentals	:	
Controls	:	
			
DNA	100	bp	ladder	
DNA	100	bp	ladder	
WT	
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Figure	17.	SCL-Cre-ERT;	R26R	Td-tomato	mice	breeding	and	genotyping.	A)	SCL-driven	Cre	
activity	is	switched	on	following	tamoxifen	treatment.	Activated	Cre-recombinase	mediates	
excision	of	a	 loxp-flanked	LoxP	–flanked	stop	codon	upstream	of	a	Td-tomato	coding	gene	
that	is	under	the	activity	of	the	Rosa26	promoter,	giving	rise	to	the	expression	of	Td-tomato	
in	endothelial	cells.	B)	SCL-Cre-ERT	male	mice	were	crossed	with	R26R	Td-tomato	fl/fl	females,	
the	 genotypes	 of	 expected	 progeny	 are	 indicated.	 C)	PCR	 followed	 by	 gel	 electrophoresis	
was	 carried	 out.	SCL-Cre-ERT	 (approx.	 300bp	band)	was	 detected	 in	 approximately	 50%	of	
the	litter.	All	the	progeny	were	Td-Tomato	heterozygote;	they	expressed	both	the	R26R-Td	
tomato	floxed	allele	(297	bp	band	)	and	the	WT	allele	(196	bp	band).	
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2.2.16	Breeding	and	genotyping	of	SCL-Cre-ERT;	Gata4	KO	mice	
Since	the	absence	of	GATA4	is	embryonically	lethal	(Kuo	et	al.	1997),	conditional,	EC-
specific	 knock	 out	 (KO)	 animals	 were	 generated.	 Multiple	 breeding	 steps	 were	
carried	 out	 to	 achieve	 this.	 Firstly,	 Gata4	 floxed	 (LoxP	 sites	 flanking	 Gata4	 coding	
exons)	homozygous	female	mice	(Carrasco	et	al.	2012)	were	bred	with	heterozygous	
SCL-Cre-ERT	male	mice.	Genotyping	carried	out	as	described	previously	(Figure	18	A)	
revealed	that	50%	of	the	progeny	was	heterozygous	for	the	Gata4	floxed	allele	and	
for	the	SCL-Cre-ERT	allele,	these	SCL-Cre-ERT	+/-;	Gata4	fl/+	animals	were	then	used	for	
the	next	breeding	step.		
	
Secondly,	to	ensure	that	both	of	the	Gata4	alleles	in	the	transgenic	mice	are	floxed	
(for	complete	loss	of	function	in	EC)	SCL	Cre-ERT/+;	Gata4	fl/+	animals	were	backcrossed	
with	SCL	+/+;	Gata4	fl/fl	mice	(Figure	18	B).	Since	the	experimental	mice	are	required	
to	be	SCL	Cre-ERT/+;	Gata4	fl/fl	mice,	whilst	experimental	controls	to	be	SCL	+/+;	Gata4	fl/fl	
mice	 it	was	 important	 to	 introduce	a	 third	breeding	 step	 in	order	 to	eliminate	 the	
possibility	 of	 having	 progeny	 which	 are	 heterozygous	 for	 the	 Gata4	 floxed	 allele.	
Therefore,	SCL	Cre-ERT/+;	Gata4	fl/+	mice	were	backcrossed	with	SCL	+/+;	Gata4	fl/fl	mice.	
The	 resultant	 progeny	 were	 50%	 experimental	 and	 50%	 experimental	 controls	
(Figure	18	C).		
	
Finally,	SCL	Cre-ERT/+;	Gata4	fl/fl	mice	and	experimental	controls	SCL	+/+;	Gata4	fl/fl	were	
injected	 with	 tamoxifen	 as	 described	 previously	 to	 activate	 the	 Cre-ERT	 mediated	
gene	deletion	(Figure	9	D).	The	inserted	LoxP	sites	flank	the	coding	exons	3-5	of	the	
Gata4	 gene,	 this	 exon	 codes	 for	 the	 zinc	 finger	 binding	 domain	 and	 the	 nuclear	
localization	 signal	 that	 is	 essential	 for	 GATA4	 function.	 Cre-mediated	 deletion	
therefore	gives	rise	to	a	Gata4	deletion	in	the	endothelium	(SCL-Cre-ERT;	Gata4	ko).	
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Figure	18.	SCL-Cre-ERT;	GATA4fl/fl	mouse	breeding	and	genotyping							 	
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Figure	18.	SCL-Cre-ERT;	Gata4	 fl/flmouse	breeding	and	genotyping.	A)	SCL	Cre-ERT/+	;	Gata4	+/+	males	
were	crossed	with	SCL	 +/+		Gata4	 fl/fl	 females,	 the	 expected	progeny	genotypes	are	 indicated.	PCR	
followed	 by	 gel	 electrophoresis	 was	 carried	 out.	 All	 the	 litter	 were	 heterozygote	 for	 the	 Gata4	
floxed	 allele,	 they	 expressed	 both	 the	GATA4	 floxed	 allele	 (455	bp	 band)	 and	 the	WT	 allele	 (355	
band).	SCL-Cre-ERT	(approx.	300bp	band)	was	detected	in	approximately	50%	of	the	litter.	B)	In	the	
second	breeding	step,	males	expressing	Cre	(SCL	Cre-ERT/+	;	Gata4	+/+)	were	back	crossed	with	SCL	+/+		
Gata4	 fl/fl	 females,	 the	 expected	progeny	 and	 their	 ratios	 are	 shown.	C)	 SCL-driven	 Cre	activity	 is	
switched	on	following	tamoxifen	treatment.	Activated	Cre	recombinase	mediates	excision	of	a	lox	P	
flanked	Gata4	coding	exons,	giving	rise	to	the	Gata4	deletion	in	EC.	D)	SCL-Cre-ERT;	Gata4	fl/fl	mouse	
breeding	 and	 genotyping,	 breeding	 step	 3	 involved	 the	 crossing	 between	SCL-Cre-ERT	males	with	
Gata4	fl/fl	females,	the	expected	progeny	were	50%	Cre-positive	(SCL-Cre-ERT	)	and	50%	Cre	negative	
(Gata4	 fl/fl).	 Experimental	and	control	mice	were	 injected	with	 tamoxifen	 (2	mg/mouse/day)	 for	5	
consecutive	days	to	result	in	the	SCL-Cre	ERT	mediated	loss	of	Gata4	function	in	EC.	
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2.2.17	Breeding	and	genotyping	of	Tie2-Twist1KO	mice	
Deletion	of	 Twist1	 is	 embryonically	 lethal	 (Chen	et	 al.	 1995),	 therefore	 conditional	
Twist1	 deletion	 strategy	 in	 EC	 was	 adopted.	 The	 Tie2	 gene	 encodes	 for	 an	
angiopoetin	 receptor	 that	 is	 expressed	 in	 EC	 throughout	 embryonic	 development	
and	in	adult	cells	(Davis	et	al.	1996;	Kisanuki	et	al.	2001).	Therefore,	Tie2-driven	Cre	
expressing	mice	were	 crossed	with	 Twist1	 floxed	mice	 (lox	 P	 sites	 flanking	 coding	
exon	1)	to	create	Tie2-Twist1KO	animals	(Chen	et	al.,	2007;	Li	et	al.,	2014)	(Figure	19	
A).	 The	 Tie2-Twist1KO	(Tie2	 cre/+	 ;	 Twist1	 fl/fl	 )	 	 animals	were	 then	 backcrossed	with	
Twist1	 fl/fl	 animals	 (Tie2	 +/+	 ;	 Twist1	 fl/fl	 )	 	 (Figure	 19	 B)	 to	 give	 rise	 to	 a	 progeny	
containing	 approximately	 50%	 experimental	mice	 Tie2-Twist1KO	 and	 50%	 Twist1fl/fl	
experimental	controls	(Figure	19	C).		
2.2.18	En	face	immunostaining	of	the	mouse	aortic	arch		
To	 assess	 the	 expression	 of	 the	 proteins	 of	 interest	 in	 vivo	 at	 areas	 exposed	 to	
atherosusceptible	chronic	low		(inner	curvature)	or	atheroprotective	high	WSS	(outer	
curvature),	 en-face	 immunostaining	 was	 carried	 out	 on	 the	murine	 aortic	 arch	 as	
described	(Hajra	et	al.	2000;	Warboys	et	al.	2014;	Cuhlmann	et	al.	2011).	Briefly,	the	
mice	were	 culled	by	 I.P	 injection	of	 pentobarbital	 or	 by	 isofluorane	overdose.	 The	
mouse	ribcage	area	was	exposed	to	reveal	 the	heart,	 following	the	severing	of	 the	
right	atrium;	10	ml	of	PBS	was	injected	into	the	left	ventricle	to	flush	blood	from	the	
vasculature.	To	perfuse	fix	 the	tissue,	10	ml	of	4%	formaldehyde	was	 injected.	The	
heart/ribcage	was	 isolated	 and	 incubated	 in	 2%	 formaldehyde	 for	 1	 hour	 at	 room	
temperature	before	storage.	The	aortic	arch,	with	the	connecting	descending	aorta	
was	dissected	from	the	ribcage.	A	cut	was	made	through	the	aortic	arch	to	reveal	the	
inner	 and	 outer	 curvature	 regions	 (Figure	 20),	 which	 were	 then	 processed	 for	
immunostaining	 in	 a	 96	well,	 flat	 bottom	plate.	 The	 tissue	was	 permeabilised	 and	
blocked	by	incubating	with	20%	goat	serum	in	0.5%	Triton-X	overnight	at	4⁰C.	To	be	
able	 to	 assess	 expression	 in	 endothelial	 cells	 lining	 the	 intimal	 layer	 of	 the	 tissue.	
Conjugated	 488-alexafluor-anti	 mouse	 CD31	 antibodies	 (in	 5%	 BSA	 in	 0.1%	 PBST)	
were	incubated	with	aortic	preparations	for	4	days	at	4⁰C.		
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Figure	19	Tie2Twist1KO	breeding	and	genotyping			
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Figure	19.	Tie2Twist1KO	breeding	and	genotyping.	A)	The	expression	of	Cre	driven	by	the	
Tie2	 promoter	 results	 in	 cre-mediated	 recombination	 of	 the	 loxP	 flanked	 Twist1	 coding	
exon	 and	 subsequently	 a	 loss	 of	 Twist1	 expression	 in	 endothelial	 cells.	 B)	 Tie2-Twist1KO	
(Tie2	cre/+;	Twist1	fl/fl)	male	mice	were	crossed	with	Twist1fl/fl	(Tie2	+/+;	Twist1	fl/fl)	 	females.	
The	expectant	progeny	were	50%	positive	for	Cre	expression	and	50%	were	Cre	negative.	
C)	Standard	PCR	 followed	by	gel	 electrophoresis	was	 carried	 out.	Tie2-Cre	 (100bp	band)	
was	detected	in	approximately	50%	of	the	litter.	An	internal	positive	control	(324	bp	band)	
was	 used	 in	 the	 reaction	 to	 further	 validate	 a	 lack	 of	 Cre	 expression.	 Following	 Cre	
mediated	 recombination	 the	 Tie2-Twist1	 KO	 allele	 (310bp	 band)	 was	 detected	 in	 mice	
expressing	Tie2-Cre,	further	confirming	the	genotype	of	the	Tie2-Twist1KOmice.	
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Figure	20.	Schematic	for	en	face	preparation	on	the	murine	aortic	arch		
Murine'aorta'
En'face'immunostaining'on'
'regions'of'interest'
Low'WSS' High'WSS'
Low$WSS$
High$WSS$
CD31/TOPRO'
Figure	 20.	 Schematic	 of	 en	 face	 preparation	 on	 the	murine	 aortic	 arch.	 To	 study	 the	 protein	
expression	of	proteins	of	 interest	at	 specific	 flow	sites	 in	 the	murine	aorta,	regions	of	 the	 inner	
curvature	(low	wSS)	and	the	outer	curvature	(high	WSS)	were	cut	open	out	(dotted	 lines)	of	the	
dissected	aortic	arch	and	opened	en	face.	 Immunostaining	revealed	the	distinct	EC	alignment	 in	
cells	 at	 the	 distinct	 flow	 regions,	 CD31	 (green)	 labelled	 the	 endothelium	 and	 the	 nuclei	 were	
stained	using	TOPRO	DNA	binding	dye.	The	WSS	map	of	the	murine	aortic	arch	was	 taken	from	
Suo	et	al.,	2007.	
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The	tissue	segments	were	then	washed	with	PBS	x3	for	5	min	at	room	temperature.	
This	was	followed	by	incubating	the	tissue	with	primary	rabbit	antibodies	against	the	
mouse	proteins	of	interest	or	an	isotype	control	overnight	at	4⁰C.	Following	washing	
of	the	segments	(with	PBS	x3	for	5	min,	at	room	temperature)	they	were	incubated	
with	goat	anti-rabbit	alexafluor568	labeled	secondary	antibodies	(in	5%	BSA	in	0.1%	
PBST)	for	5	hours,	at	room	temperature.	This	was	followed	by	washing	steps	(PBS	x3,	
5	min,	room	temperature).	To	label	the	nuclei,	a	DNA-binding	dye	Topro-3	was	used.	
The	segments	were	then	opened	en	face	and	mounted	facedown	on	glass	coverslips	
using	Prolong	gold	anti-fade	mountant	which	were	then	placed	on	microscope	slides.	
The	 tissue	 segments	were	 imaged	 using	 confocal	 laser	 scanning	microscopy	 (Zeiss	
LSM510	 NLO	 inverted	 microscope).	 The	 isotype	 control	 stained	 tissue	 segments	
were	used	as	a	control	for	non-specific	staining.	The	same	exposure	settings	on	the	
microscope	were	used	for	all	samples.	At	 least	5	 images	were	captured	from	every	
WSS	 region	 (i.e.	 5	 images	 from	 the	 outer	 and	 5	 from	 the	 inner	 curvature).	 The	
expression	 of	 the	 proteins	 of	 interest	 was	 quantified	 by	 either	 assessing	 the	
fluorescent	 intensity	 of	 blindly	 selected	 multiple	 cells	 (at	 least	 50	 per	 site)	 using	
Image	J	(version	1.49p)	or	by	determining	the	%	positive	cells.	Different	experimental	
numbers	(N)	correspond	to	different	animals.	
	
2.2.19	Insertion	of	flow	altering	cuff	into	murine	carotid	artery	
To	gain	 a	 causal	 relationship	between	 flow	and	protein	 expression	 in	 vivo,	 a	 flow-	
altering	 cuff	 method	 was	 used	 to	 directly	 create	 distinct	 regions	 of	 flow	 in	 the	
inserted	 vessel	 .	 Cuff	 insertion	alters	 flow,	 giving	 rise	 to	 low	WSS	upstream	of	 the	
cuff,	high	WSS	in	the	cuff	region	and	low,	oscillating	WSS	in	the	region	downstream	
of	 the	 cuff	 (Cheng	 et	 al.	 2006;	 Cuhlmann	 et	 al.	 2011).	 Constrictive	 cuffs	 with	 an	
internal	diameter	of	400	μm	diameter	tapering	to	200	μm	over	1.5	mm	were	used	
(manufactured	 by	 PTFE).	 The	 cuffs	 were	 inserted	 into	 the	 right	 carotid	 artery	 of	
isofluorane-anaethetised	 mice	 (8	 weeks	 old,	 C57BL/6	 or	 SCL-Cre-ERT;	 R26R-Td	
tomato	animals)	following	published	methods	(Cheng	et	al.,	2006;	Cuhlmann	et	al.,	
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2011).	The	left	carotid	artery	did	not	have	a	cuff	inserted	and	was	therefore	used	as	
a	sham	control.	
	
2.2.20	Statistics	
Quantitative	analyses	were	carried	out	on	at	 least	three	 independent	experimental	
repeats.	 Every	 experimental	 repeat	 corresponds	 to	 an	 experiment	 carried	 out	
independently	 using	 either	 different	 animals	 or	 independently	 isolated	 HUVEC	 or	
PAEC.	All	the	quantitative	analyses	shown	are	presented	as	the	mean	value	±	SEM.	
For	the	assessment	of	significant	differences,	paired,	unpaired	students	t-tests,	one	
or	 two	 way	 ANOVA	 (Bonferroni’s	 multiple	 comparison	 test)	 statistical	 tests	 were	
carried	out.	Data	was	accepted	as	being	statistically	significant	when	the	P	value	was	
p<0.05.	
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Chapter	3:		Low	shear	stress	promotes	TWIST1	
expression	via	GATA4	
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3.1	Introduction	
TWIST1	and	GATA4	transcription	 factors	play	 indispensable	 roles	during	embryonic	
development.	 TWIST1	 is	 important	 for	 regulating	 gastrulation	 and	 mesoderm	
migration	(Simpson	1983;	Thisse	et	al.	1988).	GATA4	is	an	upstream	master	regulator	
of	 the	 gene	 network	 controlling	 cardiac	 development	 and	 specification(Kuo	 et	 al.	
1997;	Zeisberg	et	al.	2005).	Although	TWIST1	and	GATA4	regulate	distinct	processes	
during	embryonic	development,	 they	both	play	 important	roles	 in	controlling	valve	
formation	in	the	developing	atrioventricular	canal.	Both	TWIST1	and	GATA4	function	
in	a	common	developmental	pathway	that	drives	EndMT	 in	valve	 formation.	 It	has	
been	 shown	 that	 GATA4	 regulates	 twist-family	 transcription	 factors	 during	 this	
process	(Zeisberg	et	al.	2005;	Mcfadden	et	al.	2002;	Vrljicak	et	al.	2012).	
	
EC	lining	the	vasculature	are	known	to	alter	physiology	according	to	the	mechanical	
environment	 they	 are	exposed	 to.	 EC	 in	 the	 atherosusceptible	 sites	 (low	WSS)	 are	
“primed”	 for	 atherogenesis	 where	 they	 display	 a	 higher	 rate	 of	 cell	 proliferation,	
permeability	 and	 activation	 compared	 to	 quiescent	 EC	 in	 the	 atheroprotected	
regions	(high	WSS)	(Lin	et	al.	2000;	Passerini	et	al.	2004;	Davies	2009;	Davies	et	al.	
2013).		
	
Although	the	mechanical	activation	of	TWIST1	and	GATA4	has	been	shown	 in	non-
endothelial	cell	types	(Desprat	et	al.	2008;	Wei	et	al.	2015;	Tenhunen	et	al.	2004),	it	
is	 unknown	 whether	 TWIST1	 and	 GATA4	 are	 modulated	 by	WSS	 in	 EC	 and	 more	
specifically	if	the	GATA4-	TWIST1	network	is	involved	in	EC	mechanotransduction.	
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3.2	Hypothesis		
I	hypothesised	that	WSS	differentially	regulates	the	expression	of	TWIST1	and	GATA4	
in	EC	exposed	to	flow	using	in	vitro	flow	systems.	
	
	
	
	
	
3.3	Aims	
To	address	the	hypothesis	the	following	aims	were	assessed;	
	
1. To	confirm	that	TWIST1	and	GATA4	are	differentially	expressed	at	low	and	
high	WSS	sites	in	the	porcine	aorta	
	
2. To	directly	assess	the	effect	of	WSS	on	TWIST1	and	GATA4	induction	in	
cultured	EC,	using	in	vitro	flow	systems.	
	
	
3. To	assess	if	TWIST1	and	GATA4	cross-regulate	one	another	in	EC	exposed	to	
WSS.	
	
	
	
	
	
WSS	
TWIST1	 GATA4	
?	
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3.3	TWIST1	and	GATA4	expression	was	elevated	at	sites	of	low	WSS	in	
the	porcine	aorta	
The	microarray	 study	 carried	out	by	our	 group	 suggested	 that	 TWIST1	 and	GATA4	
were	more	highly	expressed	at	low	WSS	sites	of	the	porcine	aorta	compared	to	high	
WSS	 sites	 (Figure	 21	A).	 To	 validate	 the	microarray	 results,	 EC	were	 isolated	 from	
distinct	 flow	sites	 (low	WSS	vs.	high	WSS)	of	 the	aorta	 in	a	separate	cohort	of	pigs	
and	 gene	 expression	 was	 assessed	 by	 qRT-PCR.	 Several	 quality	 control	 measures	
were	put	 in	place	 to;	1)	 ensure	 that	 the	RNA	 samples	were	 from	pure	EC	and	not	
from	 the	 underlying	 smooth	muscle	 cells.	 This	was	 accomplished	 by	 assessing	 the	
relative	expression	of	Cd31	(EC	marker)	with	α-Sma	(smooth	muscle	cell	marker).	2)	
To	confirm	that	the	RNA	samples	were	from	the	distinct	flow	sites,	the	expression	of	
several	known	flow-induced	genes	was	assessed.	Mcp-1	is	a	gene	that	is	known	to	be	
more	highly	expressed	in	EC	exposed	to	low	WSS	(Hwang	et	al.,	2003),	whereas	our	
group	 has	 previously	 shown	 that	 c-Jun	 expression	 is	 preferentially	 expressed	 EC	
exposed	to	high	WSS	(De	Luca,	Serbanovic-Canic	and	Evans,	manuscript	submitted).	
In	 all	 samples	 used,	 Cd31	 levels	 were	 at	 least	 three	 fold	 higher	 in	 expression	
compared	to	α-Sma	levels	and	Mcp-1	expression	was	enhanced	at	the	low	WSS	sites	
and	c-Jun	at	the	high	WSS	sites	 (Figure	21	B,	21	C).	Samples	that	did	not	meet	the	
quality	 control	 criteria	 were	 excluded	 from	 further	 analysis.	 Twist1	 and	 Gata4	
expression	 was	 enriched	 in	 EC	 exposed	 to	 low	WSS	 compared	 to	 high	 WSS	 sites	
(Figure	21	D)	therefore	validating	the	results	from	the	microarray	experiment.		
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Figure	21.	Low	WSS	was	associated	with	elevated	Twist1	and	GATA4	expression	in	the	porcine	aorta			 	
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Figure	21.	Low	WSS	was	associated	with	elevated	Twist1	and	Gata4	expression	in	the	porcine	aorta.	
A)	The	transcriptome	of	EC	was	studied	at	low	WSS	(inner	curvature)	and	high	WSS	(outer	curvature)	
regions	of	the	porcine	aorta.	Differentially	expressed	genes	were	identified	using	microarray	analysis	
(N=5	pigs)	and	 the	expression	patterns	of	Twist1	 and	Gata4	 are	presented	 as	a	 heat	map	with	 red	
indicating	an	increase	in	gene	expression.	To	validate	the	microarray	results,	RNA	was	 isolated	from	
EC	at	 low	and	high	WSS	of	the	porcine	aorta	using	collagenase.	Quality	control	checks	were	carried	
out	 to	ensure	that	 the	samples	were	 from	the	endothelium;	B)	Cd31	expression	relative	to	smooth	
muscle	cell	marker	α-Sma	was	assessed	in	samples	from	the	low	and	high	WSS	regions	(N=6).	C)	The	
expression	of	flow-responsive	genes	Mcp-1	and	eNos	was	assessed	in	samples	from	the	low	vs.	high	
WSS	regions	(N=6)	D)	In	quality	controlled	samples,	Twist1	and	Gata4	expression	levels	were	assessed	
in	high	quality	samples	from	low	and	high	WSS	regions	(N=6).	Mean	levels	±	SEM	are	shown.	*	p<0.05,	
**p<0.01,	***p<0.001.	
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3.4	Low	WSS	promoted	TWIST1	expression	via	GATA4	
The	enhanced	expression	of	Twist1	and	Gata4	at	low	WSS	sites	in	the	porcine	aorta	
could	 be	 attributed	 to	 factors	 other	 than	WSS	 such	 as	 the	 effect	 of	 altered	mass	
transport	 and	 inflammation.	 Therefore,	 to	 establish	 whether	 a	 direct	 link	 exists	
between	the	expression	of	Twist1	and	Gata4	and	WSS,	the	expression	of	these	genes	
was	studied	under	flow	using	 in	vitro	model	systems.	Two	complementary	systems	
were	 used,	 an	 orbital	 plate	 system	 and	 a	 parallel	 plate	 apparatus.	 Our	 group	 and	
others	 have	 previously	 used	 computational	 fluid	 dynamics	 to	 define	 WSS	 in	 an	
orbiting	 6-well	 plate	 system,	 which	 generates	 relatively	 constant	 low	 WSS	 (4.8	
dyne/cm2),	with	rapid	variations	in	direction	in	the	centre	of	the	well	and	generates	
a	 high	mean,	 pulsatile	WSS	 (13	 dyne/cm2)	 in	 a	 relatively	 uniform	 direction	 in	 the	
periphery	 of	 the	well	 (Warboys	 et	 al.	 2010;	 Dardik	 et	 al.	 2005).	 HUVEC	 and	 PAEC	
were	 exposed	 to	 flow	 using	 the	 orbital	 plate	 system	 and	 following	 72h	 of	 orbital	
shaking,	 cells	 in	 the	 periphery	 of	 the	 well	 displayed	 the	 characteristic	 aligned	
morphology	(observed	at	high	WSS	sites	 in	vivo)	whereas	cells	 in	 the	centre	of	 the	
well	 exhibited	 a	 characteristic	 polygonal,	 cobble-stone-like	 morphology.	 RNA	 was	
isolated	from	cells	at	the	low	and	the	high	WSS	sites.	The	expression	of	known	flow-
responsive	 genes	 was	 assessed	 as	 a	 quality	 control	 check	 to	 ensure	 that	 the	
response	of	EC	to	WSS	recapitulated	those	observed	previously	(Hwang	et	al.	2003;	
Fang	et	al.	2010;	SenBanerjee	et	al.	2004;	Jiang	et	al.	2015;	Lee	et	al.	2006).	Mcp-1		
(pro-inflammatory	 gene)	 expression	 was	 higher	 in	 cells	 exposed	 to	 low	 WSS	 in	
HUVEC	(Figure	22	A)	and	PAEC	(Figure	22	B).	Whereas	the	expression	of	Klf4	 (anti-
oxidative	gene)	was	enhanced	in	cells	exposed	to	high	WSS	(Figure	22	A	for	HUVEC;	
Figure	 22	 B	 for	 PAEC)	 thus	 validating	 the	 system.	 Subsequently,	 the	 expression	 of	
Twist1	and	Gata4	was	enhanced	by	low	WSS	at	the	mRNA	level	in	PAEC	(Figure	22	C)	
and	in	HUVEC	both	at	the	mRNA	(Figure	22	D)	and	protein	level	(Figure	22	E).	Twist1	
and	GATA4	protein	localisation	was	almost	exclusively	nuclear,	indicating	that	these	
transcription	factors	were	active	in	EC	exposed	to	low	WSS.		
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Figure	22.	Low	WSS	induced	Twist1	and	GATA4	expression	in	cultured	EC	in	vitro	
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Figure	22.	Low	WSS	induced	Twist1	and	Gata4	expression	in	cultured	EC	in	vitro.	EC	were	exposed	to	flow	using	
the	orbital	plate	 system	 for	 72h.	 RNA	was	 isolated	 from	cells	exposed	 to	 low	 and	 high	WSS	 conditions.	Quality	
control	checks	were	carried	out,	by	assessing	the	expression	of	known	flow-responsive	genes	MCP1	and	KLF4	in	A)	
HUVEC	(N=7)	and	in	B)	PAEC	(N=7).	The	expression	of	Twist1	and	Gata4	was	assessed	by	qRT-PCR	in	EC	exposed	to	
low	 and	 high	WSS	 conditions	 in	 C)	 PAEC	 and	 D)	 HUVEC	mRNA	 	 (N=7)	 and	 E)	 Expression	 of	 Twist1	 and	 Gata4	
proteins	 in	HUVEC	exposed	 to	 low	or	high	WSS	was	determined	by	 immunofluorescent	 staining	using	Twist1	or	
Gata4	antibodies	(green)	and	the	nuclei	were	stained	with	DAPI	(blue),	N=4.	Scale	bar,	50	μm.	Protein	expression	
levels	 were	 quantified	 by	 assessing	 fluorescent	 intensity	 levels	 of	 signals	 detected	 in	 the	 nucleus,	 shown	 are	
average	values	F)	EC	were	exposed	to	flow	using	the	ibidi™	parallel	plate	system	for	72h.	RNA	was	isolated	from	
cells	 exposed	 to	 high,	 low	 and	 low/oscillatory	 WSS	 conditions.	 F)	 Quality	 control	 checks	 were	 carried	 out,	 by	
assessing	the	expression	of	known	flow-responsive	genes	Mcp1	and	Klf2.	G)	The	expression	of	Twist1	and	Gata4	
was	assessed	by	qRT-PCR	in	cells	exposed	to	high,	low	and	low/oscillatory	WSS	conditions	Mean	levels	±	SEM	are	
shown.	*	p<0.05,	**p<0.01,	***p<0.001.	
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Similarly,	exposure	of	HUVEC	to	flow	using	the	Ibidi™	parallel	plate	system	revealed	
that	the	expression	of	quality	control	genes,	MCP1	was	enhanced	under	low	WSS	(4	
dyne/cm2)	 compared	 to	 high	 WSS	 (13	 dyne/cm2)	 and	 low,	 oscillatory	 WSS	 (4	
dyne/cm2	,	with	0.2	Hz	oscillations),	whereas	KLF2	(anti-oxidative	gene)	was	induced	
by	high	WSS,	 (Figure	22	 F).	Using	 this	 system,	 the	expression	of	 Twist1	 and	Gata4	
was	elevated	under	low	compared	to	high	WSS	(Figure	22	G).	These	results	provide	
direct	evidence	that	low	WSS	promotes	the	expression	of	TWIST1	and	GATA4	in	EC.	
	
It	was	next	determined	whether	TWIST1	and	GATA4	cross-regulated	one	another	in	
EC	 exposed	 to	 low	WSS.	 This	 was	 assessed	 using	 siRNA-mediated	 gene	 silencing,	
Twist1	 and	 Gata4	 gene	 silencing	 was	 carried	 out	 using	 specific	 siRNA	 molecules	
transfected	 into	 HUVEC	 prior	 to	 the	 exposure	 to	 flow	 via	 orbital	 shaking.	 Gene	
silencing	was	validated	by	showing	a	reduction	in	expression	at	the	mRNA	(Figure	23	
A)	 and	 the	 protein	 level	 (Figure	 23	 B).	 The	 expression	 of	 GATA4	 was	 assessed	 in	
Twist1-silenced	cells,	which	showed	that	Gata4	mRNA	expression	was	not	affected	
by	 the	 reduction	 of	 Twist1	 expression	 (Figure	 24	 A).	 However,	 Gata4	 silencing	
resulted	 in	 a	marked	 reduction	 in	 Twist1	 expression	 (Figure	 24	 A),	 indicating	 that	
GATA4	 is	 required	 for	 the	 expression	 of	 TWIST1	 in	 EC	 exposed	 to	 low	 WSS.	 	 I	
hypothesised	 that	GATA4	directly	 regulates	 TWIST1	 transcription	 in	 EC	 exposed	 to	
low	WSS.	A	 search	 for	putative	 consensus	GATA4	 sequence	 (A/TGATAA	 (G))	 in	 the	
Twist1	 promoter	 (-500	 to	 +100bp	 relative	 to	 transcriptional	 start	 site)	was	 carried	
out	 using	 a	 transcription	 factor	 binding	 site	 database	 (TF	 SEARCH).	 The	 results	
revealed	 the	 presence	 of	 multiple	 GATA4	 binding	 sites	 in	 the	 Twist1	 promoter	
sequence	(bp	51	to	150;	Figure	24	B).	To	test	directly	 if	GATA4	binds	to	the	Twist1	
promoter	 ChIP	 coupled	 to	 qRT-PCR	 revealed	 Twist1	 promoter	 sequences	 co-
precipitated	with	anti-GATA4	antibodies	but	not	with	non-specific	isotype	IgG	(Figure	
24	C).	Collectively,	these	observations	demonstrate	that	low	WSS	promotes	TWIST1	
expression	via	a	GATA4-mediated	transcriptional	mechanism,	whereas	this	network	
is	inhibited	in	cells	exposed	to	high	WSS.	
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Figure	23.	Validation	of	Twist1	and	Gata4	silencing	in	cells	exposed	to	low	WSS.	HUVEC	
were	 transfected	with	Twist1,	Gata4	or	 scrambled,	non-targeting	siRNA	oligonucleotides,	
prior	to	the	exposure	of	flow	using	the	orbital	plate	system	for	72h.	To	assess	the	effect	of	
gene	silencing,	transcript	levels	were	assessed	by	A)	qRT-PCR	(N=3)	and	protein	levels	by	B)	
immunocytochemistry,	cells	were	stained	with	TWIST1	or	GATA4	antibodies	(green).	Nuclei	
were	stained	using	DAPI	(blue).	Scale	bar,	50μm.	Mean	levels	±	SEM	are	shown.	**p<0.01,	
***	p<0.01.	
Figure	23.	Validation	of	Twist1	and	GATA4	silencing	in	cells	exposed	to	low	WSS	
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Figure	24.	Low	WSS	induced	Twist1	expression	via	a	GATA4	transcriptional	mechanism		 	
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Gata4	 Twist1	A	
B	 C	
AGCCCCAGCAATCCCAAATCGGCCCCACGGACCTAGAGGGCTCTTGGGCGAGATG	
AGACATCACCCACTGTGTAGAAGCTGTTGCCATTGCTGCTGTCACAGCCACTCCGG	
ATGGGGCTGCCACCGCGGCCAGGACAGTCTCCTCCGACCGCTTCCTGGGCTGCGC	
TAGGGTTCGGGGGCGCTGCCCGCACGCTCCGGCGGGGAAGGAAATCGCCCCGCG	
CCCGCCGGAGGAAGGCGACGGGGAGGGAAGGGGGAGGGCGGCTAGGAGGCGG	
GTGGAGGGGCCGGCCGCCCGGGCCAGGTCGTTTTTGAATGGTTTGGGAGGACGA	
ATTGTTAGACCCCGAGGAAGGGAGGTGGGACGGGGGAGGGGGACTGGAAAGCG	
GAAACTTTCCTATAAAACTTCGAAAAGTCCCTCCTCCTCACGTCAGGCCAATGACAC	
TGCTGCCCCCAAACTTTCCGCCTGCACGGAGGTATAAGAGCCTCCAAGTCTGCAGC	
TCTCGCCCAACTCCCAGACACCTCGCGGGCTCTGCAGCACCGGCACCGTTTCCAGG	
AGGCCTGGCGGGGTGTGCGTCCAGCCGTTGGGCGCTTTCTTTTTGGACCTCGG	
		
Figure	24.	Low	WSS	induced	TWIST1	expression	via	a	GATA4	transcriptional	mechanism.	
A)	HUVEC	were	treated	with	Twist1	or	Gata4	or	scrambled	siRNA	oligonucleotides	prior	to	the	
exposure	of	flow	using	the	orbital	plate	system	for	72h.	Transcript	levels	of	Twist1	and	Gata4	
were	quantified	by	qRT-PCR	in	cells	exposed	to	low	WSS	(N=3).	B)	Twist1	promoter	sequence	
was	 interrogated	for	putative	GATA4	binding	sites	 (A/TGATAA	(G).	Multiple	predicted	GATA4	
binding	sites	were	detected	(blue)	and	their	position	in	relation	to	the	transcriptional	start	site	
(red)	 is	 shown.	 Lower	 panel	 shows	 position	 weight	 matrix	 for	 the	 GATA	 binding	 motif	
(provided	from	JASPAR).	C)	HUVEC	were	exposed	to	orbital	shaking	for	72h	prior	to	ChIP	using	
anti-GATA4	or	irrelevant	isotype-control	antibodies.	The	levels	of	Twist1	promoter	DNA	were	
assessed	by	qRTPCR	and	fold	enrichment	in	anti-GATA4	compared	to	control	precipitates	was	
calculated	(N=4).	Mean	levels	±	SEM	are	shown.	*	p<0.05,	**p<0.01.	
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 3.5	Conclusions	
	
1. Low	WSS	promotes	TWIST1	and	GATA4	expression	in	the	porcine	aorta	and	in	
cultured	cells	(HUVEC	and	PAEC).	
	
2. GATA4	transcriptionally	promotes	Twist1	expression	 in	cells	exposed	to	 low	
WSS.	
	
3.6	Discussion	
3.6.1	TWIST1	and	GATA4	expression	is	driven	by	WSS	magnitude	
In	this	chapter	I	have	shown	that	Twist1	and	GATA4,	genes	that	orchestrate	essential	
processes	during	embryonic	development	were	enriched	at	atheroprone	sites	in	the	
porcine	 aorta.	 It	 was	 hypothesised	 that	 disturbed	 flow	 at	 these	 sites	 enhances	
TWIST1	 and	 GATA4	 expression	 by	 generating	 low	 WSS	 on	 EC.	 However,	 the	
enrichment	of	Twist1	and	GATA4	at	 these	sites	may	be	attributed	 to	other	 factors	
such	 as	 the	 presence	 of	 circulating	 inflammatory	 mediators	 that	 are	 readily	
transported	into	EC	at	atherosusceptible	sites	due	to	an	increase	in	mass	transport	
(Tarbell	 2003;	Bailey	et	 al.	 2015).	Another	 factor	 could	be	 the	embryonic	origin	of	
the	 specific	 areas	 of	 the	 aorta	 (Trigueros-Motos	 et	 al.	 2013;	 Cheung	 et	 al.	 2014).	
Therefore,	 to	 address	 if	 the	 enhanced	 expression	 of	 Twist1	 and	 Gata4	 at	 the	
atheroprone	sites	was	directly	affected	by	WSS,	the	expression	of	these	genes	was	
tested	using	two	simplistic,	complementary	in	vitro	flow	systems,	the	orbital	shaking	
plate	and	the	Ibidi™	parallel	plate	systems.	The	expression	of	Twist1	and	Gata4	was	
enhanced	 in	 the	 centre	of	 the	orbital	 plate,	where	 flow	 is	 disturbed	and	 complex,	
differing	in	magnitude	and	direction	(low	and	oscillatory	WSS).	
	
	Although	flow	in	the	centre	of	the	well	recapitulates	flow	at	regions	of	branches	and	
bends	 in	 the	 vasculature	where	 flow	 also	 exerts	 low	 and	 oscillatory	WSS,	 the	 co-
existence	 of	 high	 WSS	 in	 the	 periphery	 of	 the	 well	 with	 low,	 oscillatory	 WSS	
conditions	 in	the	centre	of	the	well	 results	 in	a	number	of	caveats	 in	assessing	the	
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expression	of	Twist1	and	Gata4	and	in	concluding	that	WSS	is	directly	affecting	the	
expression	 of	 these	 genes;	 1)	 It	 is	 known	 that	 WSS	 can	 modulate	 the	 release	 of	
cytokines	and	endothelial	microvesicles	(Dolan	et	al.	2012;	Vion	et	al.	2013),	thus	the	
physiology	of	cells	 in	 the	periphery	of	 the	well	 could	be	affected	by	 the	 release	of	
factors	from	the	centre	of	the	well	and	vice	versa,	2)	Cell	turnover	is	also	influenced	
by	WSS	where	a	transient	loss	of	EC-EC	contacts	in	the	monolayer	as	a	result	of	cell	
turnover	 could	 result	 in	 the	 migration	 of	 cells	 from	 the	 different	 regions	 in	 the	
orbiting	well.	 Therefore,	 such	 factors	 could	have	affected	 the	expression	of	Twist1	
and	Gata4	 in	cells	exposed	to	 flow	using	 the	orbital	plate	system.	To	 firstly	dissect	
whether	WSS	magnitude	or	direction	that	is	driving	Twist1	and	Gata4	expression	in	
the	 centre	 of	 the	 well	 (where	 WSS	 is	 low,	 oscillatory),	 and	 secondly	 to	 test	 the	
expression	of	these	genes	in	cells	exposed	to	spatially	distinct	WSS	environments,	I	
tested	 the	expression	of	 Twist1	 and	Gata4	 in	 the	 Ibidi™	parallel	 plate	 system.	The	
results	revealed	that	Twist1	and	Gata4	were	more	highly	induced	in	cells	exposed	to	
low,	 unidirectional	WSS	 compared	 to	 low,	 oscillatory	 and	high,	 unidirectional	WSS	
conditions.	Given	that	TWIST1	and	GATA4	expression	was	enhanced	in	cells	exposed	
to	 low,	 oscillatory	 WSS	 in	 the	 orbital	 plate	 system	 and	 in	 cells	 exposed	 to	 low,	
unidirectional	WSS	in	the	parallel	plate	system,	this	suggests	WSS	magnitude	is	the	
dominant	factor	in	triggering	the	expression	of	TWIST1	and	GATA4	in	cells	exposed	
to	flow	using	in	vitro.		
	
However,	it	could	be	argued	that	the	conclusions	made	on	the	expression	of	TWIST1	
and	GATA4	using	in	vitro	flow	systems	are	premature,	as	these	flow	systems	do	not	
fully	 recapitulate	 the	 flow	 environment	 cells	 are	 exposed	 to	 in	 vivo.	 Cells	 in	 the	
vasculature	 at	 distinct	 flow	 sites	 are	 exposed	 to	 flowing	 blood,	 containing	
inflammatory	 cells	 and	 secreted	 factors,	 which	 could	 have	 an	 additive	 effect	with	
WSS	 in	 driving	 the	 expression	 of	 TWIST1	 and	 GATA4.	 Also,	 although	 flow	 in	 the	
orbital	plate	and	the	parallel	plate	systems	is	pulsatile,	the	pulsatility	differs	to	that	
in	 the	 vasculature	 and	 in	 different	 vascular	 beds.	Moreover,	 the	 pulsatility	 in	 vivo	
results	in	mechanical	stretching	of	the	vessel	wall,	which	does	not	occur	in	vitro	due	
to	 cells	 being	 cultured	 on	 plastic,	 thus	 mechanical	 stretching	 could	 also	 have	 an	
additive	effect	with	WSS	in	driving	TWIST1	and	GATA4	expression.	EC	in	the	orbital	
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plate	and	the	parallel	plate	systems	were	attached	using	gelatin.	This	is	different	to	
extracellular	matrix	attachments	in	the	vasculature.	EC	present	at	low	WSS	and	high	
WSS	sites	bind	to	either	collagen	or	 fibronectin	 (Meng	et	al.	2007;	Orr	et	al.	2005)	
and	 ECM-cell	 interactions	 can	 alter	 signalling	 pathways	 and	 subsequently	 gene	
expression	(Orr	et	al.	2005).		
	
To	conclude,	 in	vitro	 flow	systems	are	subject	 to	caveats	of	not	 fully	 recapitulating	
flow	 conditions	 in	 vivo,	 hence	 the	 use	 of	 multiple	 flow	 systems	 in	 vitro	 and	 the	
validation	of	 in	vitro	observations	 in	vivo	are	 important	 in	 fully	understanding	how	
WSS	modulates	TWIST1	and	GATA4	gene	expression.		
	
3.6.2	How	does	WSS	modulate	GATA4-	TWIST1	expression?	
The	 regulation	 of	 TWIST1	 and	 GATA4	 by	 mechanical	 forces	 has	 been	 shown	
previously.	 TWIST1	 is	 responsive	 to	 mechanical	 cues,	 such	 as	 tissue	 deformation	
during	gastrulation	in	the	Drosophila	embryo	(Desprat	et	al.	2008)	and	in	response	to	
matrix	 stiffness	 in	 tumour	 cells	 (Wei	 et	 al.	 2015).	 Also,	 Twist1	 expression	 was	
reported	to	be	enhanced	in	cells	lacking	primary	cilia,	suggesting	that	the	expression	
of	 Twist	 is	 mechanosensitive	 (Sanchez-Duffhues	 et	 al.	 2015).	 Similarly	 GATA3,	 a	
member	 of	 the	 GATA	 transcription	 factor	 family,	 regulates	 the	 function	 of	 the	
mechanically-sensitive	 vestibular	 inner	 ear	 sensory	 organ	 (Alvardo	 et	 al.	 2011).	 In	
addition,	GATA4	induces	target	genes	involved	in	cardiac	hypertrophy	in	response	to	
pressure	 overload	 in	 the	 heart	 ventricle	 (Tenhunen	 et	 al.	 2004).	 The	 activity	 of	
Twist1	 and	 GATA4	 has	 been	 linked	 with	 a	 number	 of	 known	 mechano-sensing	
components	 such	 as	 Ras	 homolog	 gene	 family	 (Rho),	 kinase	 (ROCK),	 (RhoA/ROCK)	
signalling	and	integrins	(Yanazume	et	al.	2002;	Liu	et	al.	2004;	Yang	et	al.	2012;	Liu	et	
al.	 2009;	 Alexander	 et	 al.	 2006).	 In	 addition,	 TWIST1	 and	 GATA4	 regulate	 valve	
formation,	a	process	in	itself	that	has	been	shown	to	be	regulated	by	blood	flow	in	
the	heart	 (Bartman	et	al.	2004;	Hove	et	al.	2003).	 In	summary	these	studies	either	
directly	 or	 indirectly	 link	 Twist1	 and	 GATA4	 activation	 with	 mechanical	 cues.	
However,	here	 I	 reveal	 for	 the	first	 time	that	WSS	can	activate	TWIST1	and	GATA4	
expression	in	EC.	 I	then	showed	that	GATA4	transcriptionally	activates	Twist1	 in	EC	
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exposed	 to	 low	WSS.	 These	 results	 are	 consistent	with	 previous	 studies	 that	 have	
demonstrated	a	 transciptional	 link	between	GATA4	and	TWIST-family	 transcription	
factors	 during	 embryonic	 development	 (Mcfadden	 et	 al.,	 2005).	 GATA4	 interacts	
with	 binding	 partners	 such	 as	 FOG2,	MEF2C,	 TBX5	 and	 GATA6	 to	 promote	 target	
gene	 activation	 (Chia	 et	 al.	 2015;	 Charron	 et	 al.	 1999;	Garg	 et	 al.	 2003;	 Lee	 et	 al.	
1998)	 it	 would	 therefore	 be	 interesting	 to	 investigate	 whether	 GATA4	 binding	
partners	are	modulated	by	WSS	and	whether	they	are	required	to	promote	GATA4-
induced	Twist1	transcriptional	activation	under	low	WSS.	The	mechanism	for	GATA4-
driven	Twist1	activation	by	WSS	should	be	investigated	in	future	work.	The	potential	
mechanisms	by	which	low	WSS	could	be	driving	GATA4-	TWIST1	activation		will	now	
be	discussed.	
	
3.6.2.1	Transcriptional	regulation	of	GATA4	by	low	WSS-sensitive	signalling	
pathways	
The	 transcriptional	 activation	 of	 GATA4	 in	 cells	 exposed	 to	 low	 WSS	 could		
potentially	 be	mediated	 via	 several	WSS-sensitive	 signalling	 pathways	 (Figure	 25).	
Low	WSS	activates	pro-inflammatory	p38	MAPK	signalling	(Chaudhury	et		al.	2010).	It	
has	 been	 reported	 that	 p38	 regulates	 GATA4	 transcriptionally	 and	 post	
transcriptionally	to	enhance	GATA4	binding	to	its	target	DNA	sequences	(Charron	et	
al.	2001;	Rysä	et	al.	2010).	Interestingly,	in	response	to	mechanical	loading	in	the	rat	
heart	ventricle,	GATA4	is	activated	via	p38	and	ERK	leading	to	subsequent	activation	
of	GATA4-target	genes	involved	in	cardiac	hypertrophy	(Tenhunen	et	al.	2004).	Low	
WSS	 is	 also	 known	 to	 promote	 inflammatory	 NF-κB	 signalling	 (Zakkar	 et	 al.	 2008;	
Cuhlmann	 et	 al.	 2011).	 One	 member	 of	 the	 NF-κB	 family	 C-Rel	 promotes	 GATA4	
transcription	in	cardiac	cells	during	cardiac	hypertrophy	and	fibrosis	(Gaspar-Pereira	
et	al.	2012).	Thus	it	is	plausible	that	low	WSS	induces	GATA4	via	p38	and/or	NF-κB.	
TGF-β	 signalling	 via	 	 BMP	 is	 activated	 in	 cells	 exposed	 to	 low	WSS	 and	 has	 been	
shown	to	be	involved	in	focal	atherogenesis	(Sorescu	et	al.	2004;	Jo	et	al.	2006;	Kim	
et	 al.	 2013).	 BMP4-mediated	 TGF-β	 signalling	 and	 downstream	 homeobox	 binding	
proteins	(HOX	)	regulate	Gata4	gene	expression	during	embryogenesis	(Daoud	et	al.	
2014;Rojas	et	al.	2009)	these	factors	may	also	induce	Gata4	at	atheroprone	sites.	
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Figure	25.	Potential	mechanisms	for	GATA4	activation	in	cells	exposed	to	low	WSS.	A	schematic	
for	the	potential	regulation	of	GATA4	in	EC	exposed	to	low	WSS	via	A)	WSS-sensitive	pathways	B)	
Mechanosensors	and	C)	WSS-sensitive	epigenetic	regulators.	
Figure	25.	Potential	mechanisms	for	GATA4	activation	in	cells	exposed	to	low	WSS	
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Moreover	low	WSS	promotes	an	increase	in	ROS	production	in	EC,	which	promotes	
EC	dysfunction	(Willett	et	al.	2011).	ROS	may	contribute	to	GATA4	induction	by	low	
WSS	since	it	promotes	GATA4	activation	in	other	systems	via	two	mechanisms.	The	
first	mechanism	involves	the	activation	of	CBF/NF-Y	transcription	factor	which	then	
promotes	 GATA4	 trasncription	 (Park	 et	 al.	 2010).	 The	 second	mechanism	 involves	
ROS-mediated	ERK	activation	via	RhoA/ROCK	signalling.		Subsequently,	activated	ERK	
promotes	GATA4	transcriptional	activity	(Liu	et	al.	2004).		
	
3.6.2.2	Transcriptional	regulation	of	GATA4	by	mechanosensors	
GATA4	 transcription	 under	 low	 WSS	 is	 likely	 to	 be	 controlled	 by	 upstream,	 cell	
surface	mechanosensing	 components.	 Several	of	 these	are	discussed	 in	 relation	 to	
GATA4	expression.	Integrins	are	involved	in	mechanosensing	in	EC	in	reponse	to	WSS	
(Ingber	1991;	Shyy	&	Chien	2002).	In	endoderm	cells	integrin	α1β1	(also	expressed	in	
adult	EC)	promotes	GATA4	nuclear	 localisation,	 thus	 increasing	the	transcription	of	
GATA4	target	genes	(Liu	et	al.	2009).	Rho/ROCK	signalling	promotes	cytoskeletal	re-
organisation	 in	 response	 to	 mechanical	 force	 (Tzima	 2006;	 Wojciak-Stothard	 &	
Ridley	2003).	This	pathway	activates	GATA4	in	cardiac	cells	and	it	is	plausible	that	it	
may	function	in	mechanically-stimulated	EC	(Tenhunen	et	al.,	2004).	Calcium	flux	in	
response	 to	 mechanosensors	 such	 as	 primary	 cilia,	 glycocalyx,	 caveloae	 and	 ion	
channels	 is	 a	 well	 studied	 mechanoresponse	 (Ando	 and	 Yamamoto	 et	 al,	 2013).	
During	cardiac	muscle	contraction	calcium	flux	activates	calmodulin	which	activates	
the	transcription	factor	NFAT.	Active	NFAT	interacts	with	GATA4	in	the	nucleus	and	
enhances	GATA4	transcription	of	target	genes	(Sussman	et	al.	1998;	Dolmetsch	et	al.	
1997;	Jones	et	al.	1998).	It	will	be	interesting	to	assess	if	parallel	systems	exist	in	EC.	
It	has	recently	been	shown	by	Rotherham	and	El	Haj	that	cell	surface	WNT	receptors	
Frizzled	 proteins	 (FZD)	 are	 mechanosensors	 (Rotherham	 &	 El	 Haj	 2015).	 They	
showed	 that	 the	 application	 of	 oscillatory	 force	 using	 anti-FZD2	 coated	 magnetic	
nanoparticles	 promoted	 the	 activation	 of	 β-catenin-mediated	 WNT	 signalling	
(Rotherham	&	El	Haj	2015).	GATA4	is	a	direct	transcriptional	target	of	β-catenin	(Lin	
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&	Xu	2008),	thus	FZD2-mechanoactivation	could	be	driving	GATA4	expression	in	EC.	
Primary	 cilia,	 another	 mechanosensor	 has	 been	 linked	 with	 GATA4	 activation.	
Clement	et	al	have	showed	that	cardiomyocytes	with	gene	knock	downs	of	primary	
cilium	components	 ift88	 and	 ift20	 showed	a	 reduction	 in	GATA4	mRNA,	 indicating	
that	GATA4	transcription	is	dependent	on	primary	cilia	activity	(Clement	et	al.	2013)	
(Clement	 et	 al.,	 2009).	 Since	 at	 low	WSS	 sites	 in	 the	 vasculature	 EC	 express	 cilia	
whereas	 EC	 at	 high	 WSS	 do	 not	 (Van	 der	 Heiden	 et	 al.	 2007),	 this	 could	 be	 a	
mechanism	by	which	GATA4	activation	occurs	in	EC	exposed	to	low	WSS	conditions.	
Additionaly,	 syndecan-1	 (a	 component	 of	 the	 glycocalyx)	 is	 a	 positive	 regulator	 of	
WNT	signalling	in	cancer	cells	(Rehmet	et	al.	2007;	Alexander	et	al.	2000).	Moreover,	
WNT	signalling	is	a	known	activator	of	Gata4	gene	expression(Morad	&	Suzuki	2000;	
Lin	 &	 Xu	 2008),	 therefore	 Gata4	 expression	 under	 low	 WSS	 may	 be	 indirectly	
controlled	by	glycocalyx	mechanotransduction.	
	
3.6.2.3	Epigenetic	and	miRNA	regulation	of	GATA4	expression	
Another	mechanism	for	the	activation	of	GATA4	in	cells	exposed	to	 low	WSS	could	
be	 through	 epigenetic	 regulation	 of	GATA4	mRNA.	 Low	WSS	 gives	 rise	 to	 genome	
wide	DNA	methylation	changes	through	DNA	methyltransferase	1	(DNMT1)	(Dunn	et	
al.	2014).	Histone	deactylases	are	another	example	of	low	WSS-mediated	epigenetic	
mediators	(Lee	et	al.	2012).	In	addition,	DNMT1	and	HDAC	inhibit	Gata4	expression	
during	 stem	 cell	 differentiation	 (Oda	 et	 al.	 2013;	 Stefanovic	 et	 al.	 2014).	 Thus,	
potentially,	HDAC	and	DNMT1-mediated	Gata4	gene	inhibition	in	EC	exposed	to	low	
WSS	 could	 be	 a	 	 balance-keeping	mechanism	 to	 ensure	 that	 GATA4	 levels	 do	 not	
exceed	a	certain	threshold.	
	
miRNA	molecules	are	likely	to	be	regulating	GATA4	expression	in	EC	exposed	to	low	
WSS.	 MiR-1,	 26b,	 144	 and	 208a	 regulate	 Gata4	 gene	 expression	 during	 cardiac	
hypertrophy	and	embryonic	development	(Callis	et	al.	2009;	Han	et	al.	2012;	Ikeda	et	
al.	 2009).	 Although	 low	 WSS	 differentially	 activates	 the	 expression	 of	 miRNA	
molecules	(Schober	et	al.	2014;	Son	et	al.	2013;	Callis	et	al.	2009;	Fang	et	al.	2010),	it	
is	unknown	whether	the	miRs	implicated	in	GATA4	regulation	are	modulated	by	WSS	
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in	EC,	but	it	could	be	a	potential	mechanism	for	GATA4	mRNA	stability	in	EC	exposed	
to	low	WSS.	
	
To	 conclude,	 the	 activation	 of	 GATA4-TWIST1	 in	 cells	 exposed	 to	 low	WSS	 could	
potentially	 involve	a	number	of	post	 transcriptional,	 transcriptional	 and	epigenetic	
mechanisms	(Figure	16).	Future	work	will	be	focused	on	dissecting	the	mechanisms	
upstream	of	GATA4	activation	by	low	WSS	in	EC.	
	
3.7	Future	experiments	
To	further	assess	if	GATA4	transcriptionally	activates	Twist1	under	low	WSS;	
1. The	 induction	 of	 Twist1	 by	 GATA4	 could	 be	 assessed	 using	 a	 luciferase	
reporter	 gene	 in	 vitro	 assay.	 This	 would	 involve	 inhibiting	 or	 enhancing	
GATA4	expression,	followed	by	the	assessment	of	luciferase	activity.	
	
2. To	 assess	whether	 GATA4	 promotes	 Twist1	 gene	 expression	 via	 binding	 to	
interacting	partners.	This	could	be	tested	by	expressing	a	Gata4	gene	that	is	
mutated	in	the	sites	required	for	interacting	partner	binding,	followed	by	the	
assessment	of	Twist	expression.	
	
3. Studying	 the	 relative	 effect	 of	 WSS	 on	 GATA4	 mRNA	 stability	 vs.	
transcription.	
	
4. Determining	mechanosensitive-signalling	pathways	upstream	of	GATA4.	
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Chapter	4:	TWIST1	and	GATA4	control	
proliferation	and	permeability	in	cells	exposed	to	
low	WSS	in	vitro	
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4.1	Introduction	
TWIST1	 and	 GATA4	 regulate	 a	 number	 of	 processes	 involved	 in	 cellular	
reorganisation	 and	 patterning	 during	 embryonic	 development;	 these	 processes	
include	 cell	 proliferation,	 migration,	 and	 invasion	 (Shelton	 &	 Yutzey,	 2008	 Lee	 &	
Yutzey	2011;	Rojas	et	al.	2008;	Vrlijcak	et	al.	2012).	TWIST1	and	GATA4	have	been	
implicated	 in	 EMT	 in	epithelial	 cells	 and	 in	 the	parallel	 process	 in	 endothelial	 cells	
known	as	EndMT.	
	
EndMT	is	essential	during	cardiac	valve	formation,	this	process	is	heavily	dependent	
on	the	expression	of	TWIST1	and	GATA4	(Zeisberg	et	al.	2005;	Vrlijicak	et	al.	2012,	
reviewed	 in	 Lamouille	 et	 al.	 2014;	 Yang	 et	 al.	 2004;	 Rivera-Feliciano	 et	 al.	 2006).	
During	 EndMT	 cells	 transform	 into	 a	 more	 mesenchymal	 state,	 characterized	 by	
several	 physiological	 and	 morphological	 changes	 (Reviewed	 in	 Medici	 &	 Kalluri	
2012).	 Firstly,	 cells	 express	 EndMT	 master	 regulators	 such	 as	 TWIST1,	 SNAIL	 and	
SLUG	 bHLH	 transcription	 factors,	 which	 trigger	 subsequent	 changes	 in	 gene	
expression	 involving	 loss	 of	 EC	 markers	 such	 as	 VE-cadherin	 and	 CD31	 and	 the	
expression	 of	 mesenchymal	 genes	 such	 as	 N-cadherin	 and	 α-SMA.	 Secondly,	 as	 a	
result	 of	 the	 change	 in	 gene	 expression	 the	 cells	 display	 morphological	 changes	
where	they	become	more	spindle-like	and	undergo	the	so-called	“cadherin	switch”,	
which	 involves	 the	expression	of	N-cadherin	 and	disorganisation	of	VE-cadherin	 at	
the	 cellular	 junctions	 (Maddaluno	 et	 al.	 2013).	 The	 cells	 also	 become	 more	
proliferative,	invasive,	migratory	and	as	a	consequence	more	“leaky”	with	higher	cell	
permeability.	 Eventually	 EndMT	 can	 result	 in	 cellular	 delamination	 (reviewed	 in	
Medici&	Kalluri,	2012	and	Birukova	et	al.	2004).	
	
In	addition	to	its	role	in	development,	EndMT	has	also	been	linked	with	a	number	of	
pathological	 conditions	 including	 cancer,	 renal	 fibrosis	 and	 cerebral	 cavernous	
malformations	 (Maddaluno	 et	 al.	 2013;	 Zeisberg	 et	 al.	 2007;	 Zeisberg	 et	 al.	 2008;	
Ranchoux	 et	 al.	 2015).	 Consistent	 with	 this,	 TWIST1	 and	 GATA4	 are	 known	 to	 be	
prominent	oncogenes	that	trigger	metastatic	cell	migration	via	the	induction	of	EMT	
(Takagi	et	al.	2014;	Yang	et	al.	2004).	However,	it	has	not	been	explored	yet	whether	
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TWIST1	 and	 GATA4	 regulate	 EC	 function	 in	 cells	 exposed	 to	 low	 WSS	 and	 in	
particular	if	they	do	this	via	EndMT.	
	
4.2	Hypothesis		
TWIST1	and	GATA4	regulate	EC	function	under	low	WSS	via	inducing	EndMT.	
	
4.3	Aims:	
1- To	 study	 TWIST1	 and	 GATA4	 functions	 in	 cells	 exposed	 to	 low	WSS	 by	
assessing	tube	formation,	proliferation,	migration	and	permeability.	
	
2- To	 assess	 if	 low	WSS	 promotes	 EndMT	 and,	 if	 so,	whether	 TWIST1	 and	
GATA4	are	drivers	of	this	process.	
	
	
	
	
	
Low	WSS	
GATA4	 TWIST1	
Prolifera2on	
Migra2on	
Permeability	
?	
EndMT	
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4.3	TWIST1	and	GATA4	regulate	proliferation,	migration	and	permeability	in	cells	
exposed	to	low	WSS	
The	potential	role	of	TWIST1	and	GATA4	in	tube	formation,	a	process	that	 involves	
migration	and	proliferation	was	studied.	EC	were	exposed	to	72h	of	flow	via	orbital	
shaking	and	then	cells	from	the	low	or	high	WSS	regions	were	seeded	onto	collagen-
coated	wells	 for	up	to	48h	under	static	conditions	(Figure	26	A).	Cells	seeded	from	
the	 low	WSS	 region	 showed	 significantly	 more	 tube	 formation	 compared	 to	 cells	
seeded	 from	 the	 high	WSS	 region	 as	 quantified	 by	 the	 cumulative	 length	 of	 tube	
structures	and	by	quantifying	the	number	of	branch	points	(Figure	26	B).		Twist1	and	
Gata4	silencing	reduced	tube	length	and	complexity	(branch	points)	in	cells	exposed	
to	low	WSS	(Figure	26	C)	suggesting	that	they	promote	tube	formation	in	these	cells.		
	
To	further	dissect	function	the	contribution	of	TWIST1	and	GATA4	to	cell	migration	
and	 proliferation	was	 studied.	 For	 cell	migration	 a	 “scratch”	was	made	 across	 the	
well	of	pre-sheared	cells	to	form	a	wound.	Cell	migration	into	the	wounded	area	was	
quantified	 by	measuring	 the	 distance	 and	 the	 velocity	 of	 the	migrating	 cells.	 Cells	
exposed	to	low	WSS	showed	a	higher	rate	of	cell	migration	as	indicated	by	distance	
and	velocity	compared	to	cells	exposed	to	high	WSS	(Figure	27)	and	the	silencing	of	
Twist1	and	Gata4	resulted	in	a	reduction	in	this	process	(Figure	28).	
	
	Next,	 cell	 proliferation	 by	 ki67	 immunofluorescent	 staining	 was	 assessed	 in	 cells	
exposed	 to	 flow.	 Initial	 studies	 revealed	 that	 there	was	no	significant	difference	 in	
proliferation	in	cells	exposed	to	low	vs.	high	WSS	using	the	orbital	plate	system	(data	
not	 shown),	 indicating	 that	 the	 flow	 parameters	 were	 not	 sufficient	 to	 induce	 a	
difference	 in	 proliferation.	 However,	 since	 TWIST1	 and	 GATA4	 expression	 was	
significantly	enhanced	in	cells	exposed	to	low	WSS	via	orbital	shaking,	the	effect	of	
Twist1	 and	 Gata4	 gene	 silencing	 on	 cell	 proliferation	 was	 assessed	 under	 these	
conditions.	Twist1	and	Gata4	silencing	reduced	cell	proliferation	in	cells	exposed	to	
low	WSS	(as	assessed	by	quantifying	%	positive	ki67	cells/frame	of	view)	(Figure	29).		
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Figure	26.	TWIST1	and	GATA4	regulate	tube	formation	in	cells	exposed	to	low	WSS.	HUVEC	were	treated	
with	 siRNA	 targeting	 Twist1	 and	Gata4,	 or	with	 scrambled	 non-targeting	 siRNA	 (or	were	 untreated	 as	 a	
control)	A)	Cells	were	exposed	to	flow	via	orbital	shaking	and	were	then	plated	onto	collagen	coated	wells	
and	cultured	for	up	to	48h	in	media	containing	VEGF	to	mediate	tube	formation.	B)	The	cells	were	fixed	and	
stained	with	DAPI	(blue)	and	PKH26	(red)	to	label	the	tube	structures	formed,	and	were	then	visualised	by	
fluorescent	microscopy.	 Representative	 images	 are	 shown.	 Scale	 bar,	 75	 μm.	 (B-C)	 The	 cumulative	 tube	
length	and	number	of	branch	points	were	determined	 for	multiple	 fields	of	 view	and	mean	values	were	
calculated.	 Data	 were	 pooled	 from	 5	 independent	 experiments	 and	 mean	 values	 ±	 SEM	 are	 shown.	 *	
p<0.05	using	paired	t-test	or	a	one-way	ANOVA.	
Figure	26.	Twist1	and	
GATA4	regulate	tube	
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Figure	27.	Cells	exposed	to	low	WSS	displayed	enhanced	migration	compared	to	cells	exposed	to	
high	WSS			
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Figure	 27.	 Cells	 exposed	 to	 low	WSS	 displayed	 enhanced	migration	 compared	 to	 cells	
exposed	 to	high	WSS.	HUVEC	were	exposed	to	72h	of	 flow	via	orbital	shaking.	A	scratch	
was	made	using	a		P	200	pipette	tip	across	the	well,	to	form	a	wound	in	areas	of	high	and	
low	WSS.	Migration	into	the	wounded	area	was	visualised	by	time-lapse	microscopy,	cells	
were	imaged	every	3	minutes	for	20h.	Representative	images	captured	at	5h	intervals	are	
shown.	Scale	bar,	100	μm.	The	distance	migrated	 into	the	wounded	area	was	quantified	
from	at	 least	three	points	 in	the	monolayer.	 	Average	velocity	was	calculated.	Data	were	
pooled	 from	 5	 independent	 experiments	 and	mean	 values	 ±	 SEM	 are	 shown.	 *	 p<0.05,	
using	a		paired	t-test.	
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Figure	28.	Twist1	and	GATA4	promoted	cell	migration	in	cells	exposed	to	low	WSS	 	
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Figure	28.	TWIST1	and	GATA4	promoted	cell	migration	in	cells	exposed	to	low	WSS.	
HUVEC	were	treated	with	siRNA	targeting	Twist1,	Gata4	or	a	scrambled	non-targeting	
siRNA,	 followed	by	 the	 exposure	 of	 flow	 via	 orbital	 shaking	 for	 72h.	A	 scratch	was	
made	using	a	P	200	pipette	tip	across	the	well,	to	form	a	wound	in	areas	in	the	well	
of	high	and	low	WSS.	Migration	into	the	wounded	area	was	visualised	by	time-lapse	
microscopy,	 cells	 were	 imaged	 every	 3	 minutes	 for	 20h.	 Representative	 images	
captured	at	5h	 intervals	are	 shown.	Scale	 bar,	100	μm.	The	 distance	migrated	 into	
the	 wounded	 area	 was	 quantified	 from	 at	 least	 three	 points	 in	 the	 monolayer.		
Average	velocity	also	calculated.	Data	were	pooled	from	5	independent	experiments	
and	mean	values	±	SEM	are	shown.	*	p<0.05,	using	a		One-way	ANOVA.	
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Figure	29.	Twist1	and	GATA4	promoted	proliferation	in	cells	exposed	to	low	WSS		 	
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Figure	29.	TWIST1	and	GATA4	promoted	proliferation	in	cells	exposed	to	low	WSS.	HUVEC	
were	 treated	 with	 siRNA	 targeting	 Twist1,	 Gata4	 or	 a	 scrambled	 non-targeting	 siRNA,	
followed	 by	 the	 exposure	 of	 flow	 via	 orbital	 shaking	 for	 72h.	 Cells	 were	 fixed	 and	
immunostained	with	anti-ki-67	antibodies	 (green)	 	 to	 label	proliferative	 cells	and	were	co-
stained	 with	 DAPI	 (blue).	 Representative	 images	 are	 shown.	 Scale	 bar,	 50	 μm.	 %	 ki-67-
positive	cells	was	calculated.	Data	were	pooled	from	5	independent	experiments	and	mean	
values	±	SEM	are	shown.	*	p<0.05,	**p<0.01		using	a	paired	t-test.	
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The	above	data	demonstrate	that	TWIST1	and	GATA4	are	positive	regulators	of	cell	
migration	 and	 proliferation	 under	 low	WSS	 conditions.	 Since	 these	 processes	 are	
known	 to	 enhance	 vascular	 permeability	 (Cancel	 et	 al.	 2011,	 Cancel	 et	 al.	 2010	
Birukova	 et	 al.	 2004)	 I	 determined	 whether	 TWIST1	 and	 GATA4	 regulate	 EC	
permeability	under	low	WSS.	A	method	developed	by	the	Weinberg	group	was	used	
(Warboys	et	al.	2010),	which	involved	culturing	cells	on	transwell	inserts,	followed	by	
orbital	 shaking	 at	 150	 rpm	 for	 72	 h.	 	 CFD	 analysis	 demonstrated	 that	 cells	 are	
exposed	 to	 a	 relatively	 constant	 low	 WSS	 across	 the	 transwell	 insert	 (0.2	 to	 3.6	
dyne/cm2)	with	a	 spatially	and	 temporally	average	value	of	 the	entire	well	of	1.82	
dyne/cm2	 	 (Warboys	 et	 al.	 2010).	 Following	 the	 exposure	 to	 flow,	 a	 rhodamine-
albumin	 tracer	was	added	to	 the	 top	compartment	of	 the	 transwell	and	 incubated	
for	1	h	under	static	conditions.	Media	from	the	bottom	compartment	was	collected	
to	measure	the	concentration	of	tracer	as	a	measure	of	cell	permeability	(Figure	30	
A).	 To	 validate	 the	 use	 of	 the	 system	 in	 our	 laboratory,	 I	 repeated	 an	 experiment	
reported	 by	 the	 Weinberg	 group	 (Warboys	 et	 al.	 2010),	 by	 comparing	 cell	
permeability	 in	 cells	 either	 exposed	 to	 prolonged	 flow	 (72h)	 of	 orbital	 shaking	 or	
cultured	 under	 static	 conditions.	 It	 was	 revealed	 that	 cells	 exposed	 to	 flow	 had	 a	
higher	 level	of	 cell	permeability	 compared	 to	cells	 cultured	under	 static	 conditions	
(Figure	 30	 B),	 thus	 replicating	 experimental	 findings	 from	 Warboys	 et	 al.,	 2010.	
Following	 the	 validation	 of	 the	 system,	 Twist1	 and	 Gata4	 were	 silenced	 and	 cell	
permeability	was	assessed.	It	was	revealed	that	silencing	of	either	gene	reduced	cell	
permeability	(Figure	30	C),	indicating	that	they	promote	this	process	in	cells	exposed	
to	 low	 WSS.	 Therefore,	 it	 was	 concluded	 that	 the	 application	 of	 low	 WSS	 to	 EC	
monolayers	 led	to	GATA4-mediated	 induction	of	TWIST1,	promoting	cell	migration,	
proliferation	and	increased	permeability	to	macromolecules.	
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Figure	30.	Twist1	and	GATA4	promoted	cell	permeability	in	cells	exposed	to	low	WSS		 	
0
5
10
15
20
25
co
nc
en
tra
tio
n o
f R
d-A
lbu
mi
n
(µg
/m
l)
*
siRNA			Scrambled													Gata4	
0
5
10
15
20
25
co
nc
en
tra
tio
n o
f R
d-A
lbu
mi
n
(µg
/m
l)
*
siRNA					Scrambled															Twist1							
	C
on
ce
nt
ra
9o
n	
of
	R
d-
Al
bu
m
in
	
	(μ
g/
m
l)	
Orbital	shaking	(72	h)	
	
Upper		
compartment	
Lower	
compartment	
Rd-Albumin	tracer		
Sta9c	(1	h)	
Measure	
tracer	
concentra9on	
	C
on
ce
nt
ra
9o
n	
of
	R
d-
Al
bu
m
in
	
	(μ
g/
m
l)	
0
1
2
3
4
 C
on
ce
nt
ra
tio
n 
of
 R
d-
A
lb
um
in
 
(µ
g/
m
l)
	C
on
ce
nt
ra
9o
n	
of
	R
d-
Al
bu
m
in
	
	(μ
g/
m
l)	
WSS										Sta9c																					Low							
B	
C	
A	
Figure	30.	TWIST1	and	GATA4	promoted	cell	permeability	 in	cells	exposed	to	 low	WSS.		A)	
HUVEC	were	seeded	onto	transwell	plates	and	exposed	to	flow	via	orbital	shaking	at	150	rpm	
for	72h.	Following	orbital	shaking,	a	rhodamine-albumin	tracer	was	incubated	for	1	hour	under	
static	 conditions.	 Media	 from	 the	 bottom	 compartment	 was	 collected	 to	 assess	 the	
concentration	 of	 tracer	 as	 a	 measure	 of	 cell	 permeability.	 B)	 To	 validate	 the	 method,	 we	
replicated	results	from	the	study	which	the	method	was	adapted	(Warboys	et	al.,	2010).	Cells	
exposed	to	static	conditions	had	higher	levels	of	cell	permeability	compared	to	cells	exposed	
to	 prolonged	 flow	 (72h),	 N=1.	 C)	 Prior	 to	 the	 exposure	 of	 flow,	 the	 cells	were	 treated	with	
Twist1,	 Gata4	 or	 scrambled	 non-targeting	 siRNA.	 And	 cell	 permeability	 was	 assessed.	 Data	
were	pooled	from	5	independent	experiments	and	mean	values	±	SEM	are	shown.	*	p<0.05,	
using	a	paired	t-test.	
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4.4	GATA4-TWIST1	regulate	EC	physiology	under	low	WSS	via	a	mechanism-
involving	SNAIL.	
Cell	proliferation	and	migration	are	processes	that	are	also	known	to	occur	 in	cells	
undergoing	EndMT	and	Twist1	and	GATA4	promote	EMT	and	EndMT	in	other	cellular	
systems.	Therefore,	 I	next	hypothesised	that	GATA4-Twist1	signalling	promotes	the	
induction	 of	 EndMT	 in	 cells	 exposed	 to	 low	 WSS.	 Consistent	 with	 this,	 several	
markers	 of	 EndMT	 (Snail,	 Slug,	N-cadherin,	α-SMA)	were	 enriched	 at	 the	 low	WSS	
site	 in	 the	 porcine	 aorta	 (Figure	 31	 A)	 and	were	 induced	 by	 low	WSS	 in	 cultured	
HUVEC	(Figure	31	B,D)	and	PAEC	(Figure	31	C).	Furthermore,	HUVEC	exposed	to	low	
WSS	expressed	a	significantly	higher	level	of	N-cadherin	at	the	cell	junctions	(Figure	
31	 E)	 and	 displayed	 VE-cadherin	 disorganisation	 as	 assessed	 by	 measuring	 VE-
cadherin	junctional	width	compared	to	cells	exposed	to	high	WSS	conditions	(Figure	
31	 F).	However,	 although	 cells	 exposed	 to	 low	WSS	displayed	EndMT-like	 features	
such	 as	 expressing	 EndMT	marker	 genes	 and	 the	 N-cadherin/	 VE-cadherin	 switch,	
the	 retention	 of	 EC	markers	 and	 the	 absence	 of	 a	 spindle-like	morphology	 that	 is	
characteristic	of	EndMT	suggested	 that	 the	 transition	 to	a	mesenchymal	 state	was	
partial.		
	
I	next	assessed	the	potential	 involvement	of	GATA4-TWIST1	signalling	 in	regulating	
partial	 EndMT	 under	 low	WSS.	 Gene	 silencing	 of	 Twist1	 and	 Gata4	 resulted	 in	 a	
marked	 reduction	 in	 the	 junctional	 expression	 of	 N-cadherin	 (Figure	 32	 A)	 and	
reduced	 VE-cadherin	 disorganisation,	 by	 reducing	 VE-cadherin	 junctional	 width	
(Figure	 32	 B)	 indicating	 that	 they	 are	 positive	 regulators	 of	 changes	 in	 junctional	
expression	induced	by	low	WSS.	The	expression	of	EndMT	markers	was	determined	
to	 understand	 the	 molecular	 mechanism.	 Gene	 silencing	 of	 Twist1	 and	 Gata4	
significantly	reduced	the	expression	of	the	EndMT	inducer	Snail	 in	cells	exposed	to	
low	WSS	 (Figure	 32	 C	 and	 D).	 To	 further	 validate	 the	 link	 between	 GATA4-Twist1	
signalling	 with	 Snail,	 protein	 expression	 was	 assessed.	 Cells	 exposed	 to	 low	 WSS	
displayed	 a	 higher	 SNAIL	 expression	 compared	 to	 cells	 exposed	 to	 high	WSS	 and	
Twist1	and	Gata4	gene	silencing	resulted	in	a	reduction	of	SNAIL	protein	(Figure	33).		
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Figure	31.Low	WSS	promoted	partial	EndMT			 	
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Figure	31.	 Low	WSS	promoted	partial	EndMT.	A)	EndMT	marker	transcipts	were	assessed	 in	cells	 isolated	
from	 low	 (inner	 curvature	 and	high	WSS	 (outer	 curvature)	of	 the	 porcine	 aorta,	N=4.	 B-D)	 EndMT	marker	
transcipts	were	assessed	 in	cells	exposed	to	72h	of	 flow	via	orbital	shaking	or	via	the	parallel	plate	 	 ibidi™	
system,	N=4.	The	dotted	 line	 indicates	high	WSS	expression	to	which	the	 low	WSS	expression	values	were	
normalised.	 E-F)	 Following	 72h	 of	 exposure	 to	 flow	 via	 orbital	 shaking,	 cells	 were	 fixed	 and	 were	
immunostained	 with	 anti-N-cadherin	 (green)	 and	 VE-cadherin	 (red)	 antibodies,	 cells	 were	 counterstained	
with	DAPI	 (blue).	Representative	 images	are	shown.	Scale	bar,	50	μm	E)	The	expression	of	N	cadherin	was	
calculated	as	%	positive	cells	expressing	junctional	N-cadherin.	F)	VE-cadherin	junctional	width	was	measured	
using	 Image	J.	Left	panel	shows	 zoomed	 image,	arrows	 indicate	VE-cadherin	 junctional	width.	At	 least	 four	
measurements	were	taken	in	one	field	of	view.	%	positive	cells	expressing	VE-cadherin	was	calculated	(right	
panel).	 Data	 was	 pooled	 from	 5	 independent	 experiments.	 Mean	 values	 ±	 SEM	 are	 shown.	 *	 p<0.05,	
**p<0.01	,	***p<0.001		using	a	one	way	ANOVA	or	un	paired	t-test.	
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Figure	32.	Twist1	and	GATA4	regulated	partial	EndMT	in	cells	exposed	to	low	WSS						 	
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Figure	32.	TWIST1	 and	GATA4	 regulated	partial	EndMT	 in	 cells	exposed	 to	 low	WSS.	HUVEC	
were	treated	with	siRNA	targeting	Twist1,	Gata4	or	a	scrambled	non-targeting	siRNA,	followed	
by	the	exposure	of	 flow	via	orbital	shaking	for	72h.	A-B)	Cells	exposed	to	 low	WSS	were	fixed	
and	were	 immunostained	with	anti-N-cadherin	 (green)	and	VE-cadherin	 (red)	antibodies.	Cells	
were	counterstained	with	DAPI	 (blue).	Representative	 images	are	 shown.	Scale	bar,	50μm.	 	A)	
The	expression	of	N	cadherin	was	calculated	as	%	positive	cells	expressing	junctional	N-cadherin,	
N=5.	 B)	 VE-cadherin	 junctional	 width	was	measured	 using	 Image	 J,	 N=5.	 Arrows	 indicate	 VE-
cadherin	 junctional	 width.	 Atleast	 four	 measurements	 were	 taken	 in	 each	 field	 of	 view/per	
region.	C-D)	EndMT	marker	transcipts	were	assessed	in	cells	exposed	to	low	WSS,	following	the	
silencing	 of	 Twist1	 (C)	 or	Gata4	 (D)	N=3).	Mean	 values	 ±	SEM	are	 shown.	*	p<0.05,	**p<0.01	
using	a	One-way	ANOVA	or	an	unpaired	t-test.	
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Figure	33.	Twist1	and	GATA4	regulated	Snail	protein	in	cells	exposed	to	low	WSS	
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Figure	33.	TWIST1	and	GATA4	regulated	SNAIL	protein	expression	in	cells	exposed	to	low	
WSS.	HUVEC	were	treated	with	siRNA	targeting	Twist1	and	Gata4,	or	with	scrambled	non-
targeting	siRNA	(or	were	untreated	as	a	control)	prior	to	the	exposure	to	flow	via	orbital	
shaking	 for	 72h.	 Cells	were	 fixed	 and	 immunostained	with	 anti-SNAIL	 (green)	 antibodies	
and	 the	 cells	 were	 counterstained	 with	 DAPI	 (blue).	 Representative	 images	 are	 shown,	
N=3.	 Scale	bar,	 50	μm.	 Fluorescent	 intensity	 in	 the	nuclei	of	multiple	 cells	was	 assessed	
using	Image	J.	Mean	levels	±	SEM	are	shown	*	p<0.05,	using	a	One-way	ANOVA	or	paired	t-
test.	
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These	 results	 suggest	 that	 TWIST1	 and	 GATA4	 promote	 SNAIL	mRNA	 and	 protein	
expression	 in	 cells	 exposed	 to	 low	 WSS.	 To	 assess	 if	 this	 regulation	 was	 at	 the	
transcriptional	level,	ChIP	analysis	was	carried	out,	which	revealed	that	GATA4	binds	
to	the	Snail	promoter	region	(GATA4	binding	site	located	at	bp	423-450)	(Figure	34	
A,	 B)	 suggesting	 that	 GATA4-Twist1	 signalling	 induces	 Snail	 via	 a	 transcriptional	
mechanism.	
	
I	 then	assessed	whether	Snail	promotes	EndMT-related	transcriptional	changes.	To	
do	 so,	 snail	 gene	 silencing	 was	 first	 validated	 in	 cells	 exposed	 to	 low	WSS	 at	 the	
mRNA	and	protein	level	(Figure	35).	EndMT	marker	expression	was	assessed,	which	
showed	that	the	silencing	of	Snail	resulted	in	a	reduction	of	EndMT	markers	Slug,	α-
Sma	 and	 N-cadherin,	 which	 indicated	 that	 SNAIL	 promotes	 EndMT	 marker	
expression	in	cells	exposed	to	low	WSS	(Figure	36).	
	
Interestingly,	cell	migration	(Figure	37	A)	proliferation	(Figure	37	B)	and	permeability	
(Figure	37	C)	were	all	reduced	in	cells	with	Snail	gene	silencing,	suggesting	that	Snail	
regulated	these	processes.	Therefore,	these	results	suggest	that	TWIST1	and	GATA4	
co-operate	to	induce	SNAIL	in	cell	exposed	to	low	WSS,	and	this	transcription	factor	
contributes	 to	 EC	proliferation,	migration	and	permeability	under	 these	 conditions	
(Figure	38).	
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Figure	34.	GATA4	transcriptionally	regulated	Snail	expression	in	cells	exposed	to	low	WSS	 	
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Figure	34.	GATA4	 transcriptionally	 regulated	 Snail	expression	 in	 cells	 exposed	 to	 low	
WSS.	A)	The	Snail	promoter	sequence	was	interrogated	for	putative	GATA4	binding	sites	
(A/TGATAA	 (G).	A	predicted	GATA4	binding	site	was	detected	 (blue)	and	 its	position	 in	
relation	to	the	transcriptional	start	site	(red)	is	shown.	B)	HUVEC	were	exposed	to	orbital	
shaking	 for	 72h	 prior	 to	 ChIP	 using	 anti-GATA4	 or	 irrelevant	 isotype-control	
antibodies.The	 levels	 of	 Snail	 promoter	 DNA	 were	 assessed	 by	 q-RTPCR	 and	 fold	
enrichment	in	anti-GATA4	compared	to	control	precipitates	was	calculated	(N=4).	Mean	
levels	±	SEM	are	shown.	*	p<0.05,		using	an		unpaired	t-test.		
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Figure	35.	Validation	of	Snail	silencing			 	
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Figure	35.	Validation	 of	 Snail	 silencing.	HUVEC	were	transfected	with	 	 siRNA	 targeting	
Snail	or	scrambled,	non-targeting	siRNA,	prior	to	the	exposure	of	flow	using	the	orbital	
plate	 system	 for	 72h.	 To	 assess	 the	 effect	 of	 gene	 silencing,	 transcript	 levels	 were	
assessed	by	A)	qRT-PCR	(N=3)	and	protein	levels	by	B)	immunocytochemistry,	cells	were	
stained	anti-SNAIL	antibodies	 (green).	Nuclei	were	stained	using	DAPI	 (blue).	 Scale	bar,	
50	μm.	Mean	levels	±	SEM	are	shown.		**p<0.01,	using	an	unpaired	t-test.	
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Figure	36.	Snail	promoted	EndMT	marker	expression	in	cells	exposed	to	low	WSS				 	
0.0
0.5
1.0
1.5
Re
la
tiv
e 
Sl
ug
  m
RN
A 
ex
pr
es
si
on
*
0.0
0.5
1.0
1.5
Re
la
tiv
e 
α
-S
M
A 
 m
RN
A 
ex
pr
es
si
on
*
α
-S
M
A
	m
RN
A
		l
ev
el
s	
	
Sl
ug
		m
RN
A
		l
ev
el
s	
	
N
-c
ad
he
ri
n	
	m
RN
A
		l
ev
el
s	
	
siRNA					Scrambled									Snail						 siRNA				Scrambled									Snail						 siRNA				Scrambled									Snail						
0.0
0.5
1.0
1.5
R
el
at
iv
e 
N
-c
ad
he
rin
  m
R
N
A
 e
xp
re
ss
io
n 
*
Figure	 36.	 SNAIL	 promoted	 EndMT	marker	 expression	 in	 cells	 exposed	 to	 low	WSS.	
HUVEC	were	transfected	with	targeting	Snail	or	scrambled,	non-targeting	siRNA,	prior	to	
the	 exposure	 of	 flow	using	 the	 orbital	 plate	 system	 for	 72h.	 EndMT	marker	 transcipts	
were	assessed	in	cells	exposed	to	low	WSS	N=3.	Mean	values	±	SEM	are	shown.	*	p<0.05		
using	an	unpaired	t-test.	
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Figure	37.	Snail	promoted	cell	migration,	proliferation	and	permeability	in	cells	exposed	to	low	WSS	
Figure	37.	SNAIL	promoted	cell	migration,	proliferation	and	permeability	in	cells	exposed	
to	low	WSS.	HUVEC	were	transfected	with	targeting	Snail	or	scrambled,	non-targeting	siRNA,	
prior	to	the	exposure	of	flow	using	the	orbital	plate	system	for	72h.	A)	A	scratch	was	made	
using	a	P200	pipette	tip	across	the	well,	to	form	a	wound	in	areas	in	the	well	of	high	and	low	
WSS.	Migration	into	the	wounded	area	was	visualised	by	time-lapse	microscopy,	cells	were	
imaged	every	3	minutes	for	20h.	Representative	images	captured	at	5h	intervals	are	shown.	
Scale	 bar,	 100	μm.	 The	 distance	migrated	 into	 the	wounded	 area	was	 quantified	 from	at	
least	 three	 points	 in	 the	 monolayer.	 	 Average	 velocity	 also	 calculated	 by	 quantifying	 the	
slope,	N=4.	 B)	 Cells	were	 fixed	 and	 immunostained	with	 an	 anti-ki-67	 (green)	 antibody	 to	
label	 proliferative	 cells	 and	 were	 co-stained	 with	 DAPI	 (blue).	 Representative	 images	 are	
shown.	Scale	bar,	50μm.	%	Ki-67-positive	cells	was	calculated	as	a	measure	of	proliferation,	
N=4.	C)	HUVEC	were	seeded	onto	transwell	plates	and	exposed	to	flow	via	orbital	shaking	at	
150	rpm	for	72h.	Following	orbital	shaking,	a	rhodamine-albumin	tracer	was	incubated	for	1	
hour	under	static	conditions.	Media	from	the	bottom	compartment	was	collected	to	assess	
the	concentration	of	tracer	as	a	measure	of	cell	permeability,	N=5.	*	p<0.05,	**p<0.01		using	
a	paired	t-test.	
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Figure	38.	Model	for	the	role	of	Twist1	and	GATA4	in	regulating	EC	physiology	in	
cells	exposed	to	low	WSS	in	vitro.	Low	WSS	promoted	GATA4-Twist1	expression.	
Twist1	 and	 GATA4	 promote	 partial	 EndMT	 by	 inducing	 SNAIL	 and	 N-cadherin	
expression.	 Twist1,	 GATA4	 and	 Snail	 promote	 proliferation,	 migration	 and	
permeability.	
	
Figure	38.	Model	for	the	role	of	Twist1	and	GATA4	in	regulating	EC	physiology	in	cells	
exposed	to	low	WSS	in	vitro	
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4.5	Conclusions	
	
1. TWIST1	and	GATA4	promote	cell	proliferation,	migration	and	permeability	in	
cells	exposed	to	low	WSS.	
	
	
2. TWIST1	and	GATA4	induce	SNAIL	and	markers	of	EndMT	in	EC	exposed	to	low	
WSS.		
	
	
3. SNAIL	 promotes	 cell	 proliferation,	 migration	 and	 permeability	 in	 cells	
exposed	to	low	WSS.	
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4.6	Discussion	
4.6.1	GATA4	and	TWIST1	control	EC	proliferation,	migration	and	permeability	via	
the	induction	of	EndMT	in	cells	exposed	to	low	WSS.		
In	 this	 chapter,	 I	 have	 demonstrated	 that	 cell	 migration,	 proliferation	 and	 tube	
formation	 are	 enhanced	 in	 cells	 exposed	 to	 low	 WSS	 compared	 to	 high	 WSS	
conditions,	which	is	consistent	with	previous	studies	(Szymanski	et	al.	2008;	Lin	et	al.	
2000;	Tressel	et	al.	2007).	
	
Previous	 studies	 have	 showed	 that	 EC	 exposed	 to	 low	 WSS	 in	 vivo	 and	 in	 vitro	
showed	 a	 higher	 rate	 of	 cell	 proliferation	 compared	 to	 cells	 exposed	 to	 high	WSS	
(Chaudhury	et	al.	2010;	Obikane	et	al.	2007;	Schober	et	al.	2014;	Davies	et	al.	1986).	
However,	I	did	not	detect	a	difference	in	cells	exposed	to	low	or	high	WSS	via	orbital	
shaking.	There	are	multiple	 reasons	 to	explain	 this	discrepancy;	1)	 it	 is	known	that	
cells	 change	 their	 responses	 based	 on	 particular	 thresholds	 of	 WSS	 (Dolan	 et	 al.	
2012;	Ostrowski	et	al.	2014).	It	may	be	that	WSS	in	the	orbital	plate	does	not	reach	
the	threshold	required	to	trigger	proliferation.	2)	Cells	exposed	to	low	WSS	and	high	
WSS	 exist	 within	 the	 well	 of	 the	 orbiting	 well,	 therefore	 the	 release	 of	 autocrine	
factors	and	the	effects	of	cell	migration	from	the	different	flow	regions	could	have	
contributed	 to	 cell	 turnover.	 To	 overcome	 this,	 I	 assessed	 EC	 proliferation	 in	 cells	
exposed	 to	 flow	 using	 the	 Ibidi™	 parallel	 plate	 system.	 The	 results	 revealed	 that	
proliferation	was	significantly	enhanced	in	cells	exposed	to	 low,	unidirectional	WSS	
(data	 not	 included).	 Future	 experiments	will	 include	 assessing	 TWIST1	 and	GATA4	
function	using	the	Ibidi™	parallel	plate	system.		
	
Nevertheless,	 TWIST1	 and	 GATA4	 expression	 was	 significantly	 enhanced	 in	 cells	
exposed	to	low	WSS	using	the	orbital	plate,	therefore	I	tested	whether	the	increase	
in	expression	results	in	a	functional	change	in	EC	physiology	using	this	system.	I	have	
shown	 that	 Twist1	 and	 Gata4	 silencing	 reduced	 tube	 formation,	 proliferation	 and	
migration	indicating	that	the	expression	of	these	genes	under	low	WSS	controls	cell	
function.	 Since	 cell	 proliferation	 and	 migration	 are	 processes	 that	 give	 rise	 to	 a	
transient	loss	in	EC-EC	contacts	(Cancel	et	al.	2011,	Cancel	et	al.	2010,	Birukova	et	al.	
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2004;	Forteinois	et	al.	2008)	cell	permeability	was	assessed	using	a	transwell	plate.		
It	 was	 evident	 that	 Twist1	 and	 GATA4	 genes	 also	 promoted	 permeability	 in	 cells	
exposed	to	low	WSS.	However,	the	transwell	based	method	which	was	used	to	study	
EC	permeability	under	flow	exhibited	much	lower	WSS	magnitude	compared	to	cells	
that	 are	 exposed	 to	 flow	 in	 the	 centre	 of	 the	 6-well	 orbital	 plate	 (1.82	 vs.	 4.8	
dyne/cm2	respectively).	 In	addition,	 in	the	flow	of	media	 in	orbiting	transwell	plate	
may	exert	 interstitial	 forces	on	 the	cells.	Thus,	 there	are	differences	 in	 the	 type	of	
flow	 used	 to	 study	 proliferation,	 migration	 and	 permeability	 and	 it	 may	 be	
incompletely	accurate	to	compare	the	effect	of	GATA4	and	TWIST1	on	migration	and	
proliferation	detected	using	the	orbital	system	to	their	effect	on	permeability	using	
the	 transwell	 system.	 To	 overcome	 this,	 a	method	 developed	 by	 Velasco	 et	 al.	 of	
measuring	cellular	impedance	(as	a	measure	of	permeability)	of	cells	 located	in	the	
centre	of	the	6-well	orbital	plate	could	be	used	(Velasco	et	al.	2015).		Collectively,	I	
have	 demonstrated	 for	 the	 first	 time	 that	 GATA4-TWIST1	 signalling	 contributes	 to	
low	WSS-induced	changes	in	cell	function,	including	cell	proliferation,	migration	and	
permeability.	
	
The	observations	discussed	above	are	consistent	with	previous	studies.	TWIST1	and	
GATA4	 are	 known	 to	 regulate	 cell	 proliferation	 and	 migration	 during	 embryonic	
development	 (valve	 formation,	 gastrulation,	 heart	 development)	 and	 in	 cancer	
(Zeisberg	et	al.	2005;	Vrlijicak	et	al.	2012;	Yang	et	al.	2004).	Moreover,	other	GATA	
family	transcription	factors	(GATA2	and	6)	regulate	angiogenesis	by	controlling	tube	
formation,	 migration	 and	 proliferation	 (Froese	 et	 al.	 2011;	 Song	 et	 al.	 2009).	 In	
addition,	 it	 has	 been	 shown	 by	 the	 Ingber	 lab	 that	 GATA2	 regulates	 retinal	
angiogenesis	in	vivo,	involving	migration	and	proliferation	in	response	to	changes	in	
matrix	 stiffness,	 providing	 a	 precedent	 for	 the	 regulation	 of	 EC	 physiology	 in	
response	to	mechanical	cues	via	GATA	family	genes	(Mammoto	et	al.	2009).	TWIST1	
also	 regulates	 retinal	 angiogenesis	 through	 promoting	 cell	 proliferation	 and	
migration	(Li	et	al.	2014).	In	addition,	Li	et	al.	demonstrated	the	role	of	TWIST1	in	the	
regulation	 of	 EC	 permeability	 in	 the	 lung	 vasculature	 via	 a	 Tie2-dependent	
mechanism	 (Mammoto	 et	 al.	 2013),	 and	 it	 will	 	 be	 interesting	 to	 see	 whether	 a	
similar	mechanism	for	cell	permeability	operates	under	low	WSS	conditions.	
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I	then	hypothesised	that	TWIST1	and	GATA4	regulate	cell	function	via	EndMT	due	to	
the	 following	 reasons;	 1)	 TWIST1	 and	 GATA4	 are	 inducers	 of	 EndMT	 during	 valve	
development	 (Zeisberg	 et	 al.	 2005;	 Vrlijicak	 et	 al.	 2012;	 Chakraborty	 et	 al.	 2010;	
Rivera-Feliciano	et	al.	2006),	2)	Recently,	studies	have	linked	the	induction	of	EndMT	
by	 low	WSS	 (Chen	et	 al.	 2015;	Moonen	et	 al.	 2015;	 Sanchez-Duffhues	 et	 al.	 2015;	
Mahler	 et	 al.	 2014),	 3)	 TWIST1	 and	 GATA4	 regulate	 cell	 functions	 including	 cell	
proliferation	and	migration,	processes	that	are	attributed	to	EndMT	(Zeisberg	et	al.	
2005;	Yang	et	al.	2004;	Vrlijicak	et	al.	2012;	Chakraborty	et	al.	2010).	In	this	chapter	I	
have	 demonstrated	 that	 low	 WSS	 promotes	 a	 partial	 transition	 into	 EndMT	 as	
evidenced	 by	 cells	 expressing	 EndMT	 markers	 (α-Sma,	 Slug,	 N-cadherin)	 but	
retaining	 EC	 marker	 VE-cadherin.	 These	 findings	 are	 in	 agreement	 with	 recent	
studies	 that	 have	 shown	 that	 low	 WSS	 or	 no	 flow	 (cells	 lacking	 cilia)	 conditions	
promote	 EndMT	 marker	 expression	 compared	 to	 cells	 exposed	 to	 high	 WSS		
(Ergorova	et	al.,	2011,	Mahler	et	al.,	2014,	Moonen	et	al.	2015;	Sanchez-Duffhues	et	
al.	2015;	Chen	et	al.	2015).	In	addition,	these	in	vitro	studies	demonstrate	that	cells	
exposed	either	low	WSS	or	no	flow	conditions		(with	TGF-β	)	show	a	reduction	in	VE-
cadherin.	 However,	 in	 my	 studies	 I	 did	 not	 detect	 a	 reduction	 in	 VE-cadherin	
expression	 in	 cells	 exposed	 to	 low	 WSS.	 This	 discrepancy	 could	 due	 to	 TGF-β	 (a	
known	EndMT	 inducer),	which	was	used	 in	studies	demonstrating	VE-cadherin	 loss	
but	 not	 in	 my	 work,	 which	 showed	 VE-cadherin	 retention	 under	 low	 WSS.	
Alternatively,	 the	 transition	 into	 a	 mesenchymal	 state	 depends	 on	 the	 precise	
mechanical	conditions	that	the	cells	are	exposed	to,	which	varies	in	different	in	vitro	
flow	 systems.	 Therefore,	 it	 could	 be	 that	 a	 full	 or	 partial	 transition	 into	 a	
mesenchymal	state	depends	on	the	conditions	that	the	cells	are	exposed	to.		
	
I	 showed	that	TWIST1	and	GATA4	promoted	partial	EndMT	 in	cells	exposed	to	 low	
WSS	as	they	promoted	the	induction	of	N-cadherin	and	the	EndMT	regulator	SNAIL.	
GATA4	 transcriptionally	 activated	 Snail	 expression	 as	 revealed	 by	 ChIP	 analysis	 on	
the	 Snail	 promoter,	 indicating	 the	 GATA4	 and	 Twist1	 co-operate	 to	 induce	 Snail	
expression.	Previous	 studies	have	 shown	 that	Twist1	and	GATA4	can	activate	 snail	
and	N-cadherin	 expression	 (Vrljicak	 et	 al.	 2012;	 Smit	 et	 al.	 2009;	Moskowitz	 et	 al.	
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2011),	however	I	show	for	the	first	time	that	this	activation	occurs	in	EC	exposed	to	
low	 WSS.	 The	 molecular	 mechanism	 proposed	 by	 other	 studies	 for	 the	 WSS-
dependent	 induction	 of	 EndMT	 involves	 TGF-β,	 FGF	 and	 antioxidant	 signalling	 via	
KLF4	and	MAPK	(ERK5)	signalling	(Egorova	et	al.	2011;	Moonen	et	al.	2015;	Sánchez-
Duffhues	et	al.	2015;	Mahler	et	al.	2014;	Chen	et	al.	2015).	Interestingly,	both	GATA4	
and	 TWIST1	 interact	 with	 these	 signalling	 pathways	 by	 either	 directly	 regulating	
these	 pathways	 or	 as	 downstream	 targets	 (Rivera-Feliciano	 et	 al.	 2006;	 Xue,	 D.	 F.	
Restuccia,	 et	 al.	 2012;	 Belaguli	 et	 al.	 2007;	 Connerney	 et	 al.	 2008;	O’Rourke	 et	 al.	
2002).	It	would	therefore	be	of	interest	to	assess	if	TGF-β,	FGF,	antioxidant	signalling	
via	KLF4	and	MAPK	signalling	pathways	promote	TWIST1and	GATA4	to	drive	EndMT	
in	 cells	 exposed	 to	 low	WSS	or	whether	 TWIST1and	GATA4	act	 upstream	of	 these	
pathways	to	drive	EndMT	in	cells	exposed	to	low	WSS.	
	
Gene	 silencing	 studies	 revealed	 that	 SNAIL	 contributes	 to	 the	 regulation	 of	 partial	
EndMT	 and	 to	 regulating	 functions	 that	 are	 promoted	 by	 TWIST1	 and	 GATA4.	
Consistent	 with	 previous	 studies,	 Snail	 has	 been	 well	 established	 in	 controlling	
EndMT	 and	 subsequent	 changes	 in	 cell	 proliferation	 and	migration	 (Kokudo	 et	 al.	
2008;	 Timmerman	 et	 al.	 2004;	 Leroy	 &	 Mostov	 2007).	 However,	 the	 molecular	
mechanism	 of	 Twist1	 and	GATA4	 regulation	 of	 cell	 function	 under	 low	WSS	 could	
potentially	involve	targets	other	than	Snail	(Figure	39).	These	potential	mechanisms	
will	now	be	discussed.	
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4.6.2	Potential	mechanisms	for	cell	proliferation	
TWIST1	 and	 GATA4	 have	 been	 shown	 to	 promote	 the	 activation	 of	 target	 genes	
involved	in	proliferation	including	Tbx20,	Pdgfr-a,	Foxm1,	cell	division	control	protein	
(CDC)	42,	cyclinD2,	cyclinA2,	cyclin-dependent	kinase		(Cdk)4	and	growth	arrest	and	
DNA-damage-Inducible	(Gadd)45α	 	 (Lee	&	Yutzey	2011;	Heineke,	Auger-messier,	et	
al.	2007;	Chia	et	al.	2015;	Rojas	et	al.	2008)	Qian	2013.	Moreover,	Twist1	and	GATA4	
interact	with	and	regulate	p38	and	WNT	signalling	(Lin	&	Xu	et	al.	2009;	Tenhunen	et	
al.	 2004;	Hong	et	 al.	 2011).	 Since	p38	MAPK	and	WNT	 signalling	have	been	 linked	
with	 the	regulation	of	 low	WSS-mediated	cell	proliferation	 (Chaudhury	et	al.	2010;	
Rotherham	&	El	Haj	2015;	R.	Li	et	al.	2014;	Biswas	et	al.	2003;	Masckauchán	et	al.	
2005)	this	could	be	a	potential	mechanism	by	which	TWIST1and	GATA4	regulate	this	
process.	 In	addition,	Twist1	promotes	 the	expression	of	miR-199a	and	miR214	and	
both	GATA4	and	TWIST1	promote	the	expression	of	miR1,	all	of	which	regulate	cell	
proliferation	in	cancer	cells	and	in	cardiomyocytes	(Sun	et	al.	2010;	Schlesinger	et	al.	
2011;	Yin	et	al.	2010).	It	is	plausible	that	these	mechanisms	operate	in	EC	exposed	to	
low	WSS.	
	
TWIST1	and	GATA4	could	regulate	cell	proliferation	through	 indirect	mechanisms.	 I	
have	shown	that	TWIST1	and	GATA4	promoted	N-cadherin	protein	expression	at	the	
cell	 junctions,	this	could	also	contribute	to	cell	proliferation.	 It	has	been	previously	
demonstrated	 that	 the	 expression	 of	 N-cadherin	 at	 cellular	 junctions	 enhanced	
proliferation	 compared	 to	 the	 expression	 of	 VE-cadherin	 (Luo	 &	 Radice	 2005;	
Giampietro	 et	 al.	 2012)	 via	 a	 potential	 mechanism	 involving	 the	 interaction	 of	
cytoplasmic	catenin	proteins	and	downstream	signalling	events	 (Zhang	et	al.	2013;	
Giampietro	et	al.	2012).	TWIST1	and	GATA4	indirectly	regulate	cell	cycle	progression	
through	 p53.	 TWIST1	 inhibits	 p53-mediated	 cell	 cycle	 arrest,	 apoptosis	 and	
senescence	in	cancer	cells	(Piccinin	et	al.	2012;	Burns	et	al.	2013).	Whereas,	GATA4	
promotes	p53	expression	and	senescence	in	fibroblasts	in	response	to	DNA	damage	
(Kang	et	al.	2015).		
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Figure	39.	Potential	mechanisms	by	which	Twist1	and	GATA4	drive	EC	proliferation,	migration	
and	permeability	under	low	WSS.		
	
Figure	39.	Potential	mechanisms	by	which	Twist1	and	GATA4	drive	EC	proliferation,	migration	and	permability	under	
low	WSS	
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The	regulation	of	p53	by	TWIST1	and	GATA4	is	indicative	of	their	role	in	differentially	
regulating	 cell	 cycle	 progression	 and	 subsequently	 proliferation	 under	 specific	
contexts.	Moreover,	it	is	interesting	that	TWIST1	and	GATA4	can	play	opposing	roles	
in	p53-mediated	senescence,	this	indicates	that	even	though	TWIST1	and	GATA4	co-
operate	 to	drive	 the	same	 functions	 (proliferation,	migration,	permeability)	 in	cells	
exposed	to	 low	WSS	they	can	play	opposing	roles	 in	other	 functions	depending	on	
the	cellular	context.		
	
4.5.3	Potential	mechanism	for	the	regulation	of	migration	
TWIST1	 and	GATA4	 promote	 the	 activation	 of	 several	migratory	 genes	 such	 as	 N-
cadherin,	 cadherin	 11	 (OB-cadherin),	 claudin	 5,	 Sema3c	 and	 Tbx20	 (Lee	 &	 Yutzey	
2011;	Rojas	et	al.	2008;	Chakraborty	et	al.	2010;	Soo	et	al.	2002;	Song	et	al.	2006).	
The	 induction	 of	 N-cadherin	 at	 the	 cell	 junctions	 by	 TWIST1	 and	 GATA4	 in	 cells	
exposed	to	low	WSS	could	be	an	inducer	of	cell	migration	since	N-cadherin	promotes	
an	 increase	 in	 cell	 motility	 in	 other	 systems	 (Reviewed	 Shih	 &	 Yamada	 2012;	
Giampietro	et	al.	2012).	Moreover,	 in	cancer	cells,	Twist1	has	been	shown	to	drive	
metastasis	via	PDGFR-α	mediated	formation	of	invadopodia	(Eckert	et	al.	2011)	and	
this	could	also	be	involved	in	EC	exposed	to	low	WSS.		
	
	
	
4.5.4	Potential	mechanism	for	the	regulation	of	permeability.	
Cell	migration	 and	 proliferation	 is	 associated	with	 an	 increase	 in	 cell	 permeability	
(Cancel	 et	 al.	 2011;	 Cancel	 et	 al.2010;	 Birukova	 et	 al.,	 2004).	 TWIST1	 and	GATA4-
mediated	induction	of	these	processes	could	be	a	potential	mechanism	of	in-directly	
promoting	 cell	 permeability.	 TWIST1	 has	 been	 linked	 with	 the	 regulation	 of	 EC	
permeability	in	the	lung	vasculature	via	regulating	the	levels	of	Tie2	(Mammoto	et	al.	
2013).	An	analogous	mechanism	may	control	permeability	in	sheared	EC.	Moreover,	
the	 regulation	 of	 TWIST1	 and	 GATA4	 of	 VE-cadherin	 junctional	 width	 may	 be	 a	
mechanism	by	which	cell	permeability	 is	 controlled	by	 these	genes.	An	 increase	 in	
VE-cadherin	 junctional	 width	 is	 associated	 with	 increased	monolayer	 permeability	
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(Huynh	et	al.	2011).	The	proposed	molecular	mechanism	has	been	suggested	to	be	
via	 Src-mediated	 VE-cadherin	 phosphorylation,	 which	 promotes	 VE-cadherin	
internalisation	 from	 the	 cellular	 junctions	 (Orsenigo	et	 al.	 2012;	Gavard	&	Gutkind	
2006;	 Miao	 et	 al.	 2005).	 Since	 VE-cadherin	 is	 in	 competition	 with	 N-cadherin	 for	
junctional	 expression	 (Navarro	 et	 al.	 1998;	 Giampietro	 et	 al.	 2012)	 this	 could	
promote	 N-cadherin	 expression	 at	 the	 junctions.	 Therefore,	 whether	 TWIST1	 and	
GATA4	 regulate	 VE-cadherin	 phosphorylation	 via	 interacting	 with	 signalling	
mediators	upstream	of	Src,	whether	this	process	indirectly	promotes	the	expression	
of	 N-cadherin	 at	 the	 cellular	 junctions	 and	 the	 contribution	 of	 these	 processes	 to	
permeability	under	low	WSS	conditions	should	be	investigated.	
	
In	 summary,	 low	 WSS	 is	 known	 to	 drive	 changes	 in	 cell	 physiology,	 including	
proliferation,	migration	and	permeability	to	macromolecules.	Here	I	provide	a	novel	
molecular	mechanism	for	low	WSS-induced	changes	in	cell	function.	Specifically,	low	
WSS	 promotes	 GATA4-	 TWIST1	 signalling	 which	 then	 promote	 Snail	 expression,	
contributing	 to	 the	 induction	 of	 partial	 EndMT	 and	 changes	 in	 cell	 function.	
However,	 more	 experiments	 are	 required	 to	 fully	 establish	 whether	 the	 GATA4-	
TWIST1-SNAIL	axis	controls	cell	proliferation,	migration	and	permeability	via	EndMT	
or	whether	these	processes	occur	independently.	Moreover,	it	would	be	interesting	
to	test	whether	cells	undergo	partial	EndMT	in	vivo	at	atherosusceptible	sites	in	the	
murine	 aorta	 and,	 if	 so,	 whether	 the	 molecular	 mechanism	 involves	 the	 GATA4-	
TWIST1-SNAIL	axis.	The	latter	question	is	addressed	in	the	next	chapter.	
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4.6	Future	work	
1- To	validate	whether	TWIST1	and	GATA4	regulate	EC	proliferation,	migration	
and	permeability	 via	SNAIL,	overexpression	 studies	 should	be	performed	 to	
test	 if	 Snail	 can	 rescue	 the	 resulting	 phenotype	 of	 TWIST1	 and	 GATA4	
silencing.	Moreover,	to	assess	if	Twist1	also	regulates	Snail	transcriptionally,	
a	TWIST1	ChIP	could	be	carried	out.	
	
	
2- To	assess	if	changes	in	cell	function	with	TWIST1	and	GATA4	are	attributed	to	
low-WSS	 induced	 EndMT,	 known	 EndMT	 inhibitors	 such	 as	 SB-431542	 and	
LY294002	could	be	used	to	test	this.	
	
3- To	 assess	 the	potential	 involvement	 of	 TGFβ	 and	MAPK	 signalling	with	 low	
WSS-mediated	regulation	of	EC	function	by	Twist	and	GATA4;	1)	Cells	would	
be	treated	with	TGF-β	and	TWIST1	and	GATA4	siRNA	will	be	used	to	assess	
Snail	 expression	 and	 EC	 function,	 2)	 These	 pathways	 could	 be	 blocked	
(pharmacologically	or	 via	 siRNA)	prior	 to	assessment	of	TWIST1	and	GATA4	
expression.		
	
4- To	 gain	 a	 deeper	 mechanistic	 insight	 into	 the	 regulation	 of	 TWIST1	 and	
GATA4	of	cell	function,	target	genes	should	now	be	investigated	by	carrying	
out	ChIP-seq	analyses.	
	
5- The	functional	significance	of	the	cadherin	switch	in	cells	exposed	to	low	WSS	
can	be	assessed	by	the	silencing	of	N-cadherin	and/or	enhanced	expression	
of	VE-cadherin	prior	to	the	assessment	of	cell	function.	
	
6- Gata4,	Twist1	and	Snail	gene	function	could	be	validated	under	low	WSS,	by	
using	a	second	in	vitro	flow	system,	e.g.	the	Ibidi™	parallel	plate	system.	
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Chapter	5:	GATA4-TWIST1	signalling	controls	
focal	EC	dysfunction	at	sites	exposed	to	low	WSS	
flow	in	vivo	
	 	
	 146	
	
	
5.1	Introduction	
WSS	plays	a	prominent	role	in	controlling	the	spatial	distribution	of	atherosclerosis.	
Despite	the	presence	of	systemic	risk	factors,	atherosclerosis	preferentially	develops	
at	 branches	 and	 bends	 in	 the	 vasculature,	 areas	 that	 are	 exposed	 to	 low	 WSS,	
whereas	 areas	 exposed	 to	 high	WSS	 are	 protected.	 The	 physiology	 of	 EC	 at	 sites	
exposed	to	low	WSS	includes	an	enhanced	rate	of	cell	proliferation	and	permeability,	
processes	 that	 are	 characteristic	 of	 EC	 dysfunction.	 This	 in	 turn	 promotes	 EC	
activation	and	renders	these	sites	“hot	spots”	for	atherogenesis.	On	the	other	hand,	
EC	in	the	vasculature	that	are	exposed	to	high	WSS	are	quiescent	and	these	sites	are	
therefore	atheroprotected	(Reviewed	in	Chiu	&	Chien	2011).	
	
I	 have	 showed	 in	 the	 previous	 chapters	 that	 TWIST1	 and	 GATA4	 control	 partial	
EndMT	 in	 cells	 exposed	 to	 low	WSS	 in	 cultured	 cells.	 I	 have	 also	 shown	 that	 the	
activation	 of	 the	 GATA4-TWIST1-SNAIL	 axis	 promotes	 proliferation,	 migration	 and	
permeability.	However,	 these	observations	were	made	using	 in	 vitro	 flow	systems,	
which	 do	 not	 fully	 recapitulate	 the	mechanical	 and	 physiological	 environments	 EC	
are	exposed	 to	 in	 vivo.	 Thus,	 it	 is	 important	 to	validate	 the	TWIST1	and	GATA4	by	
low	 WSS	 and	 secondly	 the	 functional	 role	 of	 these	 transcription	 factors	 in	 cells	
exposed	to	low	WSS	conditions.		
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5.2	Hypothesis	
GATA4-TWIST1	 mechanotransduction	 promotes	 focal	 EC	 dysfunction	 and	
atherosusceptibility.	
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5.3	Aims	
	
1. To	assess	 if	 low	WSS	correlates	with	Twist1,	GATA4	and	Snail	expression	 in	
the	murine	aortic	arch.	
	
2. To	directly	test	whether	WSS	regulates	Twist1,	GATA4	and	Snail	in	vivo,	using	
a	flow-altering	constrictive	cuff.	
	
3. To	assess	if	Twist1	is	expressed	in	adult	endothelial	cells,	under	low	WSS	via	
cell	tracing	experiments.	
	
4. To	 assess	 Twist1	 and	 GATA4	 function	 in	 cells	 exposed	 to	 low	 WSS	 in	 the	
murine	aortic	arch	using	EC-specific,	conditional	knock	out	animal	models.	
	
5. To	 assess	 the	 expression	 of	 Twist1	 in	 human	 and	 murine	 atherosclerotic	
plaques.	
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5.4	TWIST1,	GATA4	and	SNAIL	expression	is	enhanced	by	atheroprone	
flow	in	the	murine	aorta	
As	GATA4-mediated	TWIST1	expression	was	enhanced	by	low	WSS	flow	conditions	in	
cultured	cells,	 this	suggested	that	TWIST1	and	GATA4	are	 involved	 in	mediating	EC	
responses	 to	 flow.	 To	 validate	 this	 in	 vivo,	 it	was	 firstly	 investigated	whether	WSS	
correlates	with	the	expression	of	TWIST1,	GATA4	and	SNAIL	in	the	murine	aortic	arch	
of	C57BL/6	animals.	The	expression	of	all	three	proteins	was	assessed	at	regions	of	
low	WSS	 (inner	 curvature)	 and	 high	WSS	 (outer	 curvature).	 All	 three	 transcription	
factors	 TWIST1,	GATA4	and	 SNAIL	 showed	a	marked	 increase	 in	 expression	 at	 low	
WSS	 sites	 compared	 to	 high	 WSS	 sites	 (Figure	 40).	 Moreover	 the	 proteins	 were	
expressed	almost	exclusively	in	the	nucleus,	 indicating	that	they	are	active	in	these	
cells.	 These	 data	 reflected	 that	 the	 expression	 of	 these	 genes	 correlates	with	 low	
WSS	in	vivo.		
	
Atherosusceptible	 regions	 of	 arteries	 are	 associated	 with	 increased	 inflammation	
and	 altered	 uptake	 of	 substances	 from	 the	 arterial	wall	 as	well	 as	 low	WSS.	 Thus	
these	 observations	 only	 provide	 a	 correlation	 between	WSS	 and	 gene	 expression.	
Moreover,	at	these	regions	the	flow	patterns	are	disturbed,	as	characterised	by	low	
and	 oscillating	WSS,	 thus	 it	 is	 important	whether	 flow	magnitude	 or	 directionality	
are	the	driving	forces	in	TWIST1	and	GATA4	activation	 in	vivo.	To	establish	a	causal	
link	 between	WSS	 and	 gene	 activation,	 a	 constrictive,	 flow-altering	 cuff	was	 used.	
The	insertion	of	the	cuff	into	the	right	carotid	arteries	results	in	a	constriction,	which	
consequently	alters	flow,	giving	rise	to	high	WSS	at	the	stenosis,	low	WSS	upstream	
and	low,	oscillatory	WSS	downstream	and	the	left	carotid	artery	was	used	as	a	sham	
control.	Following	14	days	of	cuff	 insertion,	both	carotids	and	the	aortic	arch	were	
isolated	and	prepared	for	en	face	immunostaining.	In	the	cuff-inserted	vessels,	it	was	
revealed	 that	 TWIST1,	 GATA4	 and	 SNAIL	 showed	 enhanced	 expression	 at	 the	
upstream	 site	 compared	 to	 the	 stenosis	 (Figure	 41),	 indicating	 that	 low	WSS	 is	 an	
activating	stimulus	for	all	three	genes.		
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Figure	40.	Low	WSS	correlated	with	Twist1,	GATA4	and	Snail	expression	in	the	murine	aortic	arch	
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Figure	40.	Low	WSS	correlated	with	TWIST1,	GATA4	and	SNAIL	expression	in	the	murine	aortic	arch.	
Expression	 levels	 of	 Twist1,	 GATA4	 or	 Snail	 in	 EC	 were	 assessed	 by	 en	 face	 	 immunofluorescent	
staining	of	low	WSS	(susceptible)	or	high	WSS	(protected)	regions	of	the	aorta	in	C57BL/6	mice	(red).	
EC	were	 identified	 by	 co-staining	with	 anti-CD31	 antibodies	 conjugated	 to	 FITC	 (green).	 Cell	 nuclei	
were	 identified	 using	 TOPRO	 (blue).	 Representative	 images	 are	 shown,	 scale	 bar	 20μm.	 TWIST1,	
GATA4	and	SNAIL	expression	was	quantified	by	measuring	fluorescent	intensity	of	the	cells	per	field	of	
view	using	Image	J.	Data	were	pooled	from	5	independent	experiments	and	mean	values	±	SEM	are	
shown.	*	p<0.05,	**p<0.01			using	a	paired	t-test.	
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Figure	41.	Low	WSS	promoted	Twist1,	GATA4	and	Snail	expression	in	cuff-inserted	carotid	murine	
arteries		 	
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Figure	 41.	 Low	 WSS	 promoted	 TWIST1,	 GATA4	 and	 SNAIL	 expression	 in	 cuff-inserted	
carotid	murine	arteries.	Flow-altering,	constrictive	cuffs	were	placed	on	the	right	carotid	
arteries	of	C57BL/6	mice.	Right	carotid	arteries	were	harvested	after	14	days	and	en	face	
staining	was	performed	using	anti-TWIST1,	anti-GATA4	or	anti-SNAIL	antibodies	(red),	anti-
CD31	antibodies	conjugated	to	FITC	(green)	and	 the	nuclear	 counter	 stain	TOPRO	 (blue).	
Representative	images	and	quantitation	of	TWIST1,	GATA4	or	SNAIL	expression	(mean	+/-	
SEM)	 are	 shown.	 Scale	 bar,	 10	 μm.	 Data	 were	 pooled	 from	 four-six	 independent	
experiments.	*	p<0.05,	**p<0.01,	using	a	one-way	ANOVA.	
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Surprisingly,	GATA4	and	SNAIL	were	found	to	be	induced	at	the	downstream	region,	
where	TWIST1	expression	was	reduced.	 In	the	non-cuff	 inserted	 left	carotid	vessel,	
the	 expression	 of	 all	 three	 transcription	 factors	 was	 assessed	 at	 regions	 that	 are	
equivalent	to	the	cuff-inserted	vessel	as	a	control.	The	data	revealed	that	there	was	
no	 significant	 difference	 in	 TWIST1,	 GATA4	 and	 SNAIL	 expression	 at	 the	 different	
sites	(Figure	42),	which	suggested	that	the	differences	in	expression	detected	in	the	
cuff-inserted	vessels	were	directly	due	to	the	different	flow	conditions.	
	
5.5	TWIST1	was	expressed	in	adult	EC	exposed	to	low	WSS	in	the	
murine	aorta	
I	hypothesised	that	TWIST1	was	expressed	in	adult	EC	in	response	to	WSS.	However,	
since	TWIST1	is	a	mesenchymal	gene	there	could	be	other	potential	mechanisms	to	
explain	 the	 accumulation	 of	 TWIST1-positive	 EC	 at	 sites	 of	 low	WSS.	 For	 example,	
there	has	been	evidence	 from	the	Xu	group	to	suggest	 that	endothelial	progenitor	
cells	migrate	into	sites	of	low	WSS	in	the	murine	vasculature	(Foteinos	et	al.	2008).	
To	 distinguish	 between	 these	 possibilities	 Cre-based	 cell	 tracking	 was	 used	 to	
determine	whether	TWIST1	expression	occurs	 in	differentiated	carotid	artery	EC	at	
sites	 of	 low	 WSS.	 This	 was	 performed	 using	 transgenic	 mice	 containing	 a	 loxP-
flanked	 STOP	 cassette	 preventing	 the	 transcription	 of	 a	 fluorescent	 Td-Tomato	
transgene,	under	the	expression	of	the	ROSA26	promoter	(Rosa26-tdTomato)	and	an	
inducible	Cre	that	is	exclusively	expressed	in	adult	endothelial	cells	under	the	control	
of	the	5’SCL	promoter	(SCL-Cre-ERT;	R26R-Td	tomato	transgenic	mice).	The	SCL-Cre-
ERT	protein	is	activated	upon	tamoxifen	treatment,	which	allows	the	translocation	of	
the	 protein	 into	 the	 nucleus	where	 it	 promotes	 the	 excision	 of	 the	 STOP	 cassette	
through	loxP	site	recombination,	allowing	the	irreversible	activation	of	the	R26R-Td	
tomato	gene	and	the	labelling	of	EC	(Figure	43	A).	To	validate	the	use	of	the	reporter	
system,	 SCL-Cre-ERT;	 R26R-Td	 tomato	 mice	 were	 treated	 with	 tamoxifen	 for	 five	
consecutive	days	and	the	expression	of	the	R26R-Td	tomato	protein	was	assessed	via	
en	face	immunostaining.		
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Figure	42.	Expression	of	Twist1,	GATA4	and	Snail	in	non	cuff-inserted,	sham	control	arteries		 	
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Figure	 42.	 Expression	 of	 TWIST1,	 GATA4	 and	 SNAIL	 in	 non	 cuff-inserted,	 sham	 carotid	
arteries.	As	a	control	 for	 cuff-insertion	on	the	right	 carotids,	 the	 left	carotids	did	not	have	a	
cuff	 insertion	and	were	used	as	 sham	controls.	Left	carotid	arteries	were	harvested	after	14	
days	 and	 en	 face	 staining	 was	 performed	 using	 anti-TWIST1,	 anti-GATA4	 or	 anti-SNAIL	
antibodies	 (red),	 anti-CD31	 antibodies	 conjugated	 to	 FITC	 (green)	 and	 the	 nuclear	 counter	
stain	 TOPRO	 (blue).	 Representative	 images	 and	 quantitation	 of	 TWIST1,	 GATA4	 or	 SNAIL	
expression	 (mean	 +/-	 SEM)	 are	 shown.	 Scale	 bar,	 10	 μm.	 Data	 were	 pooled	 from	 four-six	
independent	experiments.	Statistical	analysis	was	carried	out	using	a	one-way	ANOVA.	
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Figure	 43.	 Validation	 of	 an	 EC	 tracking	 system	 in	 mice.	 A)	 Transgenic	 SCL-Cre-
ERT/R26RtdTomato	mice	were	used	to	track	endothelial	cells.	This	strain	drives	endothelial	cell	
expression	 of	 a	 form	 of	 Cre	 that	 can	 be	 activated	 by	 tamoxifen.	 The	 administration	 of	
tamoxifen	induces	nuclear	localization	of	Cre,	which	subsequently	excises	a	floxed	STOP	signal	
from	the	tdTomato	promoter	thus	 inducing	tdTomato	expression.	B)	To	validate	the	system,	
SCL-Cre-ERT/R26RtdTomato	 mice	 were	 treated	 with	 tamoxifen	 for	 5	 consecutive	 days	 (+	
TAMOXIFEN).	Alternatively,	mice	were	treated	with	vehicle	as	a	control	(-	TAMOXIFEN).	After	7	
days,	 carotid	 arteries	 were	 harvested	 and	 en	 face	 staining	 was	 performed	 using	 anti-CD31	
antibodies	 (green),	 and	 the	 nuclear	 counter	 stain	 TOPRO	 (blue).	 Representative	 images	 are	
shown.	TdTomato	(red)	was	expressed	 in	the	majority	of	EC	 in	mice	treated	with	tamoxifen,	
but	was	not	identified	in	untreated	mice.	Representative	images	are	shown,	scale	bar	10	μm.	
To	 quantify	 TdTomato	 labelling	 of	 EC,	 %Td-tomato	 cells	 that	 were	 CD31	 positive	 was	
calculated.	Data	were	pooled	 from	3	 independent	 experiments	and	mean	 values	±	SEM	are	
shown.	Statistical	analysis	was	carried	out	using	a	one	way	ANOVA.	
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Figure	43.	Validation	of	an	EC	tracking	system	in	mice	
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Moreover,	to	exclude	the	possibility	of	labelling	efficiency	being	altered	by	flow	the	
expression	of	the	Cre-reporter	in	CD31-positive	cells	was	assessed	in	the	descending	
aorta,	aortic	arch	(inner	and	outer	curvature)	and	the	carotid	artery,	sites	that	differ	
in	 flow	 magnitude,	 directionality	 and	 pulsatility.	 The	 expression	 of	 the	 R26R-Td	
tomato	 protein	 was	 apparent	 in	 all	 studied	 vascular	 sites	 and	 there	 was	 no	
significant	 difference	 in	 the	 labelling	 efficiencies	 as	 determined	 by	 quantifying	 %	
positive	 R26R-Td	 tomato	 cells	 that	 are	 CD31	 positive	 (Figure	 43	 B).	 Next,	 the	
expression	of	Twist1	was	assessed	in	adult	EC	exposed	to	low	WSS	via	cuff	insertion	
in	SCL-CreERT;	R26R-Td	 tomato	mice.	The	procedure	 involved	 the	 treatment	of	 the	
transgenic	mice	with	tamoxifen	for	5	days	to	label	adult	EC	irreversibly	followed	by	
cast	insertion	for	two	weeks	to	induce	low	WSS.	TWIST1	expression	was	enhanced	at	
the	 upstream	 site	 (low	 WSS)	 compared	 to	 the	 stenosis	 (high	 WSS)	 and	 Twist1-
expressing	cells	were	>90%	R26R-Td	 tomato	positive	 (Figure	44	A-C).	These	 results	
show	that	TWIST1	expression	at	sites	of	low	WSS	occurs	in	adult	EC,	thus	excluding	
the	 possibility	 of	 TWIST1-positive	 cells	 being	 derived	 from	 bone	 marrow	 derived	
EPCs.		
5.6	Low	WSS	promoted	partial	EndMT	in	vivo.	
I	have	shown	that	low	WSS	promotes	partial	EndMT	in	EC	in	vitro	by	promoting	the	
expression	of	EndMT	markers,	including	N-cadherin.	It	was	next	determined	whether	
low	WSS	alters	cadherin	expression	in	vivo.	Junctional	N-cadherin	expression	and	VE-
cadherin	disorganisation	(as	assessed	by	junctional	width)	were	both	enhanced	in	EC	
at	low	WSS	sites	(Figure	45	A,B),	indicating	that	low	WSS	altered	cadherin	expression	
(increased	 N-cadherin	 and	 induced	 VE-cadherin	 disorganisation)	 in	 EC	 in	 vivo.	
However	the	expression	of	VE-cadherin	and	CD31	was	not	abolished	 in	cells	at	the	
low	 WSS	 site,	 suggesting	 that	 the	 transition	 into	 EndMT	 was	 partial.	 To	 further	
investigate	 the	 effect	 of	 low	WSS	on	 EndMT	 I	 determined	 the	direct	 effect	 of	 low	
WSS	 on	 EC	 delamination	 using	 SCL-CreERT;	 R26R-Td	 tomato	 cell	 tracking	 coupled	
with	 cuff	 inserted	 into	 the	 carotids	 of	 these	 animals.	 It	 was	 investigated	whether	
labelled	EC	were	present	beyond	the	sub-endothelial	layers	of	the	mouse	aorta.		
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Figure	44.	Low	WSS	promoted	Twist1	expression	in	adult	EC.	
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Figure	 44.	 Low	 WSS	 promoted	 TWIST1	 expression	 in	 adult	 EC.	 Transgenic	 SCL-Cre-
ERT/R26RtdTomato	 mice	 were	 treated	 with	 tamoxifen	 for	 5	 consecutive	 days	 to	 activate	
tdTomato	 (red)	 expression	 in	 EC.	 One	 week	 after	 the	 final	 tamoxifen	 treatment,	 flow-altering	
constrictive	cuffs	were	placed	on	the	right	carotid	arteries.	After	14	days,	the	aortic	arch	(A)	and	
carotid	 arteries	 (B)	 were	 harvested	 and	 en	 face	 staining	 was	 performed	 using	 anti-Twist1	
antibodies	 (green),	 and	 the	 nuclear	 counter	 stain	 TOPRO	 (blue).	 Representative	 images	 and	
quantitation	of	TWIST1	expression	(mean	+/-	SEM)	are	shown.	Scale	bar,	10	μm.*p<0.05	using	a		
paired	t-test	or	one-way	ANOVA.	C)	Twist1	positive	cells	were	quantified	as	a	percentage	of	Td-
tomato	labelled	cells	in	the	arotic	arch	and	carotid	arteries.	
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Figure	45.	Low	WSS	promoted	the	EndMT	cadherin	switch	in	the	murine	aorta	 	
hwss$
0
1
2
3
4
5
%
 p
os
iti
ve
  f
or
 ju
nc
tio
na
l N
-c
ad
he
rin *
!WSS!!!!!!!!!High!!!!!!!!!!!!!!!!!!!!Low!
Ju
nc
/o
na
l!N
3c
ad
he
rin
!p
os
i/
ve
!ce
lls
!
!(%
)!
Low!WSS! High!WSS!
0
1
2
3
Le
ng
th 
of 
VE
- c
ad
he
rin
 at
 ce
ll- 
ce
ll j
un
cti
on
s 
(µm
)
**
!WSS!!!!!!!!!High!!!!!!!!!!!!!!!!!!!Low!
VE
3c
ad
he
rin
!ju
nc
/o
na
l!w
id
th
!
!(μ
m
)!
Low!WSS! High!WSS!
N3
ca
dh
er
in
/C
D3
1/
TO
PR
O!
A!
B!B	
A	
VE
-c
ad
he
rin
	
VE-cadherin	junc/onal	width	
N-cadherin	expression		
Figure	45.	Low	WSS	promoted	the	EndMT	cadherin	switch	in	the	murine	aorta.	A)	Expression	
levels	of	N-cadherin	(green)	in	EC	were	assessed	by	en	face	staining	of	low	WSS	(susceptible)	
or	high	WSS	(protected)	regions	of	the	aortic	arch	of	C57BL/6	mice.	EC	were	identified	by	co-
staining	with	anti-CD31	antibodies	conjugated	to	FITC	(green).	Cell	nuclei	were	identified	using	
TOPRO	 (blue).	Representative	 images	 are	 shown,	 scale	bar	10	 μm	EC.	N-cadherin	 junctional	
expression	 was	 quantified	 by	 assessing	 junctional	 overlap	 with	 CD31	 staining	 (arrows)	 and	
data	 was	 expressed	 as	 percentage	 positive.	 B)	 Expression	 levels	 of	 VE-cadherin	 (red)	 in	 EC	
were	assessed	by	en	face	staining	of	low	WSS	(susceptible)	or	high	WSS	(protected)	regions	of	
the	 aortic	 arch.	 Representative	 images	 are	 shown,	 scale	 bar	 10	 μm.	VE-cadherin	width	was	
assessed	 by	measuring	 	 jucnctional	 width	 (arrows)	 using	 image	 J	 of	 atleast	 5	 cells/	 field	 of	
view.	 Representative	 images	 are	 shown	 from	 N=4-5	 independent	 experiments.	 *	 p<0.05,	
**p<0.01,	using	a		paired	t-test.	
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The	 rationale	 was	 if	 cells	 at	 low	 WSS	 sites	 where	 GATA4,	 TWIST1	 and	 SNAIL	
expression	 is	 enhanced	 were	 undergoing	 EndMT	 they	 would	 separate	 from	 the	
endothelial	 layer,	 invade	and	migrate	into	the	underlying	smooth	muscle	cell	 layer.	
Confocal	 microscopy	 coupled	 with	 Z-stack	 imaging	 revealed	 that	 Td-tomato	 cells	
were	present	only	in	the	endothelial	cell	layer	and	were	absent	from	the	underlying	
smooth	muscle	 cell	 layer	 (Figure	 46),	 suggesting	 lack	 of	 delamination.	 This	 further	
supports	 the	 hypothesis	 that	 cells	 exposed	 to	 low	 WSS	 do	 not	 undergo	 a	 full	
transition	into	a	mesenchymal	state.	
5.7	GATA4-TWIST1	mechanotransduction	regulated	EC	proliferation	
and	partial	EndMT	at	low	WSS	sites	in	the	murine	aorta	
Since	it	 is	known	that	EC	dysfunction,	which	involves	cell	proliferation,	 is	enhanced	
at	atheroprone	sites	in	the	vasculature	that	are	exposed	to	low	WSS,	EC	proliferation	
was	assessed	by	en	face	immunostaining	in	the	murine	aorta.	The	data	revealed	that	
ki67	 staining	 was	 enhanced	 in	 cells	 at	 low	 WSS	 compared	 to	 high	 WSS	 sites,	 as	
quantified	by	%Ki67	positive	 cells	 (Figure	47).	 In	addition,	 the	number	of	 cells	was	
also	enhanced	at	the	low	WSS	sites,	reflecting	the	increase	in	cell	proliferation,	thus	
confirming	that	EC	proliferation	 is	enhanced	 in	EC	 located	at	 low	WSS	sites	 in	vivo.	
The	 data	 provides	 a	 correlation	 between	 EC	 proliferation	 and	 the	 expression	 of	
TWIST1,	GATA4	and	SNAIL	as	the	expression	of	these	genes	is	enhanced	at	these	low	
WSS	sites,	indicating	that	the	process	is	potentially	regulated	by	these	genes.	
	
To	 assess	 the	 function	 of	 TWIST1	 and	 GATA4	 in	 EC	 at	 low	 WSS	 sites	 in	 vivo,	
conditional	 EC	 gene	 knock-out	 (KO)	 animals	 were	 generated,	 since	 the	 global	
deletion	 of	 both	 of	 these	 genes	 is	 embryonically	 lethal.	 TWIST1	 expression	 was	
deleted	from	EC	by	crossing	mice	that	contain	 loxP	sites	flanking	the	coding	Twist1	
exon	(Twist1flox/flox)	with	mice	that	express	a	Cre	gene	driven	by	the	endothelial	Tie2	
gene	 (Tie2Cre)	 to	generate	Tie2-Twist1KO	 animals.	 Similarly,	GATA4	expression	was	
deleted	 from	 EC	 by	 crossing	Gata4flox/flox	mice	 with	 SCL-Cre-ERT	 mice,	 followed	 by	
tamoxifen	 treatment	 to	 generate	SCL-Cre-ERT;	Gata4KO	 animals.	 The	 genotype	was	
confirmed	via	PCR	on	ear	tissue	from	the	mice.		 	
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Figure	46.	Intimal	endothelial	cells	exposed	to	low	WSS	did	not	migrate	into	media	 	
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Figure	 46.	 Intimal	 endothelial	 cells	 exposed	 to	 low	 WSS	 did	 not	 migrate	 into	 the	 media.	
Transgenic	 SCL-Cre-ERT/R26RtdTomato	 mice	 were	 treated	 with	 tamoxifen	 for	 5	 consecutive	
days	to	activate	tdTomato	(red)	expression	in	EC.	One	week	after	the	final	tamoxifen	treatment,	
flow-altering	constrictive	 cuffs	were	placed	on	 the	right	carotid	arteries.	After	14	days	carotid	
arteries	 were	 harvested	 and	 en	 face	 staining	 was	 performed	 using	 anti-TWIST1	 antibodies	
(green),	and	the	nuclear	counter	stain	TOPRO	(blue).	Confocal	microscopy	was	used	to	generate	
z-stacks	to	assess	whether	Td-Tomato-positive	EC	were	present	in	the	arterial	media,	at	regions	
of	 A)	 low	 WSS	 (upstream	 of	 cuff)	 and	 B)	 High	 WSS	 (stenosis).	 Representative	 images	 and	
quantitation	of	Twist1	expression	(mean	+/-	SEM)	are	shown.	Scale	bar,	10	μm.	No	evidence	of	
EC	migration	was	detected	in	either	region.	
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Figure	47.	Low	WSS	promoted	EC	proliferation	in	the	murine	aorta		 	
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Figure	47.	Low	WSS	promoted	EC	proliferation	 in	the	murine	aorta.	Expression	levels	of	
proliferation	 marker	 Ki67	 (green)	 in	 EC	 were	 assessed	 by	 en	 face	 staining	 of	 low	 WSS	
(susceptible)	or	high	WSS	(protected)	regions	of	the	aortic	arch	of	C57BL/6	mice	.	EC	were	
identified	by	co-staining	with	anti-CD31	antibodies	conjugated	to	FITC	(green).	Cell	nuclei	
were	 identified	 using	 TOPRO	 (blue).	 Representative	 images	 are	 shown	 from	 five	
independent	experiments.	scale	bar	10	μm.	Proliferating	cells	were	quantified	as	%positive	
for	ki67	and	number	of	cells	per	field	of	view	was		quantified.	*	p<0.05,	using	a		paired	t-
test.	
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To	 further	 validate	 the	 deletion	 of	 TWIST1	 and	 GATA4	 from	 EC,	 en	 face	
immunofluorescent	 staining	was	 carried	 out	 in	 aortic	 tissue	 from	 these	mice.	 This	
revealed	that	the	expression	of	TWIST1	and	GATA4	was	absent	in	EC	in	KO	animals	
compared	to	floxed	controls	(Figure	48	A,	B).		
	
Ki67-immunostaining	 in	 EC	 located	at	 low	WSS	 sites	 showed	 that	 cell	 proliferation	
was	 significantly	 reduced	 in	 SCL-Cre-ERT;	 Gata4KO	 and	 Tie2-Twist1KO	 animals	
compared	 to	 floxed	controls	 (Figure	49).	These	observations	 reflected	 that	TWIST1	
and	GATA4	control	cell	proliferation	at	low	WSS	sites,	and	thus	contributing	to	focal	
EC	dysfunction	at	atheroprone	sites.		
	
I	 validated	 the	 in	 vitro	 observation	 of	 the	 regulation	 of	 TWIST1	 by	 GATA4	 in	 EC	
exposed	to	low	WSS.	TWIST1	expression	was	assessed	by	en	face	immunostaining	in	
SCL-Cre-ERT;	Gata4	KO	aortic	arch	tissue,	at	regions	of	low	(inner	curvature)	and	high	
(outer	curvature)	WSS.	TWIST1	expression	in	EC	at	low	WSS	sites	was	reduced	in	SCL-
Cre-ERT;	Gata4KO	compared	to	the	floxed	control	(Figure	50).	These	data	suggest	that	
TWIST1	expression	in	EC	is	mediated	by	GATA4	at	low	WSS	in	vivo.		
	
I	 then	 assessed	 SNAIL	 and	 N-cadherin	 (markers	 of	 EndMT)	 expression	 in	 Tie2-
Twist1KO	animals.	SNAIL	and	junctional	N-cadherin	expression	were	both	significantly	
reduced	 in	 Tie2-Twist1KO	 animals	 compared	 to	 floxed	 controls	 (Figure	 51),	 thus	
suggesting	 that	 TWIST1	 controls	 partial	 EndMT	 at	 low	WSS	 sites	 in	 vivo.	 Overall,	
these	 studies	 demonstrate	 that	 GATA4	 is	 a	 positive	 regulator	 of	 TWIST1	 and	 that	
TWIST1	induces	partial	EndMT	associated	with	increased	EC	proliferation.	
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Figure	48.	Validation	of	endothelial	 gene	deletion	of	Twist1	and	Gata4.	A)	Expression	
levels	of	TWIST1	(red)	was	assessed	in	either	Tie2-Twist1KO	or	Twist1fl/fl	mice	by	en	face	
staining.	EC	were	identified	by	co-staining	with	anti-CD31	antibodies	conjugated	to	FITC	
(green).	Cell	nuclei	were	identified	using	TOPRO	(blue).	Representative	images	are	shown	
from	five	independent	experiments.	B)	Expression	levels	of	GATA4	(red)	was	assessed	in	
either	SCL-Cre-ERT;	Gata4	KO		or	in	Gata4fl/fl	 .	EC	were	identified	by	co-staining	with	anti-
CD31	 antibodies	 conjugated	 to	 FITC	 (green).	 Cell	 nuclei	 were	 identified	 using	 TOPRO	
(blue).	 Representative	 images	 are	 shown	 from	 five	 independent	 experiments.	 Scale	
bar,10um.		
Figure	48.	Validation	of	endothelial	gene	deletion	of	Twist1	and	GATA4	
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Figure	49.	TWIST1	and	GATA4	promoted	EC	proliferation	at	low	WSS	sites	in	the	murine	
aorta.	Expression	levels	of	proliferation	marker	Ki67	(green)	in	EC	were	assessed	by	en	face	
staining	 in	A)	Tie2-Twist1KO	or	Twist1fl/fl	mice	and	 in	B)	SCL-Cre-ERT;	Gata	KO		or	 in	Gatafl/fl	
mice.	 EC	 were	 identified	 by	 co-staining	 with	 anti-CD31	 antibodies	 conjugated	 to	 FITC	
(green).	Cell	nuclei	were	identified	using	TOPRO	(blue).	Representative	images	are	shown	
from	5	 independent	experiments.	 Scale	bar	10	μm.	Proliferating	 cells	were	quantified	as	
%positive	for	ki67	and	number	of	cells	per	field	of	view	was	quantified.	*	p<0.05,	**p<0.01,	
using	a		two-way	ANOVA.	
Figure	49.	Twist1	and	GATA4	promoted	EC	proliferation	at	low	WSS	sites	in	the	murine	aorta	
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Figure	50.	GATA4	regulated	Twist1	expression	at	low	WSS	sites	in	the	murine	aorta		 	
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Figure	50.	GATA4	regulated	TWIST1	expression	at	low	WSS	sites	in	the	murine	aorta.	
Expression	 levels	 of	 TWIST1	 (red)	 was	 assessed	 in	 either	 SCL-Cre-ERT;	 Gata4	 KO	 	 or	 in	
Gata4fl/fl	 	by	en	face	staining.	EC	were	identified	by	co-staining	with	anti-CD31	antibodies	
conjugated	to	FITC	(green).	Cell	nuclei	were	identified	using	TOPRO	(blue).	Representative	
images	are	shown	from	4	independent	experiments.	TWIST1	expression	was	quantified	by	
measuring	fluorescent	intensity	of	the	cells	per	field	of	view	using	Image	J.		
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Figure	51.	Twist1	promoted	Snail	and	N-cadherin	expression	at	low	WSS	sites	in	the	murine	aorta		 	
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Figure	51.	Twist1	promoted	SNAIL	and	N-cadherin	expression	at	low	WSS	sites	in	the	murine	
aorta.	Expression	levels	of	A)	SNAIL	(green)		or	B)	N-cadherin	(red)	was	assessed	in	either	Tie2-
Twist1KO	or	Twist1fl/fl	mice	by	en	face	staining.	EC	were	identified	by	co-staining	with	anti-CD31	
antibodies	 conjugated	 to	 FITC	 (green).	 Cell	 nuclei	 were	 identified	 using	 TOPRO	 (blue).	
Representative	 images	are	shown	from	4-5	 independent	experiments.	Scale	bar,	10um.	Data	
were	 quantified	 as	 either	 fluorescence	 intensity	 or	 %positive	 cells	 expressing	 junctional	 N	
cadherin	as	indicated	by	overlap	with	CD31	(arrows).	*	p<0.05,	**p<0.01,	using	a		paired	t-test.	
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5.8	TWIST1	expression	in	endothelial	cells	is	increased	with	
atherosclerosis	severity	in	human	and	murine	vessels	
As	GATA4-mediated	TWIST1	expression	was	enhanced	by	low	WSS	flow	conditions	in	
vitro	 and	 in	 vivo,	 this	 suggested	 that	 TWIST1	 maybe	 involved	 in	 atherosclerosis	
development.	TWIST1	expression	was	assessed	by	immunohistochemistry	in	human	
coronary	artery	 tissue	 from	 ischemic	heart	disease	patients	 (severe	atherosclerotic	
phenotype)	 and	 from	 idiopathic	 cardiomyopathy	 patients	 (mild	 atherosclerotic	
phenotype).	TWIST1	was	expressed	 in	EC	overlaying	plaques.	Notably,	 there	was	a	
significant	 increase	 in	 TWIST1	 positive	 luminal	 EC	 expression	 (identified	 by	 Von	
Willebrand	factor	(vWF)	staining)	in	tissue	from	ischemic	heart	disease	compared	to	
cardiomyopathy	 patients	 (Figure	 52).	 Thus,	 TWIST1	 expression	 correlated	 with	
atherosclerosis	 severity.	However,	 the	WSS	 conditions	 that	 EC	were	 exposed	 to	 in	
the	coronary	vessels	were	not	characterised,	thus	it	was	difficult	to	correlate	TWIST1	
expression	with	WSS	at	the	atherosclerotic	plaques.	To	overcome	this,	atherogenic	
murine	models	were	generated	by	treating	LDLR-/-	transgenic	animals	with	a	high	fat	
diet	for	6	weeks	to	promote	atherosclerosis.	As	a	control,	LDLR-/-	animals	were	given	
a	normal	chow	diet.	TWIST1	expression	was	assessed	in	the	aortic	arch	at	regions	of	
low	 WSS	 (inner	 curvature)	 and	 high	 WSS	 (outer	 curvature)	 in	 atherogenic	 and	
control	animals.	TWIST1	expression	at	the	low	WSS	site	was	enhanced	in	atherogenic	
animals	 compared	 to	 the	controls,	whereas	 there	was	no	 significant	 change	 in	 the	
high	 WSS	 site	 (Figure	 53).	 This	 observation	 suggested	 that	 TWIST1	 expression	 is	
enhanced	 in	 response	 to	 hyper-cholestrolemia.	 However	 the	 study	 is	 preliminary		
(contained	 N=2	 experiments)	 and	 requires	 further	 confirmation.	 Future	 work	 will	
involve	assessing	GATA4	and	SNAIL	expression	in	human	and	murine	atheroplaques.	
	
In	 summary	 these	 findings	 reveal	 for	 the	 first	 time	 that	TWIST1,	GATA4	and	SNAIL	
are	enhanced	in	cells	at	low	WSS	in	vivo	and	that	they	have	functional	significance.	I	
show	 that	 GATA4-mediated	 TWIST1	 mechanotransduction	 regulates	 low	 WSS-
mediated	SNAIL	and	N-cadherin	expression	and	that	transcription	factors	control	cell	
proliferation	in	these	cells,	thus	indicating	that	TWIST1	and	GATA4	mediate	focal	EC	
dysfunction	at	atheroprone	sites	(Figure	54).	 	
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Figure	52.	Twist1	expression	was	increased	with	atheroseverity	in	human	coronar	coronary	arteries		 	
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Figure	52.	TWIST1	expression	was	increased	with	atheroseverity	in	human	coronary	arteries.	
Twist1	 expression	was	 assessed	 in	 coronary	 artery	 tissue,	 donated	 from	anonymous	 ischemic	
heart	 disease	 and	 idiopathic	 cardiomyopathy	 patients	 with	 ethical	 consent.	
Immunohistochemistry	staining	was	done	on	 these	tissue	samples	using	anti-TWIST1	and	vWF	
(to	 label	 luminal	 endothelial	 cells)	 specific	 antibodies	 (brown)	 and	 the	 nuclei	 were	
counterstained	 using	 haematoxylin	 (blue).	 Representative	 images	 are	 shown.	 The	 data	 was	
quantified	 by	 calculating	 %	 positive	 luminal	 Twist1	 expression	 Data	 were	 pooled	 from	 6	
independent	experiments	and	mean	values	±	SEM	are	shown.	*	p<0.05,	using	a	paired	t-test.	
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Figure	53.	Twist1	expression	was	increased	at	low	WSS	sites	in	response	to	hypercholestrolemia		 	
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Figure	 53.	 TWIST1	 expression	 was	 increased	 at	 low	 WSS	 sites	 in	 response	 to	
hypercholestrolemia.	 LDLR-/-	 animals	 were	 treated	 with	 a	 high	 fat	 diet	 or	 LDLR-/-	 animals	
treated	with	 a	 normal	 chow	 diet	 EC	 at	 low	WSS	 (susceptible;	 inner	 curvature)	 or	 high	WSS	
(protected;	outer	curvature)	regions	of	the	aorta	in	were	studied	by	en	face	staining	using	an	
anti-TWIST1	 antibody	 (red).	 EC	 were	 identified	 by	 co-staining	 with	 anti-	 CD31	 antibodies	
conjugated	 to	 FITC	 (green).	 Cell	 nuclei	 were	 identified	 using	 TOPRO	 (blue).	 Representative	
images	are	shown.	Twist1	expression	was	quantified	by	measuring	fluorescent	intensity	of	the	
cells	per	field	of	view	using	Image	J.	(N=2/group)	
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Figure	54.	Model	for	the	function	of	TWIST1	and	GATA4	in	EC	at	 low	WSS	sites.	Low	WSS	
promoted	Twist1	expression	via	GATA4.	GATA4-Twist1	signalling	promotes	partial	EndMT	via	
the	 induction	 of	 SNAIL	 and	 N-cadherin	 at	 sites	 of	 low	WSS.	GATA4-TWIST1	 signalling	 also	
promotes	 EC	 proliferation,	 which	 influences	 EC	 dysfunction	 and	 potentially	 affecting	 focal	
atherogenesis.	
Figure	54.	Model	for	the	function	of	Twist1	and	GATA4		in	EC	at	low	WSS	sites	
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5.9	Conclusions	
	
1. TWIST1,	GATA4	and	SNAIL	expression	was	enhanced	in	EC	at	regions	of	 low	
WSS	compared	to	regions	of	high	WSS	in	the	murine	aorta	
	
2. Using	 a	 flow-altering	 cast	 it	 was	 demonstrated	 that	 TWIST1,	 GATA4	 and	
SNAIL	expression	was	driven	by	low	WSS	in	adult	EC.	
	
3. TWIST1	controls	low	WSS-mediated	partial	EndMT	at	sites	of	low	WSS	in	the	
murine	aorta	by	regulating	N-cadherin	and	SNAIL	expression.	
	
4. TWIST1	and	GATA4	drive	low	WSS-mediated	EC	proliferation	at	atheroprone	
sites	 in	 the	 murine	 aorta,	 suggesting	 that	 they	 contribute	 to	 focal	 EC	
dysfunction.	
	
	
5. TWIST1	expression	correlated	with	athero-severity	in	human	coronary	tissue	
and	was	 enhanced	 in	 response	 to	 hyper-cholestrolemia	 at	 low	WSS	 in	 the	
murine	aorta.	
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5.10	Discussion	
Atherosclerosis	is	a	focal	disease	that	is	driven	by	EC	dysfunction	involving	enhanced	
EC	 proliferation	 and	 permeability	 that	 preferentially	 occurs	 at	 sites	 of	 low	 WSS.	
However	the	molecular	mechanisms	that	govern	focal	EC	behaviour	and	dysfunction	
are	not	fully	known.	In	this	chapter	I	have	demonstrated	that	a	novel	mechanism	for	
low	 WSS-mediated	 atherogenesis	 could	 be	 via	 GATA4-	 TWIST1	 signalling,	 the	
observations	made	in	this	chapter	will	now	be	discussed.	
	
5.10.1	The	expression	of	TWIST1,	GATA4	and	SNAIL	is	driven	by	atherogenic,	low	
WSS	in	vivo	
I	have	shown	that	the	expression	of	TWIST1,	GATA4	and	SNAIL	was	enhanced	in	EC	
at	 atheroprone,	 disturbed	 flow	 (low,	 oscillatory	 WSS)	 sites	 compared	 to	
atheroprotected	non-disturbed	flow	(high	WSS)	sites,	which	proposed	a	correlation	
between	the	expression	of	these	genes	by	low,	oscillatory	WSS	 in	vivo.	Moreover,	I	
have	shown	that	the	induction	of	TWIST1	in	cells	at	low,	oscillatory	WSS	sites	occurs	
via	GATA4.	Thus,	GATA4	promoted	Twist1	expression	 in	EC	exposed	to	 low	WSS	 in	
vitro	and	in	in	vivo.		
	
To	establish	a	causal	 link	between	the	 induction	of	GATA4-Twist1	and	Snail	by	 low	
WSS	 in	 vivo	 I	 directly	 altered	 flow	 in	 the	murine	 carotid	using	 a	 flow-altering	 cuff.	
This	revealed	that	the	expression	of	TWIST1,	GATA4	and	SNAIL	was	enhanced	at	the	
low	WSS	site	(upstream	of	cuff)	compared	to	the	high	WSS	site	(stenosis).	However,	
whilst	GATA4	and	 SNAIL	 expression	was	enhanced	at	 the	 low,	oscillatory	WSS	 site	
(downstream	of	 cuff)	 TWIST1	 expression	was	 reduced.	 Several	 conclusions	 can	 be	
made	from	this	observations;	1)	In	the	inner	aortic	arch,	a	region	of	endogenous	low	
and	 oscillatory	WSS	 (disturbed	 flow)	where	 the	 expression	 of	 all	 three	 genes	was	
enhanced,	 differs	 in	 flow	 magnitude	 and	 direction	 of	 flow	 and	 pulsatility	 to	 the	
downstream	 region	 of	 the	 cuff.	 Therefore,	 it	 is	 difficult	 to	 make	 accurate	
comparisons	between	the	expression	in	the	downstream	from	the	cuff	and	the	inner	
curvature	 as	 different	 flow	 patterns	 will	 activate	 different	 mechanosensors	 that	
could	in	turn	influence	TWIST1	and	GATA4	expression.	The	data	demonstrated	that	
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flow	magnitude	 (low	WSS)	 is	 the	 primary	mechano-stimulus	 that	 is	 promoting	 the	
expression	 of	 all	 three	 genes	 in	 vivo.	 2)	 The	 activation	 of	 GATA4-TWIST1-SNAIL	
network	that	I	observed	in	the	inner	aortic	arch,	did	not	translate	into	the	expression	
of	these	genes	in	the	cuff-inserted	vessel	as	the	expression	of	GATA4	and	SNAIL	was	
enhanced	without	TWIST1.	These	observations	at	the	downstream	region	of	the	cuff,	
suggest	that	TWIST1	expression	under	cuff-induced	low/oscillatory	WSS	is	 inhibited	
by	unknown	mechanisms,	potentially	one	of	 these	mechanisms	could	be	mediated	
by	 GATA4.	 An	 increase	 in	 GATA4	 expression	 beyond	 a	 certain	 threshold	 could	
promote	 the	 activation	 of	 a	 TWIST1	 inhibitor,	 or	 it	 could	 be	 that	 the	 specific	 flow	
pattern	 in	 the	 downstream	 region	 of	 the	 cuff	 activates	 a	 GATA4-independent	
pathway	that	inhibits	TWIST1.	In	addition,	it	is	important	to	note	that	in	addition	to	
differences	 in	WSS	directionality,	 the	WSS	magnitude	at	 the	region	downstream	of	
the	 cuff	 (14	 dyne/cm2)	 is	 different	 to	 that	 in	 the	 upstream	 region	 of	 the	 cast	 (10	
dyne/cm2)	 where	 all	 three	 genes	 are	 activated.	 Taken	 together,	 this	 observation	
revealed	 that	 the	 interaction	 of	 all	 three	 genes	 is	 sensitive	 to	 changes	 in	 flow	
magnitude	 and	 directionality	 and	 suggests	 that	 a	 potential	 upstream	
mechanosensor(s)	 is	 responsible	 for	 the	 activation	 of	 GATA4-	 TWIST1-SNAIL	 axis	
under	specific	WSS	conditions.	
	
A	combination	of	 in	vitro	and	 in	vivo	 techniques	have	provided	a	close	 insight	 into	
the	mechanical	activation	of	 these	transcription	 factors	 in	EC	 (summarised	 in	 table	
10).	 In	 vitro	 observations	 using	 the	 orbital	 plate	 and	 Ibidi™	 parallel	 plate	 systems	
have	 revealed	 that	 flow	magnitude-	 low	WSS	 is	 the	 dominant	 driving	 force	 in	 the	
activation	 of	 TWIST1	 and	 GATA4.	 Consistent	with	 this,	 in	 vivo	 observations	 in	 the	
aortic	 arch	 (regions	 of	 low	 and	high	WSS)	 and	 the	 flow-constrictive	 cuff	 have	 also	
revealed	 that	 low	 WSS	 is	 also	 a	 more	 dominant	 factor	 in	 activating	 GATA4	 and	
TWIST1.	It	would	be	interesting	to	investigate	which	flow-specific	mechanosensor(s)	
are	driving	the	expression	of	these	genes	in	response	to	low	WSS	in	order	to	further	
characterize	the	nature	of	their	mechanotransduction.	
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Table	10	.	Summary	of	WSS-modulation	of	TWIST1	and	GATA4	using	in	vitro	and	in	vivo	
systems	
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Consistent	with	previous	studies,	the	expression	of	GATA4	at	atheroprone,	low	WSS	
sites	has	been	previously	reported	by	large-scale	microarray	studies	(Passerini	et	al.	
2004;	 Björck	 et	 al.	 2012)	 and	 the	 expression	 of	 the	 snail-related	 EndMT	 regulator	
Slug	has	recently	been	detected	at	atheroprone	sites	in	the	murine	aorta	(Sanchez-
Duffhues	et	al.	2015)	thus	supporting	the	activation	of	these	genes	at	atheroprone,	
low	WSS	sites	in	vivo.	I	reveal	for	the	first	time	that	TWIST1	expression	is	enhanced	
at	atheroprone	sites.	Consistent	with	this,	TWIST1	and	GATA4	expression	has	been	
shown	to	be	prominent	 in	EC	 in	 the	heart	valves	and	 in	during	valve	development	
this	 process	 is	 WSS-dependent	 and	 EC	 in	 the	 adult	 heart	 valves	 are	 mechano-
sensitive	 (Heckel	et	al.	2015).	Thus,	 suggesting	 that	WSS	has	been	 indirectly	 linked	
with	the	activation	of	GATA4	and	TWIST1	in	vivo.		
5.10.2	TWIST1	expression	is	detected	in	adult	EC	
It	 can	 be	 argued	 that	 low	WSS	 promotes	 the	 homing	 of	 progenitor	 cells	 from	 the	
bone	 marrow	 into	 atheroprone	 sites	 and	 these	 cells	 could	 be	 expressing	
mesenchymal,	embryonic	genes	including	TWIST1	(Foteinos	et	al.	2008).	Thus	to	test	
the	hypothesis	 that	TWIST1	expression	at	 low	WSS	 sites	occurs	 in	adult	 EC,	 I	 used	
SCL-Cre-ERT;	 R26R-Td	 tomato	 cell	 tracking	 system	 to	 label	 adult	 EC.	 	 The	 cuff	was	
inserted	 following	 Cre-activation	 in	 order	 to	 assess	 low	WSS-mediated	 increase	 in	
Twist1	 expression	 in	 a	 vessel	 where	 basal	 TWIST1	 expression	 is	 low.	 Therefore	
inducing	the	labelling	of	the	cells	via	an	endothelial	specific	promoter,	coupled	to	the	
creation	of	low	WSS	flow	condition	in	the	carotid	artery	provided	a	study	design	to	
clearly	conclude	the	effects	of	low	WSS	on	the	expression	of	TWIST1	in	adult	EC.	Of	
note,	any	progenitor	cells	homing	into	the	low	WSS	site	in	modified	carotid	arteries	
would	 remain	 negative	 despite	 activation	 of	 the	 SCL	 promoter	 because	 tamoxifen	
administration	was	transient	and	preceded	cuff	placement.	The	results	reflected	that	
all	TWIST1	positive	cells	regions	in	the	cuff-mediated	low	WSS	regions	were	R26R-Td	
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tomato	positive,	 thus	confirming	 that	adult	EC	express	TWIST1	at	 low	WSS	sites	 in	
vivo.	Future	work	will	 include	assessing	the	expression	of	GATA4	and	SNAIL	in	cuff-
inserted	SCL-Cre-ERT;	R26R-Td	tomato	animals.	
	
	
The	 use	 of	 the	 SCL-Cre-ERT;	 R26R-Td	 tomato	 cell	 tracking	 system	 is	 established	 to	
determine	EC	 involvement	and	to	eliminate	EPC	contribution	 (Göthert	et	al.,	2004,	
2005).	However,	 to	provide	evidence	for	the	complete	 lack	of	EPC	 involvement,	en	
face	 imaging	 of	 EPC	 cells	 in	 the	 same	 animals	 where	 cuff	 insertion	 and	 TWIST1	
expression	analysis	was	 assessed	 should	be	used	 to	determine	 the	 absence	of	 the	
Td-tomato	protein,	 to	 further	strengthen	the	conclusion	that	TWIST1	expression	at	
low	WSS	occurs	in	adult	EC.		
5.10.3	Potential	mechanisms	for	the	activation	of	TWIST1		and	GATA4	by	low	WSS	
in	vivo.	
Signalling	pathways	including	p38	MAPK,	NF-κB	and	TGF-β	signalling	via	BMP4	have	
all	been	shown	to	be	preferentially	activated	at	sites	of	 low	WSS	 in	vivo	 (Kim	et	al.	
2012;	 Jo	et	al.	2006;	Chaudhury	et	al.,	2010;	Zakkar	et	al.	2011).	 In	addition,	 these	
signalling	 pathways	 are	 linked	with	 EC	 dysfunction	 and	 atherogenesis.	 Twist1	 and	
GATA4	are	downstream	targets	of	p38	MAPK,	NF-κB	and	TGF	signalling	 in	range	of	
cell	types,	including	cardiac	cells,	cancer	cells,	and	valve	EC	(Daoud	et	al.	2014;Rojas	
et	al.,	2009;	Gaspar-Pereira	et	al.	2012;	Tenhunen	et	al.	2004;	Hong	et	al.	2011).	Thus	
it	could	be	that	these	signalling	pathways	are	driving	TWIST1	and	GATA4	expression	
in	EC	at	sites	of	low	WSS	in	vivo.	Moreover	mechanosensors	such	as	cilia,	which	are	
present	at	 low	WSS	and	absent	 from	high	WSS	sites	 in	vivo	 (Van	der	Heiden	et	al.	
2004),	 could	 also	 be	 a	 potential	 mechanism	 for	 the	 activation	 of	 GATA4-	 TWIST1	
signalling	 in	 EC	 at	 low	 WSS	 sites.	 The	 primary	 cilium	 has	 been	 linked	 with	 the	
regulation	of	canonical	 (via	β-catenin)	WNT	signalling	 (Lancaster	et	al.	2011).	Since	
WNT	 signalling	 is	 an	 activator	 of	 TWIST1	 and	 GATA4,	 it	 could	 be	 that	 cilia	 are	
controlling	GATA4-	TWIST1	activation	via	β-catenin	(Lamouille	et	al.	2014;	Lin	&	Xu	
2008).	
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TWIST1	 and	 GATA4	 DNA	 binding	 activity	 is	 enhanced	 by	 interacting	 with	 binding	
partners	 such	 as	 FOG2,	 MEF2C,	 TBX5	 for	 GATA4	 and	 E47	 and	 ID1	 for	 TWIST1	
(Reviewed	in	Schlesinger	et	al.	2011;	Ghouzzi	et	al.	1997).	Interestingly,	TWIST1	and	
GATA4	interact	with	a	common	binding	partner	HAND2	(Dai	et	al.	2002;	Firulli	et	al.	
2005;	McFadden	et	al.	2000).	A	microarray	study	by	Bjork	et	al.	identified	HAND2	as	
a	major	mechano-responsive	transcription	factor,	which	showed	a	marked	increase	
in	expression	 in	EC	exposed	 to	 low	WSS	 in	 the	 rat	 aortic	 arch	 (Björck	et	 al.	 2012).	
Therefore,	HAND2	could	be	involved	in	stabilising	and	increasing	GATA4	and	TWIST1	
activity	in	EC	exposed	to	low	WSS.	
5.10.4	Low	WSS	promoted	partial	EndMT	
I	 have	 delineated	 between	 the	 effect	 of	 low	WSS	 on	 the	 activation	 partial	 or	 full	
EndMT	 as	 evidenced	 by	 the	 following	 observations;	 1)	 Snail	 expression	 was	
enhanced	 at	 the	 low	 WSS	 sites,	 2)	 Low	 WSS	 promoted	 a	 cadherin	 switch	 by	
enhancing	 the	 expression	 of	 junctional	 N-cadherin	 and	 promoting	 VE-cadherin	
disorganisation,	 3)	 The	 expression	 of	 EC-markers	 VE-cadherin	 and	 CD31	 was	 not	
reduced	at	the	low	WSS	sites	compared	to	the	high	WSS	sites.	4)	Low	WSS	does	not	
promote	cellular	delamination,	which	EndMT	cells	undergo	by	separating	 from	the	
endothelial	 monolayer	 and	 invading	 and	migrating	 into	 the	 underlying	 cell	 layers.	
These	observations	suggest	that	low	WSS	promotes	some	EndMT-like	processes,	but	
does	not	give	rise	 to	the	 full	 transition	of	EC	 into	a	mesenchymal	state.	Consistent	
with	 this,	a	 study	by	Sanchez-Duffhues	et	al.	has	correlated	 low	WSS	 regulation	of	
EndMT	 in	 vivo,	 demonstrating	 that	 enhanced	 Slug	 expression	 occurs	 in	 EC	 at	
atheroprone,	low	WSS	sites	in	the	murine	aorta	of	LDLR-/-	animals	(Sanchez-Duffhues	
et	al.	2015).	Consistent	with	this,	a	recent	study	by	Chen	et	al.	identified	a	significant	
increase	 in	 TGF-β	 signalling	 (EndMT-promoting)	 and	 reduction	 in	 FGF	 signalling	
(EndMT-inhibiting)	 in	EC	exposed	to	 low	WSS	in	atherogenic	mice	(	ApoE-/-,	given	a	
high	 fat	diet),	whilst	 not	detecting	 a	 significant	difference	 in	 control	mice	 (ApoE-/-,	
given	a	normal	chow	diet)	(Chen	et	al.	2015).	This	suggests	that	low	WSS	alone	did	
not	directly	 induce	EndMT	 in	EC	at	 low	WSS	sites.	A	more	direct	 link	between	 low	
WSS	 and	 EndMT	 in	 vivo	 has	 been	 recently	 provided	 using	 the	 thoracic	 aortic	
constriction	method,	Moonen	et	al.	have	shown	that	downstream	of	the	constriction	
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where	flow	exerts	low	WSS	there	was	an	increase	in	the	expression	of	EndMT-linked	
proteins	such	as	α-SMA	and	Transgelin	(Moonen	et	al.	2015).	However	these	studies	
do	not	provide	evidence	 for	 loss	of	EC-marker	expression	at	 low	WSS	sites	 in	vivo.	
Thus	my	studies	are	the	first	to	suggest	that	the	proposed	transition	into	EndMT	was	
partial.		
	
5.10.5	Potential	mechanism	for	the	induction	of	partial	EndMT	in	EC	exposed	to	
low	WSS	
	Previous	 studies	 demonstrated	 that	 TWIST1	 regulated	 partial	 EMT	 in	 tubular	
epithelial	cells	during	kidney	fibrosis	(Lovisa	et	al.	2015).	In	addition,	epithelial	cells	
isolated	 from	 TWIST1	 gain	 of	 function	 mice,	 showed	 that	 Twist1	 expression	 was	
sufficient	 to	 drive	 multiple	 EndMT-like	 changes	 including	 migration	 and	 invasion,	
without	 the	 loss	 of	 E-cadherin,	 suggesting	 that	 TWIST1	 promoted	 partial	 EMT	 in	
these	 cells	 (Shamir	 et	 al.	 2014).	 GATA4	 is	 indirectly	 linked	 with	 the	 induction	 of	
partial	EMT	as	suggested	by	the	following;	GATA4	is	a	critical	regulator	of	myocardial	
infarction	responses	in	cells	of	the	epicardium	(Heineke,	Auger-messier,	et	al.	2007;	
Inagawa	et	al.	2012)	and	these	cells	undergo	partial	EMT	following	MI	(Limana	et	al.	
2007).	 Therefore,	 these	 studies	provide	 supportive	evidence	 for	 the	 induction	of	a	
partial	mesenchymal	state	in	cells	via	TWIST1	and	GATA4.	
	
Previous	 studies	 have	 shown	 that	 TWIST1	 and	GATA4	 regulate	 EndMT	 in	 valve	 EC	
during	development	(Zeisberg	et	al.	2005;	Mcfadden	et	al.	2005;	Grande	et	al.	2015;	
Vrlijicak	et	al.	2012).	In	addition,	the	induction	of	EndMT	in	valve	EC	is	triggered	by	
low	WSS	conditions	 (Mahler	et	al.	2014;	Heckel	et	al.	2015).	Thus	previous	studies	
correlated	 WSS	 with	 EndMT	 and	 TWIST1/GATA4	 expression,	 but	 did	 not	 show	
causality.	 However,	 I	 show	 for	 the	 first	 time	 the	 direct	 involvement	 of	 GATA4-	
TWIST1	signalling	in	the	induction	of	EndMT	in	EC	exposed	to	low	WSS	in	the	murine	
vasculature.	
	
There	could	be	other	mechanisms	that	are	driving	EndMT	in	EC	exposed	to	low	WSS,	
either	 alongside	or	 independently	of	 Twist1	and	GATA4.	 TGF-β	and	BMP	 signalling	
through	 Smad	1/5/8	 and	 Smad	2/3	 and	4	proteins	 is	well	 established	 in	 triggering	
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EndMT	 (Cooley	et	al.	2014;	Maddaluno	et	al.	2013;	Chen	et	al.	2015;	Medici	et	al.	
2011).	 In	 fact,	 both	 TGF-β	 and	 BMP	 factors	 have	 been	 shown	 to	 co-operatively	
mediate	 EndMT	 through	 ALK2	 and	 ALK5	 receptors	 (Medici	 et	 al.,	 2010.	 GATA4	
regulates	EndMT	in	valve	cells	via	interacting	with	Smad	4	(Moskowitz	et	al.,	2011),	
suggesting	 that	 GATA4-	 TWIST1	 signalling	 could	 be	 mediating	 EndMT	 via	 TGF-β	
signalling.	 Moreover,	 GATA4	 expression	 is	 driven	 by	 BMP4	 during	 embryonic	
development	 (Daoud	 et	 al.	 2014)	 whilst	 TWIST1	 is	 required	 for	 BMP4	 expression		
(O'Rourke	et	al.	2002).	The	expression	of	BMP4	is	enhanced	at	low	WSS	sites	in	vivo	
(Kim	 et	 al.	 2013;	 Jo	 et	 al.	 2006;	 Sorescu	 et	 al.	 2004).	 Therefore,	 GATA4-	 TWIST1	
signalling	 could	be	 interacting	with	BMP4	 in	promoting	 EndMT	 in	 cells	 exposed	 to	
low	WSS.	Chen	et	al.,	demonstrated	that	low	WSS	promotes	EndMT	by	inhibiting	FGF	
signalling,	whilst	increasing	TGF-β	signalling	(Chen	et	al.	2015).	Interestingly,	TWIST1	
controls	 the	 balance	 between	 FGF	 and	 TGF-β	 signalling	 during	 EMT	 regulation	 in	
gastrulation.	 Thus	TWIST1	 could	be	acting	as	 a	molecular	 switch,	upstream	of	 FGF	
and	TGF-β	signalling	in	EC	exposed	to	low	WSS.	
	
Another	 potential	 mechanism	 could	 be	 via	 p38	 MAPK	 signalling,	 which	 is	
preferentially	 activated	 at	 low	WSS	 sites	 (Chaudhury	 et	 al.	 2010).	 p38	 signalling	 is	
required	for	TGF-β2-mediated	EndMT	(Medici	et	al.	2011).	As	mentioned	previously,	
Twist1	and	GATA4	have	been	linked	with	p38	signalling,	suggesting	that	they	could	
be	mediating	 EndMT	 via	 p38.	 Notch	 and	WNT	 signalling	 have	 both	 been	 show	 to	
regulate	EndMT	(Maddaluno	et	al.	2013;	Aisagbonhi	et	al.	2011;	Cheng	et	al.	2013),	
and	 both	 of	 these	 pathways	 have	 been	 shown	 to	 be	WSS-sensitive	 (Watson	 et	 al.	
2013;	Rotherham	&	El	Haj	2015).	Thus	WNT	and	Notch	signalling	could	be	involved	in	
the	regulation	of	low-WSS	mediated	EndMT.	
	
Egorova	 et	 al.,	 have	 shown	 that	 the	 absence	 of	 cilia	 triggers	 EndMT	 through	 the	
absence	 of	 KLF4.	 The	 overexpression	 of	 KLF4	 in	 non-ciliated	 cells	 inhibited	 EndMT	
marker	 expression,	 thus	 suggesting	 that	 KLF4	 is	 a	 negative	 regulator	 of	 EndMT	
(Egorova	et	al.	2011).	Interestingly,	KLF4	is	a	gene	that	is	inhibited	by	low	WSS	and	is	
preferentially	activated	in	EC	exposed	to	protective,	high	WSS	(Fang	et	al.	2010;	Jiang	
et	 al.	 2015).	 It	 would	 be	 of	 interest	 to	 assess	 if	 low	 WSS	 promotes	 TWIST1	 and	
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GATA4-mediated	 inhibition	 of	 KLF4	 expression,	 thus	 enabling	 the	 EndMT	 process.	
Alternatively,	 whether	 KLF4	 inhibits	 TWIST1	 and	 GATA4	 signalling,	 subsequently	
preventing	EndMT.		
	
5.10.6	Partial	EndMT	vs.	Full	EndMT	
The	notion	of	partial	EndMT	and	partial	EMT	has	recently	been	adopted	(Grande	et	
al.	2015;	Lovisa	et	al.	2015;	Welch-Reardon	et	al.	2014).	It	is	defined	by	cells	lacking	
one	 of	 the	 established	 features	 of	 EndMT/EMT,	 this	 often	 involves	 retaining	 cell	
adhesion	 proteins	 such	 as	 VE	 and	 E-cadherin.	 Instead	 of	 cells	 separating	 and	
migrating	 individually	 as	 seen	 in	 full	 EndMT,	 in	 partial	 EndMT	 the	 cell	 monolayer	
migrates	 as	 one	 sheet.	 (Reviewed	 in	 Welch-Reardon	 et	 al.	 2014).	 For	 example,	
sprouting	 angiogenesis	 is	 a	 well-established	 example	 of	 a	 process	 that	 involves	
partial	EndMT.	During	angiogenesis,	migratory,	sprouting	cells	express	mesenchymal	
genes	 such	 as	 Snail	 and	 Slug,	 whilst	 maintaining	 cell-cell	 contacts	 (Reviewed	 in	
Welch-Reardon	et	al.,	2014).		
	
Whilst	in	vitro	studies	provide	evidence	for	the	loss	of	EC	markers	and	the	expression	
of	mesenchymal	markers	in	cells	undergoing	EndMT	(Moonen	et	al.	2015;	Egorova	et	
al.	2011;	Sanchez-Duffhues	et	al.	2015),	in	vivo	studies	fail	to	provide	evidence	for	a	
loss	 or	 a	 reduction	 in	 EC	 or	 epithelial	 markers	 in	 EndMT	 or	 EMT.	 The	 Dejana	 lab	
provided	 evidence	 for	 the	 involvement	 of	 EndMT	 in	 cerebral	 cavernous	
malformations	 (CCM),	 as	 evidenced	 by	 the	 expression	 of	 several	 mesenchymal	
markers	 such	 as	 N-cadherin,	 Snail,	 Slug	 and	 α-SMA	 in	 EC	 from	 CCM	 lesions	
(Maddaluno	 et	 al.	 2013).	 The	 study	 showed	 that	 the	 expression	 of	 these	
mesenchymal	markers	correlated	with	disorganised	 junctional	VE-cadherin,	but	did	
not	show	a	 loss	 in	either	VE-cadherin	or	CD31	expression	(Maddaluno	et	al.	2013).	
Similarly,	 studies	 showing	 the	 role	 of	 EndMT	 in	 renal	 fibrosis	 by	 Xavier	et	 al	 or	 in	
pulmonary	 arterial	 hypertension	 (PAH)	 by	 Ranchoux	 et	 al.	 have	 shown	 that	 EC	 in	
murine	 and	 human	 tissue	 express	 mesenchymal	 markers	 α-SMA	 and	 vimentin,	
without	a	loss	in	VE-cadherin	and	CD31	(Xavier	et	al.	2015;	Ranchoux	et	al.	2015).	In	
addition,	 a	 recent	 study	by	Chen	et	 al	 demonstrated	 that	 EndMT-promoting	TGf-β	
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signalling	was	enhanced	in	EC	at	low	WSS	sites	in	atherogenic	mice	(ApoE-/-	given	a	
high	 fat	diet),	without	 showing	a	 reduction	 in	EC	marker	expression.	 This	 suggests	
that	 the	 process	 identified	 in	 the	 described	 studies	 was	 partial	 EndMT,	 therefore	
providing	similar	conclusions	to	my	observation	of	the	induction	of	partial	EndMT	by	
cells	exposed	to	low	WSS.		
	
Recently,	 a	 number	 of	 studies	 have	 shown	 that	 partial	 EndMT	 is	 involved	 in	 renal	
fibrosis.	These	studies	clearly	stated	that	the	cells’	mesenchymal	transformation	was	
partial,	 since	 these	 cells	 did	 not	 show	 a	 reduction	 in	 epithelial	 cell	markers	whilst	
expressing	mesenchymal	ones	(Lovisa	et	al.	2015;	Grande	et	al.	2015).	One	of	these	
studies,	 by	 the	 Kalluri	 group	 suggests	 that	 the	 transition	 of	 cells	 into	 a	 full	
mesenchymal	state	whilst	occurring	during	development,	would	rarely	occur	 in	the	
adult	(Lovisa	et	al.	2015).	Ubil	et	al	reported	that	EndMT	is	reversible,	via	a	process	
termed	mesenchymal-endothelial	transition	(MEndT)	in	fibroblasts	following	cardiac	
injury	(Ubil	et	al.	2014).	This	study	provides	an	example	of	the	wide	spectrum	of	cell	
plasticity.	 	 The	 process	 of	 EC	 plasticity	 is	 complex	 and	 is	 very	 context	 dependent,	
thus,	 in	my	opinion;	 it	 is	not	accurate	to	restrict	EC	plasticity	under	one	definition.	
Rather	than	EC	strictly	either	undergoing	EndMT	or	not,	partial	EndMT	could	be	one	
example	of	cell	plasticity	across	a	wide	spectrum,	which	is	controlled	by	the	context	
to	which	EC	are	exposed	to.		
	
The	switch	between	the	transition	into	full	or	partial	EndMT	could	heavily	depend	on	
the	presence	of	a	specific	activating	stimulus.	Such	stimulus	could	therefore	control	
the	 magnitude	 of	 EndMT-promoting	 pathways,	 thus	 controlling	 the	 magnitude	 of	
EndMT.	It	seems	that	the	activation	of	EndMT	in	adult	EC,	in	the	disease	context	may	
be	via	a	common	stimulus.	Fibrotic	diseases,	including	atherosclerosis	and	cancer	all	
have	a	common	 link	of	EC	stress	and	 injury	 (Civelek	et	al.	2009;	Lovisa	et	al.	2015;	
Klaunig	et	al.	2010).	Thus,	 it	could	be	that	partial	EndMT	is	activated	to	provide	an	
adaptive	role	in	response	to	an	injury	stimulus.	Evolutionarily,	it	is	more	efficient	to	
re-activate	ancient	pathways	in	a	situation	that	requires	extensive	changes	in	cellular	
behavior	(proliferation	and	migration)	such	as	in	the	response	to	injury.	Thus,	it	can	
be	 argued	 partial	 EndMT	 in	 the	 adult	 has	 evolved	 to	 facilitate	 such	 changes	
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efficiently.	 The	 potential	 adaptive	 significance	 of	 TWIST1	 and	 GATA4-mediated	
regulation	of	partial	EndMT	in	response	to	low	WSS	will	be	discussed	in	detail	in	the	
next	chapter	
	
	
5.10.7	Regulation	of	EC	proliferation	by	GATA4	and	TWIST1,	is	it	detrimental	or	
protective?	
Low-WSS-mediated	 increases	 in	 EC	 proliferation	 is	 a	 key	 process	 in	 vascular	
dysfunction	 and	 atherosusceptibility	 (Obikane	 et	 al.	 2007;	 Amini	 et	 al.	 2014;	
Chaudhury	et	al.	2010;	Warboys	et	al.	2014).	I	have	shown	that	TWIST1	and	GATA4	
drive	 EC	proliferation	 at	 sites	of	 low	WSS.	 This	 suggested	 that	 TWIST1	 and	GATA4	
potentially	 regulate	 EC	 dysfunction	 at	 these	 sites.	 This	 conclusion	 was	 further	
strengthened	by	 the	 following	observations;	1)	VE-cadherin	 junctional	widths	were	
increased	at	the	 low	WSS	sites,	suggesting	an	enhancement	of	cell	permeability,	2)	
TWIST1	and	GATA4	induction	by	low	WSS	in	vitro	promoted	cell	permeability.	Since	
cell	 permeability	 is	 another	 feature	 of	 EC	 dysfunction,	 this	 further	 supports	 the	
conclusion	 that	 TWIST1	 and	 GATA4	 promote	 EC	 dysfunction	 at	 sites	 of	 low	 WSS	
through	the	induction	of	proliferation.	
	
However,	cell	proliferation	at	low	WSS	may	be	atheroprotective.	It	was	proposed	by	
Schober	 et	 al.,	 that	 proliferation	 at	 low	 WSS	 provides	 a	 protective	 function	 by	
serving	as	a	repair	mechanism	in	response	to	injury	(Schober	et	al.	2014).	It	has	been	
shown	 that	 both	 Twist1	 and	 GATA4	 play	 a	 significant	 role	 in	 wound	 healing	 and	
fibrosis	 following	 injury	 (Gupta	 et	 al.	 2013;	 Heineke,	 Auger-messier,	 et	 al.	 2007;	
Mammoto	et	al.	2013;	Lovisa	et	al.	2015).	Similarly,	EndMT	is	known	to	be	activated	
following	 an	 injury	 stimulus,	 such	 as	 in	 ischaemic/reperfusion	 injury	 (Curci	 et	 al.,	
2014).	It	has	been	shown	by	Lovisa	et	al.,	that	in	response	to	renal	injury,	Twist1	and	
Snail	are	 involved	 in	the	regulation	of	cell	proliferation	as	a	consequence	of	partial	
EMT	leading	to	kidney	fibrosis	(Lovisa	et	al.	2015).	Therefore,	the	activation	GATA4-	
TWIST1-SNAIL	signalling	in	EC	at	low	WSS	sites	and	subsequent	proliferation	could	be	
a	repair	response	to	low	WSS,	potentially	at	the	consequence	of	EC	dysfunction	and	
atherogenesis.	
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To	 fully	determine	 the	 significance	of	 the	 role	of	TWIST1	and	GATA4	 in	promoting	
cell	 proliferation	 at	 sites	 of	 low	WSS,	 conditional-EC	 knock	 out	 animals	 should	 be	
crossed	with	atherogenic	mice	followed	by	the	assessment	of	 lesion	formation	and	
composition	in	future	studies.	
	
5.10.8	Mechanism	for	the	role	of	TWIST1	and	GATA4	in	EC	proliferation	at	sites	of	
low	WSS.	
One	mechanism	for	the	regulation	of	EC	proliferation	at	low	WSS	sites	could	be	via	
SNAIL-mediated	EndMT,	since	GATA4-TWIST1	regulated	SNAIL	expression	in	vivo	and	
that	 SNAIL	 promoted	 proliferation	 in	 vitro.	 However,	 it	 could	 be	 that	 Twist1	 and	
GATA4	 promote	 cell	 proliferation	 at	 low	 WSS	 in	 vivo	 via	 an	 EndMT-independent	
mechanism	 involving	 activation	 of	 target	 genes.	 Platelet-derived	 growth	 factors	
(PDGFs)	and	their	receptors	have	been	previously	linked	with	the	promotion	of	cell	
turnover	at	low	WSS	sites	in	vivo	and	have	been	detected	in	atherosclerotic	plaques	
(Wilcox	 et	 al.	 1988;	 Son	 et	 al.	 2013;	 Son	 et	 al.	 2012;	He	 et	 al.	 2015).	 Interestingly	
Pdgfr-α	 is	a	TWIST1	 target	gene	 (Eckert	at	al.	2011),	 thus	 this	 could	be	a	potential	
candidate	 for	 elucidating	 the	mechanism	 for	 TWIST1-mediated	 EC	 proliferation	 at	
low	WSS	sites.	GATA4	has	been	shown	to	regulate	Smad	signalling	(Moskowitz	et	al.	
2011),	which	 in	 turn	has	been	 shown	 to	promote	proliferation	at	 low	WSS	 sites	 in	
vivo	 (Zhou	 et	 al.	 2013).	 Also,	 both	 TWIST1	 and	 GATA4	 can	 act	 upstream	 and	
downstream	of	p38-mediated	MAPK	signalling	(Rÿsa	et	al.	2010;	Monzen	et	al.	2001;	
Hong	et	al.,	2011,	which	is	also	induced	by	atheroprone	low	WSS	and	involved	in	the	
regulation	of	proliferation	(Zakkar	et	al.	2008;	Zhang	&	Liu	2002).		
	
Interestingly,	 p38,	 Smad5	 and	 PDGFR-α	 are	 also	 signalling	 components	 that	 have	
been	linked	with	EndMT	regulation(van	Meeteren	&	ten	Dijke	2012;	Gasperini	et	al.	
2012;	 Smith	 et	 al.	 2011)	 this	 provides	 a	 link	 between	 the	 regulation	 of	 GATA4-	
TWIST1	 of	 EndMT	 and	 potentially	 consequent	 cell	 proliferation.	 Nevertheless,	 it	
remains	 to	 be	 determined	 whether	 the	 effect	 of	 TWIST1	 and	 GATA4	 on	 cell	
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proliferation	 occurs	 via	 EndMT	 or	 via	 an	 independent	 mechanism	 or	 through	 a	
combination	of	both.	
	
	
	
5.10.9	Do	TWIST1	and	GATA4	regulate	atherogenesis?	
I	 have	 shown	 that	 TWIST1	 luminal	 EC	 expression	 was	 enhanced	 in	 tissue	 from	
ischemic	heart	disease	compared	to	cardiomyopathy	patients,	reflecting	that	TWIST1	
expression	correlated	with	athero-severity.	At	 low	WSS	sites	 in	LDLR-/-	mice,	 I	have	
shown	 that	 TWIST1	 expression	 is	 enhanced	 in	 response	 to	 hyper-cholestrolemia.	
Thus	these	observations	provide	a	correlation	between	TWIST1	activation	in	EC	and	
atherogenesis.	 Interestingly,	Cheng	et	al	 reported	enhanced	atherosclerotic	plaque	
size	 and	expression	of	 inflammatory	VCAM-1	expression	 in	 areas	 subjected	 to	 low	
WSS	upstream	of	a	flow-altering	cuff	compared	to	the	constriction	and	downstream	
sites	(Cheng	et	al.	2006).	The	upstream	area	of	the	cuff	showed	high	expression	of	
TWIST1	and	GATA4	in	my	studies,	therefore	this	provides	a	correlation	between	the	
expression	of	TWIST1	and	GATA4	with	atherosclerosis	severity	and	inflammation.	As	
discussed	 previously,	 I	 propose	 that	 GATA4-TWIST1	 signalling	 promotes	 EC	
dysfunction	 at	 low	 WSS	 sites	 via	 proliferation	 and	 permeability.	 Whilst	 this	
hypothesis	 will	 be	 tested	 in	 future	 studies,	 it	 is	 interesting	 to	 speculate	 whether	
TWIST1	and	GATA4	activation	at	low	WSS	sites	promotes	atherogenesis.	
	
	There	 is	 some	 indirect	 evidence	 to	 support	 the	 role	 of	 TWIST1	 and	 GATA4	 in	
promoting	 focal	 atherogenesis.	 Genome	 wide	 association	 studies,	 which	 identify	
associations	in	genetic	polymorphisms	(single	nucleotide	polymorphisms;	SNPs)	with	
disease	 aetiology,	 have	 shown	 that	 SNPs	 in	 the	 TWIST1	 locus	 are	 involved	 in	
ischemic	 stroke	 and	 in	 coronary	 artery	 disease	 (Samani	 et	 al.	 2007;	Matarín	 et	 al.	
2007),	suggesting	that	it	plays	a	role	in	atherogenesis.	SNPs	in	the	GATA4	locus	have	
been	 associated	 with	 plasma	 triglyceride	 levels	 in	 humans.	 Since	 an	 increase	 in	
triglyceride	levels	is	a	known	risk	factor	for	atherogenesis,	this	GWAS	study	provides	
a	link	between	GATA4	and	atherogenesis	(Lamina	et	al.	2011).	
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TWIST1	and	GATA4	are	regulated	by	and	act	upstream	to	activate	pro-inflammatory	
p38	and	NF-κB	signalling	(Rÿsa	et	al.	2010;	Hong	et	al.	2011;	Tenhunen	et	al.	2004;	Li	
et	 al.	 2012;	Gaspar-Pereria	 et	 al.	 2012),	which	 is	 suggestive	 for	 an	 involvement	 of	
TWIST1	and	GATA4	in	pro-inflammatory	signalling	and	subsequently	atherogenesis.	
TWIST1	 induction	 of	 partial	 EMT	 in	 tubular	 cells	 promotes	 inflammatory	 cell	
infiltration,	 leading	 to	 renal	 fibrosis	 (Lovisa	 et	 al.	 2015),	 thus	 providing	 a	 link	
between	 TWIST1	 and	 the	 induction	 of	 inflammation.	 In	 addition,	 GATA4	 protein	
expression	was	detected	 in	 inflammatory	bowel	disease	tissue	(Haveri	et	al.	2009),	
which	 indicates	 the	 potential	 involvement	 of	 GATA4	 in	 inflammation.	 In	 addition,	
GATA4	was	shown	to	promote	inflammation	via	NF-κB	and	the	release	of	interleukin	
6	(IL-6)	which	subsequently	promoted	cellular	senescence	in	fibroblasts,	in	response	
to	 DNA	 damage	 (Kang	 et	 al.	 2015).	 Senescence	 is	 activated	 by	 low	 WSS	 in	 EC	
(Warboys	et	al.	2014),	therefore	GATA4-mediated	senescence	in	EC	exposed	to	low	
WSS	could	be	a	mechanism	by	which	it	promotes	EC	dysfunction	and	atherogenesis.	
	
TWIST1	 and	 GATA4	 could	 be	 regulating	 inflammation	 and	 atherosclerosis	 through	
EndMT.	Chen	et	al.	proposed	that	a	reduction	in	FGF	signaling	triggers	an	increase	in	
TGF-β,	 which	 in	 turn	 triggers	 EndMT,	 including	 an	 increase	 in	 proatherogenic	
fibronectin	expression.	Additionally	Chen	et	al.	have	shown	that	EndMT	potentiates	
atherosclerosis	 development,	 as	 evidenced	 by	 an	 increase	 in	 lesion	 size	 in	
atherogenic	mice	with	an	EC-specific	deletion	of	FGF	receptor	adaptor	protein	FRS2α	
(FRS2αECKO	 Apoe–/–).	 TWIST1	 and	 GATA4	 interact	 with	 FGF	 and	 TGF-β	 signalling	
during	 embryonic	 development	 (Connerney	 et	 al.	 2008;	 Loebel	 et	 al.	 2002;	
Moskowitz	et	al.	2011;	Chen	et	al.	2014;	O’Rourke	et	al.	2002).	Specifically,	TWIST1	is	
activated	 by	 FGF	 signaling	 (in	 combination	 with	 SHH)	 and	 regulates	 the	 balance	
between	 FGF	 and	 TGF-β	 signaling	 during	 gastrulation.	 Thus	 GATA4-	 TWIST1	
activation	in	EC	exposed	to	low	WSS	could	promote	atherogenesis	through	reducing	
FGF	 signaling	 and	 increasing	 TGF-β	 signaling	 (Bialek	 et	 al.	 2004;	 Connerney	 et	 al.	
2008;	Loebel	et	al.	2002;	Rice	et	al.	2010).	Future	studies	should	include	testing	the	
effect	of	Twist1	and	GATA4	on	EC	 inflammation	at	 low	WSS	sites	and	by	assessing	
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lesion	 formation	 and	 plaque	 composition	 in	 EC-specific	 TWIST1	 and/or	 GATA4	
atherogenic	mice.	
5.10.10	Potential	therapeutic	strategies	to	inhibit	TWIST1	and	GATA4	induction	of	
EC	dysfunction.	
TWIST1	and	GATA4	are	both	prominent	oncogenes,	which	drive	cancer	cell	survival	
and	metastasis	(Chia	et	al.	2015;	Yang	et	al.	2004;	Tagaki	et	al.	2014).	Thus,	both	of	
these	 transcription	 factors	 are	 key	 anti-cancer	 drug	 targets.	 There	 are	 several	
potential	 inhibitory	 drugs	 that	 have	 been	 tested	 for	 the	 targeting	 of	 TWIST1	 and	
GATA4	 in	 cancer	 cells	 (summarised	 in	 table	 11).	 These	 drugs	 include	 widely	 used	
EndMT	inhibiting	drugs	LY364947	and	SB431542,	which	inhibit	Twist1	activation	and	
subsequent	 TGFβ2	 signalling	 (Xue	 et	 al.	 2012).	 These	 drugs	 may	 be	 useful	 in	
potentially	 reducing	 or	 preventing	 atherosclerosis	 in	 human	 patients.	 However,	
although	 Twist1	 and	GATA4	 inhibitory	 drugs	 have	 been	 shown	 to	 be	 successful	 in	
reducing	 EndMT-mediated	 fibrotic	 conditions	 and	 by	 limiting	 cancer	 cell	 survival,	
they	 are	 not	 Twist1	 and	 GATA4	 specific,	 since	 they	 inhibit	 either	 upstream	 or	
downstream	 signalling	 events.	 Therefore,	 these	 drugs	 may	 have	 off-target	
detrimental	effects.	However,	GATA4	and	Twist1-	specific	small	molecule	 inhibitors	
are	 under	 development	 (El-Hachem	&	Nemer	 2011;	 Burns	 et	 al.	 2013)	 using	 such	
drugs	 could	 a	 potential	 intervention	 for	 inhibiting	 GATA4-Twist1-mediated	 EC	
dysfunction	and	potential	atherogenesis.	
	
Another	 caveat	 in	 inhibiting	 GATA4-Twist1	 signalling	 is	 that	 the	 activation	 of	 this	
pathway	 preferentially	 occurred	 in	 EC	 at	 sites	 of	 low	 WSS,	 thus	 the	 therapeutic	
intervention	should	be	targeted	to	EC	at	 low	WSS	sites.	Recently,	a	study	by	the	Jo	
group	has	demonstrated	that	therapeutics	can	be	targeted	to	EC	at	low	WSS	sites	via	
utilising	 the	 increased	 VCAM-1	 expression	 on	 EC	 surface	 at	 low	WSS	 sites,	 the	 Jo	
group	 developed	 anti-cationic	 lipoparticles	 (CCLs)	 containing	 anti-miR-712	 and	
coated	with	a	VCAM-1	targeting	peptide	(VHPK).		The	CCLs	efficiently	delivered	anti-
miR-712	 and	 resulted	 in	 a	 marked	 reduction	 in	 low	WSS-mediated	 atherogenesis	
(Kheirolomoom	et	al.	2015).	The	use	of	CCLs	to	deliver	specific	Twist1	and/or	GATA4	
specific	inhibitors	could	be	a	novel,	promising	therapeutic	strategy	to	either	limit	or	
prevent	focal	atherosclerosis.		 	
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Table	11.	Summary	of	TWIST1	and	GATA4	inhibitory	drugs	
													 	
Drug	 Target/mechanism	 Reference	
LY-364947/	
SB-431542	
	
Inhibi'on	of	TWIST11-mediated	ac'va'on	of	
TGFβ-2	and	EndMT	
Xue	et	al.,	2012	
Maddaluno	et	al.,	2013	
Paclitaxel	
	
•  Inhibi'on	of	TWIST1	protein	and	mRNA	
•  Inhibits	cancer	cell	prolifera'on	
•  Mechanismof	ac'on	is	unknown	
Yu	et	al.,	2009	
	
Curcumin	
(Component	of	
Tumeric	
Inhibi'on	of	TWIST1	protein	expression	
through		inhibi'ng	NF-kB-Snail	axis	
	
Tao	Huang	et	al.,	2012	
	
MeHormin	 Inhibi'on	of	KLF5/GATA4/GATA6	target	genes	
and	cancer	prolifera'on	
Chia	et	al.,	2015	
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5.12	Future	work	
1. To	assess	GATA4	and	SNAIL	expression	in	human	coronary	tissue	sections	and	
in	low	WSS	sites	of	LDLR-/-	animals	vs.	controls.	
	
2. To	 determine	 the	 mechanism	 by	 which	 TWIST1	 and	 GATA4	 promote	 EC	
proliferation,	 target	 gene	 expression	 in	 the	murine	 aorta	 at	 regions	 of	 low	
and	high	WSS	will	be	carried	out,	followed	by	the	generation	of	gene-specific	
knock	outs	and	the	assessment	of	subsequent	cell	proliferation.	
	
3. To	dissect	whether	the	effect	of	Twist1	and	GATA4	on	cell	proliferation	is	via	
SNAIL-mediated	EndMT,	Twist1	and	Gata4	KO	mice	can	be	treated	with	Snail	
siRNA	or	cDNA	to	assess	the	involvement	of	Snail	signalling	on	the	effects	on	
cell	proliferation	and	on	EndMT	at	sites	of	low	WSS	in	the	murine	aorta.	
	
4. To	assess	whether	TWIST1	and	GATA4	control	cell	permeability	at	sites	of	low	
WSS.		
	
5. To	determine	whether	the	effects	of	TWIST1	and	GATA4	on	cell	proliferation	
is	 promoting	 EC	 dysfunction	 and	 atherogenesis,	 SCL-Cre-ERT;	 GATA4KO	 and	
Tie2-Twist1KO	animals	would	be	crossed	with	atherogenic	LDLR-/-	animals	and	
given	 a	 high	 fat	 diet.	 Lesion	 formation	 and	 plaque	 composition	 in	 the	 KO	
animals	 compared	 to	 the	 controls	will	 be	used	as	 a	measuring	of	 assessing	
atherogenesis.	
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Chapter	6:	General	discussion	
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6.1	Mechanical	TWIST1	activation	has	divergent	effects	during	
development	and	disease	
TWIST1	 and	 GATA4	 mechanotransduction	 is	 central	 to	 cell	 function	 in	 multiple	
contexts	 (Figure	 55);	 it	 is	 involved	 in	 gastrulation	 and	 organ	 development	 in	 the	
embryo.	 During	 morphogenesis	 in	 the	 Drosophila	 embryo,	 tissue	 deformations	
activate	TWIST1	via	a	mechanism	involving	Src42A-dependent	nuclear	translocation	
of	 β-catenin	 (Desprat	 et	 al.	 2008).	 TWIST1	 then	 subsequently	 promotes	 tissue	
differentiation.	 Additionally,	 TWIST1	 and	 SNAIL	 control	Drosophila	 gastrulation	 by	
first	 promoting	 apical	membrane	 tension,	 which	 is	 important	 for	 the	 induction	 of	
mesoderm	invagination	(Seher	et	al.	2007;	Pouille	et	al.	2009).		
	
Vascular	development	involves	the	induction	of	angiogenic	sprouting	and	the	cellular	
processes	migration	and	proliferation	are	key	to	this	step	(Ellertsdóttir	et	al.	2010).	
Since	 vascular	 development	 occurs	 prior	 to	 the	 onset	 of	 cardiac	 contraction,	 the	
process	of	angiogenic	sprouting	occurs	in	the	absence	of	flow.	The	subsequent	onset	
of	flow	influences	vascular	maturation	by	altering	EC	physiology.	For	example,	it	has	
been	 shown	 that	 during	 chick	 embryogenesis,	 the	 enhancement	 of	WSS	 inhibited	
sprouting	 angiogenesis,	 whereas	 the	 reduction	 of	 WSS	 enhanced	 this	 process	
(Chouinard-Pelletier	 et	 al.	 2013).	 Work	 from	 our	 group	 has	 shown	 that	 in	 the	
developing	 zebrafish	 embryo	 twist1	 mechano-regulation	 is	 important	 in	 vascular	
development.	 Zebrafish	 possess	 three	 orthologues	 of	 mammalian	 twist	 genes;	
twist1b,	 twist1a	 and	 twist2.	 In	 situ	 hybridisation	 revealed	 that	 each	 of	 them	was	
expressed	in	the	trunk	vasculature	before	cardiac	contraction	(Figures	56	A-56	C;	24	
hpf).	 twist	 expression	was	 reduced	 following	 the	onset	of	 flow	 in	 control	 embryos	
but	was	maintained	in	troponin	T	type	2	(tnnt2)	morphants	that	lack	flow	(Fig.	56	A-
56	C;	52hpf). The	function	of	twist	was	studied	by	enhancing	its	expression	in	vessels	
exposed	to	flow	via	injection	of	mRNA	(gain-of-function).	This	revealed	an	increase	in	
EndMT	marker	Snail	and	N-cadherin	expression	(Figures	56	D	and	56	E),	suggesting	
that	twist	regulates	EndMT	in	the	absence	of	flow.		
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Figure	55.	Schematic	of	Twist1	and	GATA4	mechanical	activation	in	embryonic	and	adult	systems			
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Figure	 55.	 Schematic	 summary	 of	 TWIST1	 and	 GATA4	 mechanical	 activation	 in	
embryonic	and	adult	systems.		
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Figure	 56.	 twist	 expression	 was	 downregulated	 by	 flow	 in	 zebrafish	 embryonic	 vasculature.	 The	
influence	 of	 flow	on	 twist	 expression	was	 studied	 using	 zebrafish	 embryos	 that	 were	 treated	with	
tnnt2	MOs	 to	 suppress	 cardiac	 contraction	or	 remained	untreated	as	a	 control.	 (A)	The	boxed	area	
identifies	the	region	studied	(Dorsal	aorta	and	posterior	caudinal	vein).	In	situ	hybridisation	analysis	of	
twist1b	 (A),	twist1a	 (B)	or	twist2	 (C)	 in	embryos	at	24	–	75	hpf.	Note	 that	 flow	was	 initiated	 in	the	
trunk	at	26	hpf	in	wild-type	fish.	Scale	bar,	100	mm.	(D-E)	Zebrafish	embryos	(wild-type	with/without	
Tg(fli1:EGFP)	 or	 Tg(kdrl:NLS-EGFP))	 were	 treated	 with	 twist1b	 mRNA	 (to	 enforce	 expression)	 or	
treated	with	mCherry	mRNA	as	a	control	 (D)	 In	situ	hybridisation	analysis	of	snail1a	 (E)	Fluorescent	
immunostaining	 of	 N-cadherin	 in	 transgenic	 Tg(fli1:EGFP)	 fish	 (EGFP-positive	 endothelium).	 F)	
Confocal	microscopy	was	used	 to	visualise	EC	nuclei	 (Tg(kdrl:NLS-EGFP);	upper	panel)	or	angiogenic	
sprouts	 (Tg(fli1:EGFP);	 lower	panels;	 arrows).	Representative	 images	are	 shown.	Cell	numbers	were	
quantified	in	multiple	embryos	and	mean	values	+/-	SEM	are	shown	(upper	right	panel).	The	length	of	
ISVs	(3rd	-5th	vessels	in	the	field	view)	was	quantified	using	image	J	software.	Data	were	collected	from	
multiple	embryos	and	mean	values	+/-	SEM	are	shown	(lower	 right	panel).	 ****	p<0.0001	using	an	
unpaired	t-test.	Scale	bar,	100	mm.	(A-E)	Data	are	representative	of	the	majority	of	embryos	analysed	
(proportion	indicated	lower	right	of	each	panel)	and	were	closely	similar	in	at	least	three	independent	
experiments.	These	data	were	generated	by	Dr.	Rosemary	Kim	in	Evan’s	laboratory.	
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Figure	56.	twist	expression	was	downregulated	by	flow	in	zebrafish	embryonic	vasculature	
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In	addition,	twist	injection	increased	proliferation	and	sprouting	(Figure	53	F).	These	
results	revealed	that	twist	controls	vascular	sprouting	and	EndMT	in	the	absence	of	
flow.	Therefore	modulation	of	the	Twist1-Snail	activation	by	WSS	plays	an	important	
role	in	regulating	angiogenic	sprouting	in	the	developing	zebrafish.	
	
	In	 the	 adult,	 TWIST1	 mechanotransduction	 is	 involved	 in	 promoting	 cancer	
metastasis	 (Yang	 et	 al.	 2004).	 GATA4	 is	 important	 in	 regulating	 mechanically	
controlled	 tissue	 homeostasis,	 as	 it	 is	 central	 to	 the	 transcriptional	 induction	 of	
cardiac	hypertrophy	following	mechanical	load	of	the	heart	ventricles	(Tenhunen	et	
al.	2004).	 	My	studies	have	 shown	 that	 in	adult	EC,	 low	WSS	activates	 the	GATA4-	
TWIST1-SNAIL	 axis	 and	 that	 GATA4-TWIST1	 promoted	 EC	 proliferation	 and	
permeability.	 Since	high	WSS	 inhibited	GATA4-TWIST1	activation	 in	 the	developing	
zebrafish	 and	 in	 adult	 EC,	 this	 indicates	 that	 there	 are	 parallels	 in	 TWIST1	
mechanotransduction	 in	 response	 to	WSS	 in	 both	 embryonic	 development	 and	 in	
focal	EC	dysfunction	 in	the	adult.	 It	could	be	argued	that	EC	responses	at	 low	WSS	
sites	 are	 a	 reflection	of	 an	early	 embryonic	 stage	before	 the	onset	of	 flow	 (Figure	
57).	
	
The	mechanism	that	drives	conserved	TWIST1	activation	in	embryo	and	adult	vessels	
should	 be	 considered.	 It	 is	 plausible	 that	 In	 the	 adult,	 EC	 retain	 “memory”	 of	 the	
WSS-mediated	cues	that	they	have	received	during	development.	This	results	 in	EC	
at	 low	 WSS	 displaying	 enhanced	 EC	 proliferation	 and	 migration,	 leading	 to	
permeability,	EC	dysfunction	and	atherogenesis.	Whereas,	this	process	is	inhibited	in	
EC	exposed	 to	high	WSS	 sites.	 Therefore,	 it	 can	be	proposed	 that	EC	 responses	 to	
flow	under	low	WSS	are	default,	whereas	responses	to	high	WSS	result	in	a	change	in	
EC	transcriptional	activity	and	function.	
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Figure	 57.	 Model	 for	 activation	 of	 GATA4-Twist1	 by	 WSS	 in	 developmental	 angiogenesis	 and	 EC	
dysfunction	in	the	adult	
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Figure	 57.	Model	 for	 activation	 of	 GATA4-TWIST1	 by	WSS	 in	 developmental	 angiogenesis	
and	EC	dysfunction	in	the	adult.	Low wall shear stress (WSS) induces Twist1 via GATA4. 
This process promotes EC proliferation and migration to drive angiogenesis (left). The 
development of a patent vessel allows blood flow which exerts high WSS on the vessel 
wall. This mechanical stimulus suppresses further angiogenic sprouting by inhibiting 
Twist expression. In adult arteries, low WSS at branches and bends triggers GATA4-
Twist1 induction which drives proliferation and enhanced permeability leading to 
atherosclerosis.	
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The	 antagonistic	 pleiotropy	 hypothesis	 coined	 by	 George	 C.	 Williams	 in	 1957	 to	
explain	 the	 evolutionary	 significance	of	 the	occurrence	of	 cellular	 senescence,	 is	 a	
description	 that	 is	 given	 to	 a	 gene	 or	 pathway	 that	 controls	 multiple	 traits	 in	 an	
organism,	 where	 one	 of	 these	 traits	 is	 beneficial	 to	 the	 organism’s	 fitness	 during	
development	and	one	trait	 is	detrimental	after	child-bearing	years	(Williams	1957).	
Although	 it	 is	 understood	 how	 low	 WSS	 promotes	 EC	 dysfunction,	 it	 is	 not	
understood	 “why”	 low	 WSS	 triggers	 EC	 dysfunction	 and	 subsequently	
atherosclerosis.	I	propose	that	there	is	an	evolutionary	explanation	to	EC	responses	
to	 low	WSS,	 where	 GATA4-	 TWIST1	 mechanotransduction	 in	 EC	 is	 an	 example	 of	
antagonistic	 pleiotropy.	 Whilst	 Twist1	 mechanotransduction	 promotes	 vascular	
development	 in	 the	 embryo,	 it	 also	 contributes	 to	 focal	 EC	 dysfunction	 and	
potentially	 atherogenesis	 in	 the	 adult,	 following	 childbearing	 years.	 TWIST1	
mechanoactivation	 in	 tumour	 metastasis	 and	 cancer	 cell	 survival	 could	 be	 other	
examples	of	Twist1	antagonistic	pleiotropy.	
	
6.1.1	Does	GATA4-TWIST1	re-activation	in	adult	EC		promote	repair	in	response	to	
low	WSS-mediated	injury?	
A	second	mechanism	for	the	activation	of	GATA4-	TWIST1	signalling	at	EC	located	at	
low	WSS	 sites	 in	 the	 adult	 vasculature	 could	 be	 to	 promote	 repair	 in	 response	 to	
injury.	It	was	proposed	by	Fry	et	al.,	in	1969	that	cell	injury	as	a	result	of	blood	flow	
is	 a	 causal	 factor	 for	 the	 spatial	 distribution	 of	 EC	 dysfunction	 and	 atherosclerosis	
(Fry	 1969).	 It	 was	 later	 revealed	 that	 EC	 at	 low	 WSS	 are	 dysfunctional	 as	 a	
consequence	 of	 the	 induction	 of	 an	 injury/	 stress	 response	 (Civelek	 et	 al.	 2009;	
Davies	 2009).	 Furthermore,	 Davies	 et	 al.	 proposed	 that	 responses	 to	 low	 WSS-
mediated	 stress	 triggers	 “a	 chronic	 low-level	 inflammatory	 state,	 an	 adaptive	
response	to	ensure	continued	function	at	the	expense	of	increased	susceptibility	to	
atherogenesis”	(Davies	et	al.	2009).			
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TWIST1	and	GATA4	signaling	and	subsequent	changes	in	cell	function	such	as	EndMT	
have	all	been	linked	with	responses	to	cell	injury	and	cell	plasticity	(Curci	et	al.	2014;	
Gupta	 et	 al.	 2013;	Heineke	et	 al.	 2007;	Mammoto	et	 al.	 2013;	 Lovisa	 et	 al.	 2015).	
Interestingly,	GATA4	and	TWIST1	activation	in	response	to	injury	in	renal	or	cardiac	
cells	promoted	repair	via	proliferation	(Heineke	et	al.	2007;	Lovisa	et	al.	2015).	This	
subsequently	 promoted	 cell	 proliferation	 and	 inflammation.	 It	 could	 be	 proposed	
that	EC	at	low	WSS	sites	are	responding	to	low	WSS-mediated	injury	by	“switching”	
to	 a	 more	 plastic	 transcriptional	 network,	 that	 is	 controlled	 by	 GATA4-	 TWIST1	
signalling,	which	could	be	controlling	EC	repair	via	proliferation.		
	
One	 potential	mechanism	 for	 the	 proliferative,	 repair	 process	 could	 partly	 involve	
the	 induction	 of	 an	 angiogenic	 response.	 This	 notion	 is	 supported	 by	 studies	 that	
demonstrated	 that	 angiogenic	 activation,	 involving	 the	 induction	 of	 proliferation	
occurs	 following	an	 injury	stimulus	 (Reviewed	 in	Khurana	et	al.	2005;	Heinke	et	al.	
2007).	 Studies	 by	 the	 Jones	 lab	 provide	 evidence	 for	 the	 role	 of	 low	 WSS	 is	
promoting	 angiogenesis	 in	 the	 developing	 chick	 (Chouinard-Pelletier	 et	 al.	 2013).	
Consistent	with	 this,	 studies	 in	 the	developing	 zebrafish	by	our	 laboratory	 showed	
that	TWIST1	controlled	angiogenesis	and	EndMT	and	that	this	process	was	inhibited	
by	high	WSS.	Therefore	there	seems	to	be	supportive	evidence	for	the	activation	of	
angiogenesis	 by	 low	WSS.	 TWIST1	 and	 GATA4	 control	 angiogenesis	 and	 are	 both	
upstream	activators	of	pro-angiogenic	VEGFR2	(Li	et	al.	2014;	Kamei	et	al.	2011).	My	
studies	have	shown	that	TWIST1	and	GATA4	control	tube	formation	under	low	WSS	
and	 that	 they	 are	 activators	 of	 partial	 EndMT,	 a	 process	 that	 is	 known	 to	 occur	
during	 angiogenesis	 (Reviewed	 in	 Welch-Reardon.	 2014).	 Taken	 together,	 the	
activation	of	GATA4-TWIST1	signalling	under	low	WSS	could	be	promoting	repair	 in	
response	to	low	WSS-mediated	injury,	this	process	may	involve	some	aspects	of	cell	
behavior	such	as	proliferation	that	are	linked	to	angiogenesis.		
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The	 induction	of	partial	EndMT	by	GATA4	and	TWIST1	could	also	be	promoting	EC	
repair	 via	 inflammation,	 which	 is	 known	 to	 be	 activated	 in	 response	 to	 injury	
(Reviewed	 in	 Libby	 2002;	 Davies	 et	 al.	 2009).	 It	 was	 recently	 shown	 that	
atherosclerosis-mediators-	 low	WSS	 and	 inflammatory	 cytokines	 have	 an	 additive	
effect	 on	 promoting	 EndMT,	 once	 active,	 EndMT	 potentiates	 atherosclerosis	
development	 (Chen	 et	 al.	 2015).	 Furthermore,	 Lovisa	 et	 al.	 showed	 that	 TWIST1-
mediated	 partial	 EMT	 controlled	 inflammatory	 activation	 and	 renal	 fibrosis.	 These	
studies	 provide	 evidence	 for	 the	 role	 of	 EndMT	 in	 promoting	 inflammation	 and	
atherosclerosis.	Therefore	partial	EndMT	induction	by	GATA4-	TWIST1	could	trigger	
EC	dysfunction	via	EC	proliferation	and	permeability,	which	 in	 turn	gives	 rise	 to	an	
“unwanted”	consequence	of	inflammation	and	atherosclerosis.	
	
6.2	TWIST1	and	GATA4	may	regulate	EC	mechanosensing	in	response	
to	low	WSS	
VE-cadherin	 is	 part	 of	 a	 cell	 surface	 complex	 in	 EC	with	 CD31	 and	 VEGFR2,	which	
together	 mediate	 EC	 mechanosensing	 in	 response	 to	 WSS	 (Tzima	 et	 al.,	 2005,	
Conway	 et	 al.,	 2013).	 This	 mechanosensory	 complex	 relays	 mechanical	 cues	 to	
integrins,	which	subsequently	activate	signalling	pathways	depending	on	the	context	
(Tzima	 et	 al.	 2005;	 Orr	 et	 al.	 2006).	 I	 have	 shown	 that	 GATA4-	 TWIST1	 activation	
promoted	an	increase	in	N-cadherin	junctional	expression	and	increased	VE-cadherin	
junctional	width,	which	is	indicative	of	VE-cadherin	endocytosis	and	disorganisation	
(Huveneers	 et	 al.	 2012;	 Orsenigo	 et	 al.	 2012;	 Miao	 et	 al.	 2005).	 Therefore,	 the	
modulation	 of	 cadherin	 expression	 could	 be	 influencing	 EC	 mechanosensing.	
Recently,	the	Schwartz	lab	studied	the	relative	contribution	of	VE	and	N-cadherin	to	
EC	mechanosensing	by	studying	EC	alignmnent	in	response	to	WSS	in	VE-cadherin-/-	
null	 cells,	 transfected	 with	 a	 lentivirus	 for	 N-cadherin	 or	 VE-cadherin	 (Coon	 et	 al.	
2015).	They	showed	that	whilst	VE-cadherin	expressing	cells	showed	an	alignment	in	
the	 direction	 of	WSS,	 N-cadherin	 expression	 completely	 abrogated	 cell	 alignment.	
Furthermore,	they	showed	that	OSS-mediated	activation	of	VCAM-1	expression	was	
mediated	by	VE-cadherin-VEGFR2/3	mechanosensing,	whereas	N-cadherin	inhibited	
VCAM-1	expression	(Coon	et	al.	2015).	Thus,	it	seems	as	though	N-cadherin	inhibits	
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EC	 mechanoresponses,	 via	 a	 possible	 mechanism	 involving	 integrins.	 Therefore,	
increased	 N-cadherin	 expression	 via	 GATA4-	 TWIST1	 in	 EC	 exposed	 to	 low	 WSS,	
could	 be	 modulating	 EC	mechanosensing	 via	 promoting	 a	 “no-flow”	 EC	 response.	
This	could	be	involved	in	driving	EC	dysfunction	and	potentially	atherogenesis.		
	
VE-	 and	N-cadherin	 balance	 is	 involved	 in	 the	 control	 of	 angiogenesis.	 N-cadherin	
promotes	 angiogenic	 processes	 including	 proliferation	 and	migration,	whereas	 VE-
cadherin	 inhibits	 these	 events	 (Giampietro	 et	 al.	 2012;	 Bentley	 et	 al.	 2014).	 This	
could	 therefore	 be	 a	mechanism	 by	which	GATA4-	 TWIST1	 signalling	 is	 promoting	
angiogenic	sprouting	in	the	developing	zebrafish	embryo	and	EC	dysfunction	in	adult	
EC.	 More	 work	 is	 required	 to	 dissect	 the	 downstream	 mechano-signalling	 and	
changes	 in	 EC	 function	 that	 occurs	 following	 the	 stimulation	 of	 N-cadherin	
expressing	cells	with	low	or	high	WSS,	along	with	the	significance	to	atherosclerosis.	
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Appendix	1.	Growth	media	constituents	
Media	name	 Serum	content	 Antibiotics	 Supplements	
	
Complete	M199	
growth	medium	
	
20%	FBS	
(Unless	specified	
otherwise)	
100U/ml	Pen-strep	
10	μg/ml	
Amphotericin	B	
	
5	mM	L-
Glutamine.	
25μg/ml	ECGF	
90μg/ml	heparin	
	
	
Transfection	media	
complete	M199	
growth	medium	
	
10%FBS	
-	 5	mM	L-
Glutamine.	
25μg/ml	ECGF	
90μg/ml	heparin	
	
Complete	DMEM	
(With	1g/L	glucose)	
growth	medium	1	
	
10%	FBS	
100U/ml	Pen-strep.	
10	μg/ml	
Amphotericin	B.	
100μg/ml	
Gentamycin	
5	mM	L-
Glutamine.	
25μg/ml	ECGF	
90μg/ml	heparin	
	
	
Complete	DMEM	
(With	1g/L	glucose)	
growth	medium	2	
	
20%	FBS	
100U/ml	Pen-strep.	
10	μg/ml	
Amphotericin	B	
	
5	mM	L-
Glutamine.	
25μg/ml	ECGF	
90μg/ml	heparin	
	
(Transport	media)	
PBS		
-	 100U/ml	Pen-strep.	
10	μg/ml	
Amphotericin	B	
100μg/ml	
Gentamycin	
-	
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ABC-	Avidin-biotin	complex	
ApoE-	Apolipoprotein	E	
bHLH-beta-Helix-Loop-Helix	
BMP-	Bone	morphogenic	protein	
CD31-	Cluster	of	differentiation	31	
CDC42-	Cell	division	control	protein	42	homolog	
Cdk4-	Cyclin-dependent	kinase	4	
ChIP-	Chromatin	immunoprecipitation	
COUP-TFII-	COUP	transcription	factor	2	
Tal-	T-Cell	Acute	Lymphocytic	Leukemia	1	
CREB-	cAMP	response	element-binding	protein	
DAB-3,3ʹ-Diaminobenzidine	
DAPI-4',6-diamidino-2-phenylindole	
Dnmt-	DNA	methyltransferase	
EC-	Endothelial	cells	
ECM-Extracellular	matrix	protein	
PDGFRα-Platelet	derived	growth	factor-α	
EFnb2-	Ephrin-B2	
EMT-	Epithelial	mesenchymal	transition	
EndMT-	Endothelial	mesenchymal	transition	
eNOS-	endothelial	Nitric	oxide	synthase	
Ephb4-	EPH	Receptor	B4	
ERBB3-	Epidermal	growth	factor	receptor	tyrosine	kinase	3	
ERK-	extracellular-signal-regulated	kinases	
FGF-	Fibroblast	growth	factor	
FOG-	Friend	of	GATA	
Fzd-	Frizzled	
Gadd45a-growth	arrest	and	DNA-damage-Inducible,		45	α	
GATA2-GATA-binding	protein	
HAT-Histone	acetyltransferase	
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HDAC-	Histone	deacetylase	
HIF-1α-Hypoxia	inducible	factor-α	
FOG	2-	Hepatocyte	nuclear	factor	
HOX	-Homeobox	binding	protein	
HUVEC-	Human	umbilical	vein	EC	
ICAM1-	intercellular	Adhesion	Molecule		
ID1-	inhibitor	of	DNA	binding-1	
IL-1-	Interleukin-1	
JAK/STAT-	Janus	kinase/	Signal	Transducer	and	Activator	of	Transcription	
JNK-	c-Jun	N-terminal	kinases	
KLF-	Kruppel-like	factor	
LDL-	Low	density	lipoproteins	
LDLR-	lipoprotein	receptor	
MAPK-	Mitogen-activated	protein	kinases	
MCP-1-	Monocyte	chemoattractant	protein-1	
Mef2c-	myocyte	enhancer	factor	2C	
MEK-MAPK/ERK	kinase	
MEndT-Mesenchymal-endothelial	transition	
miR-micro	RNA	
MMP-	Matrix	metalloproteinase	
MO-	Morpholino	
MYB-	Myeloblastosis	transcription	factor		
N-cadherin-	neuronal	cadherin	
NF-κB	-	Nuclear	factor	kappa-light-chain-enhancer	of	activated	B	cells	
NFAT-	nuclear	factor	of	activated	T-cells	
Nkx2.5-NK2	homeobox	5		
NLS-	nuclear	localisation	signal	
NO-	nitric	oxide	
Nrf2-	nuclear	factor	(erythroid-derived	2)-like	2	
nSLCC-Non-small	lung	cell	carcinoma		
OB-cadherin-	Osteoblast	cadherin	
Ox-LDL-	Oxidised	LDL	
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PAEC-Porcine	aortic	EC	
PCAF-	P300/CBP-associated	factor	
PCR-Polymerase	chain	factor	
PI3K-	Phosphatidylinositol-4,5-bisphosphate	3-kinase	
qRT-PCR-	quantitative	real	time	PCR	
Rb-	Retinablastoma	
Re-	Reynolds	
ROS-	Reactive	oxygen	species	
SCL-	Stem	cell	leukemia		
SHH-	Sonic	hedhehog	
SMA-	Smooth	muscle	cell	actin	
SNP-	Single	nucleotide	polymorphism	
Srf-	Serum	response	factor		
SRPX	-Sushi-repeat	containing	protein,	X-linked	
Tbx-T-Box	protein	
TGF-β-	Transforming	growth	factor	β	
TNF-a-	Tumour	necrosis	factor	a	
Tnnt2-	troponin	type	2	
VCAM1-	Vascular	cell	adhesion	protein	-1	
VE-cadherin-	Vascular	endothelial	cadherin	
VEGFR2-	Vascular	endothelial	growth	factor	receptor	2	
VHPK	-VCAM-1	targeting	peptide	
VIC-	Valve	interstitial	cells	
vWF-von	Willibrand	factor	
WSS-	Wall	shear	stress	
ZFN-	Zinc	finger	domain							 	
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